,words,labels,sentence_id,full sentence
14028,Other,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14029,food,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14030,ingredients,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14031,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14032,including,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14033,starch,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14034,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14035,malt,B-http://purl.bioontology.org/ontology/SNOMEDCT/710180001,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14036,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14037,alcohol,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14038,and,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14039,vinegar,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14040,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14041,may,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14042,be,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14043,derived,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14044,in,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14045,some,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14046,cases,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14047,from,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14048,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14049,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14050,rye,B-http://purl.bioontology.org/ontology/SNOMEDCT/412068007,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14051,or,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14052,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14053,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14054,the,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14055,grains,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14056,that,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14057,are,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14058,implicated,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14059,in,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14060,the,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14061,causation,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14062,of,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14063,celiac,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14064,disease,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14065,.,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14287,The,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14288,prospective,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14289,part,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14290,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14291,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14292,study,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14293,was,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14294,performed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14295,on,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14296,103,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14297,birch,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14298,pollen,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14299,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14300,hypersensitive,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14301,patients,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14302,who,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14303,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14304,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14305,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14306,free,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14307,at,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14308,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14309,time,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14310,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14311,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14312,first,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14313,visit,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14314,and,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14315,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14316,periodically,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14317,followed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14318,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14319,up,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14320,for,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14321,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14322,.,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14478,All,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14479,cases,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14480,of,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14481,cancer,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14482,(,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14483,n,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14484,=,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14485,389,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14486,),O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14487,and,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14488,polyps,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14489,(,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14490,n,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14491,=,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14492,252,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14493,),O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14494,were,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14495,incident,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14496,and,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14497,histologically,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14498,confirmed,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14499,.,O,481.0,All cases of cancer ( n = 389 ) and polyps ( n = 252 ) were incident and histologically confirmed .
14741,It,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14742,orchestrates,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14743,metabolic,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14744,responses,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14745,to,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14746,feeding,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14747,by,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14748,secreting,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14749,factors,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14750,essential,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14751,for,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14752,maintaining,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14753,metabolic,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14754,homeostasis,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14755,",",O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14756,converting,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14757,carbohydrates,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14758,to,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14759,triglycerides,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14760,for,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14761,storage,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14762,",",O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14763,and,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14764,releasing,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14765,lipids,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14766,packaged,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14767,as,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14768,lipoproteins,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14769,for,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14770,distribution,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14771,to,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14772,other,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14773,tissues,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14774,.,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
15173,Food,O,504.0,"Food cravings are extremely common , particularly among women ."
15174,cravings,O,504.0,"Food cravings are extremely common , particularly among women ."
15175,are,O,504.0,"Food cravings are extremely common , particularly among women ."
15176,extremely,O,504.0,"Food cravings are extremely common , particularly among women ."
15177,common,O,504.0,"Food cravings are extremely common , particularly among women ."
15178,",",O,504.0,"Food cravings are extremely common , particularly among women ."
15179,particularly,O,504.0,"Food cravings are extremely common , particularly among women ."
15180,among,O,504.0,"Food cravings are extremely common , particularly among women ."
15181,women,O,504.0,"Food cravings are extremely common , particularly among women ."
15182,.,O,504.0,"Food cravings are extremely common , particularly among women ."
15237,However,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15238,",",O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15239,studies,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15240,of,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15241,such,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15242,cravings,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15243,are,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15244,often,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15245,confounded,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15246,by,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15247,differing,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15248,sensory,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15249,properties,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15250,of,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15251,high,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15252,and,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15253,low,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15254,carbohydrate,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15255,foods,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15256,.,O,507.0,"However , studies of such cravings are often confounded by differing sensory properties of high and low carbohydrate foods ."
15257,There,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15258,is,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15259,some,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15260,evidence,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15261,that,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15262,sweet,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15263,",",O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15264,high,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15265,fat,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15266,foods,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15267,are,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15268,preferred,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15269,by,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15270,women,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15271,with,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15272,binge,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15273,-,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15274,eating,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15275,disorders,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15276,and,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15277,that,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15278,those,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15279,preferences,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15280,are,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15281,mediated,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15282,by,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15283,the,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15284,endogenous,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15285,opioid,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15286,system,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15287,.,O,508.0,"There is some evidence that sweet , high fat foods are preferred by women with binge - eating disorders and that those preferences are mediated by the endogenous opioid system ."
15444,The,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15445,administration,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15446,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15447,AMF,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15448,to,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15449,SHR,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15450,during,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15451,7,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15452,weeks,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15453,exerted,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15454,beneficial,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15455,effects,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15456,on,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15457,cardiovascular,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15458,risk,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15459,biomarkers,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15460,(,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15461,reduction,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15462,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15463,insulin,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15464,",",O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15465,blood,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15466,lipids,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15467,",",O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15468,increase,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15469,of,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15470,adiponectin,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15471,),O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
15472,.,O,515.0,"The administration of AMF to SHR during 7 weeks exerted beneficial effects on cardiovascular risk biomarkers ( reduction of insulin , blood lipids , increase of adiponectin ) ."
16055,The,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16056,T,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16057,pattern,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16058,was,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16059,characterized,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16060,by,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16061,low,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16062,dietary,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16063,diversity,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16064,",",O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16065,with,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16066,maize,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16067,and,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16068,maize,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16069,foods,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16070,accounting,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16071,for,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16072,~47,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16073,%,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16074,of,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16075,energy,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16076,intake,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16077,.,O,536.0,"The T pattern was characterized by low dietary diversity , with maize and maize foods accounting for ~47 % of energy intake ."
16078,This,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16079,pattern,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16080,had,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16081,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16082,lowest,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16083,contribution,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16084,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16085,most,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16086,food,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16087,groups,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16088,",",O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16089,with,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16090,the,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16091,exception,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16092,of,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16093,beans,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16094,(,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16095,~4.0,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16096,%,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16097,),O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16098,.,O,537.0,"This pattern had the lowest contribution of most food groups , with the exception of beans ( ~4.0 % ) ."
16644,The,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16645,addition,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16646,of,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16647,dairy,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16648,products,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16649,to,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16650,meals,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16651,high,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16652,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16653,carbohydrates,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16654,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16655,fat,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16656,may,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16657,lessen,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16658,these,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16659,risks,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16660,through,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16661,reductions,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16662,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16663,postprandial,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16664,glucose,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16665,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16666,triglyceride,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16667,responses,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16668,.,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16812,It,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16813,is,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16814,well,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16815,known,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16816,that,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16817,there,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16818,are,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16819,J,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16820,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16821,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16822,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16823,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16824,or,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16825,U,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16826,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16827,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16828,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16829,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16830,associations,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16831,of,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16832,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16833,consumption,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16834,with,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16835,cardiovascular,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16836,events,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16837,including,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16838,myocardial,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16839,infarction,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16840,and,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16841,stroke,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16842,.,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
17303,The,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17304,animals,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17305,were,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17306,fed,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17307,either,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17308,a,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17309,commercial,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17310,laboratory,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17311,chow,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17312,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17313,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17314,study,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17315,1,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17316,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17317,",",O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17318,containing,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17319,5,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17320,%,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17321,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17322,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17323,low,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17324,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17325,saturated,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17326,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17327,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17328,1.46,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17329,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17330,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17331,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17332,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17333,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17334,cholesterol,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17335,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17336,0.03,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17337,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17338,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17339,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17340,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17341,or,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17342,a,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17343,semi,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17344,-,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17345,synthetic,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17346,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17347,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17348,study,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17349,2,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17350,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17351,set,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17352,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17353,gelatine,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17354,",",O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17355,containing,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17356,10,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17357,%,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17358,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17359,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17360,high,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17361,in,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17362,saturated,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17363,fat,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17364,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17365,4,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17366,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17367,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17368,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17369,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17370,and,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17371,cholesterol,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17372,(,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17373,0.5,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17374,g/100,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17375,g,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17376,diet,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17377,),O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17378,.,O,578.0,"The animals were fed either a commercial laboratory chow diet ( study 1 ) , containing 5 % fat and low in saturated fat ( 1.46 g/100 g diet ) and cholesterol ( 0.03 g/100 g diet ) or a semi - synthetic diet ( study 2 ) set in gelatine , containing 10 % fat and high in saturated fat ( 4 g/100 g diet ) and cholesterol ( 0.5 g/100 g diet ) ."
17623,A,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17624,high,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17625,saturated,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17626,fat,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17627,/,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17628,high,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17629,cholesterol,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17630,diet,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17631,may,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17632,mask,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17633,the,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17634,hypercholesterolaemic,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17635,effect,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17636,of,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17637,coffee,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17638,lipids,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17639,.,O,588.0,A high saturated fat / high cholesterol diet may mask the hypercholesterolaemic effect of coffee lipids .
17640,Excess,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17641,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17642,fat,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17643,intake,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17644,leads,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17645,to,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17646,obesity,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17647,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17648,causes,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17649,a,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17650,variety,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17651,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17652,metabolic,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17653,diseases,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17654,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17655,cancer,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17656,.,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17872,A,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17873,growing,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17874,interest,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17875,has,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17876,emerged,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17877,in,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17878,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17879,beneficial,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17880,effects,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17881,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17882,plant,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17883,-,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17884,based,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17885,diets,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17886,for,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17887,the,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17888,prevention,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17889,of,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17890,cardiovascular,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17891,disease,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17892,",",O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17893,diabetes,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17894,and,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17895,obesity,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
17896,.,O,596.0,"A growing interest has emerged in the beneficial effects of plant - based diets for the prevention of cardiovascular disease , diabetes and obesity ."
18206,However,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18207,",",O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18208,nutrient,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18209,content,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18210,is,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18211,affected,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18212,by,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18213,cooking,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18214,method,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18215,;,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18216,boiling,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18217,causes,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18218,leaching,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18219,of,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18220,water,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18221,-,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18222,soluble,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18223,nutrients,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18224,",",O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18225,whereas,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18226,frying,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18227,can,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18228,increase,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18229,the,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18230,resistant,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18231,starch,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18232,content,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18233,of,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18234,the,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18235,cooked,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18236,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18237,.,O,609.0,"However , nutrient content is affected by cooking method ; boiling causes leaching of water - soluble nutrients , whereas frying can increase the resistant starch content of the cooked potato ."
18587,Beer,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18588,is,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18589,the,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18590,most,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18591,widely,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18592,consumed,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18593,alcoholic,B-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18594,drink,I-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18595,in,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18596,the,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18597,world,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18598,",",O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18599,but,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18600,it,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18601,is,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18602,not,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18603,suitable,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18604,for,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18605,patients,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18606,who,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18607,suffer,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18608,from,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18609,celiac,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18610,disease,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18611,(,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18612,CD,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18613,),O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18614,because,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18615,its,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18616,main,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18617,ingresdients,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18618,",",O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18619,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18620,or,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18621,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18622,",",O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18623,contain,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18624,gluten,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
18625,.,O,622.0,"Beer is the most widely consumed alcoholic drink in the world , but it is not suitable for patients who suffer from celiac disease ( CD ) because its main ingresdients , barley or wheat , contain gluten ."
19175,A,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19176,recent,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19177,case,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19178,-,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19179,control,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19180,study,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19181,reported,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19182,that,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19183,several,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19184,food,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19185,items,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19186,and,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19187,cooking,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19188,methods,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19189,are,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19190,associated,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19191,with,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19192,increased,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19193,or,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19194,decreased,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19195,risk,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19196,of,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19197,stomach,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19198,cancer,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19199,among,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19200,Koreans,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19201,.,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
20029,The,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20030,involved,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20031,mechanisms,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20032,included,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20033,protecting,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20034,vascular,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20035,endothelial,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20036,function,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20037,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20038,regulating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20039,lipids,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20040,metabolism,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20041,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20042,modulating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20043,blood,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20044,pressure,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20045,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20046,inhibiting,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20047,platelets,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20048,function,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20049,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20050,alleviating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20051,ischemia,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20052,/,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20053,reperfusion,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20054,injury,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20055,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20056,suppressing,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20057,thrombosis,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20058,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20059,reducing,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20060,oxidative,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20061,stress,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20062,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20063,and,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20064,attenuating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20065,inflammation,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20066,.,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20574,After,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20575,the,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20576,discovery,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20577,of,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20578,America,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20579,",",O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20580,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20581,was,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20582,introduced,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20583,in,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20584,Europe,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20585,",",O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20586,but,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20587,Christian,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20588,Europe,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20589,looked,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20590,to,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20591,this,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20592,new,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20593,exhilarating,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20594,drink,B-http://purl.bioontology.org/ontology/SNOMEDCT/230118003,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20595,with,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20596,extreme,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20597,suspiciousness,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20598,and,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20599,criticism,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20600,.,O,684.0,"After the discovery of America , chocolate was introduced in Europe , but Christian Europe looked to this new exhilarating drink with extreme suspiciousness and criticism ."
20633,However,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20634,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20635,during,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20636,the,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20637,Enlightment,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20638,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20639,the,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20640,road,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20641,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20642,therapy,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20643,separated,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20644,from,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20645,that,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20646,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20647,taste,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20648,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20649,and,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20650,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20651,mainly,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20652,maintained,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20653,its,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20654,leading,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20655,role,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20656,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20657,excipient,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20658,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20659,bearing,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20660,the,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20661,burden,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20662,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20663,over,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20664,time,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20665,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20666,of,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20667,a,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20668,negative,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20669,valence,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20670,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20671,being,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20672,associated,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20673,with,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20674,obesity,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20675,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20676,dental,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20677,problems,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20678,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20679,unhealthy,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20680,lifestyle,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20681,",",O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20682,and,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20683,so,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20684,forth,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20685,.,O,686.0,"However , during the Enlightment , the road of therapy separated from that of taste , and chocolate mainly maintained its leading role of excipient , bearing the burden , over time , of a negative valence , being associated with obesity , dental problems , unhealthy lifestyle , and so forth ."
20887,Intakes,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20888,of,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20889,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20890,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20891,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20892,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20893,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20894,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20895,",",O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20896,raw,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20897,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20898,cooked,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20899,vegetables,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20900,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20901,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20902,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20903,0.6,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20904,for,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20905,both,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20906,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20907,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20908,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20909,other,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20910,than,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20911,citrus,B-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20912,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20913,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20914,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20915,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20916,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20917,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20918,showed,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20919,a,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20920,negative,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20921,association,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20922,with,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20923,risk,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20924,.,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
21102,Breed,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21103,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21104,milking,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21105,frequency,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21106,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21107,days,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21108,in,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21109,milk,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21110,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21111,seasonality,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21112,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21113,SCC,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21114,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21115,cumulative,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21116,months,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21117,with,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21118,SCC,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21119,greater,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21120,than,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21121,"100,000",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21122,cells,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21123,/,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21124,mL,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21125,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21126,lactation,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21127,",",O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21128,and,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21129,herd,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21130,size,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21131,were,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21132,variables,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21133,included,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21134,in,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21135,the,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21136,regression,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21137,analysis,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21138,.,O,700.0,"Breed , milking frequency , days in milk , seasonality , SCC , cumulative months with SCC greater than 100,000 cells / mL , lactation , and herd size were variables included in the regression analysis ."
21207,The,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21208,largest,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21209,losses,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21210,occurred,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21211,from,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21212,increased,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21213,cumulative,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21214,test,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21215,days,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21216,with,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21217,a,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21218,SCC,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21219,"≥100,000",O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21220,cells,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21221,/,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21222,mL,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21223,",",O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21224,with,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21225,daily,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21226,losses,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21227,of,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21228,$,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21229,1.20,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21230,/,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21231,cow,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21232,per,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21233,day,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21234,in,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21235,the,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21236,first,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21237,month,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21238,to,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21239,$,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21240,2.06,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21241,/,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21242,cow,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21243,per,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21244,day,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21245,in,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21246,mo,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21247,10,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21248,.,O,704.0,"The largest losses occurred from increased cumulative test days with a SCC ≥100,000 cells / mL , with daily losses of $ 1.20 / cow per day in the first month to $ 2.06 / cow per day in mo 10 ."
21398,In,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21399,the,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21400,present,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21401,studies,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21402,",",O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21403,dosing,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21404,relied,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21405,on,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21406,injection,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21407,of,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21408,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21409,into,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21410,live,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21411,feeder,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21412,fish,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21413,for,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21414,oral,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21415,dosing,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21416,of,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21417,these,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21418,piscivorous,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21419,birds,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21420,",",O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21421,or,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21422,applying,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21423,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21424,to,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21425,body,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21426,contour,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21427,feathers,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21428,resulting,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21429,in,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21430,transdermal,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21431,oil,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21432,exposure,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21433,and,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21434,oral,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21435,exposure,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21436,through,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21437,preening,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21438,.,O,711.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
21439,Both,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21440,oral,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21441,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21442,external,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21443,oil,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21444,dosing,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21445,studies,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21446,identified,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21447,oil,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21448,-,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21449,related,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21450,toxicity,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21451,endpoints,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21452,associated,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21453,with,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21454,oxidative,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21455,stress,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21456,such,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21457,as,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21458,hemolytic,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21459,anemia,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21460,",",O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21461,liver,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21462,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21463,kidney,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21464,damage,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21465,",",O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21466,and,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21467,immuno,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21468,-,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21469,modulation,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21470,or,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21471,compromise,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21472,.,O,712.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
21591,Many,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21592,studies,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21593,have,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21594,shown,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21595,therapeutic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21596,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21597,of,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21598,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21599,including,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21600,its,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21601,antimicrobial,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21602,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21603,antiviral,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21604,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21605,antifungal,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21606,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21607,antioxidant,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21608,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21609,antitumor,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21610,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21611,antihypertensive,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21612,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21613,antilipemic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21614,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21615,antidiabetic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21616,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21617,gastroprotective,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21618,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21619,and,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21620,immunomodulatory,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21621,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21622,.,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21623,Due,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21624,to,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21625,popular,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21626,use,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21627,of,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21628,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21629,and,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21630,several,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21631,human,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21632,reports,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21633,on,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21634,adverse,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21635,events,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21636,associated,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21637,with,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21638,short,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21639,or,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21640,long,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21641,term,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21642,use,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21643,of,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21644,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21645,",",O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21646,we,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21647,aimed,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21648,to,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21649,systematically,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21650,review,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21651,its,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21652,human,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21653,reports,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21654,of,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21655,adverse,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21656,event,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21657,.,O,719.0,"Due to popular use of cinnamon and several human reports on adverse events associated with short or long term use of cinnamon , we aimed to systematically review its human reports of adverse event ."
21774,The,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21775,available,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21776,data,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21777,suggests,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21778,that,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21779,despite,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21780,the,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21781,safety,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21782,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21783,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21784,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21785,as,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21786,a,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21787,spice,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21788,and/or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21789,flavoring,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21790,agent,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21791,",",O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21792,its,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21793,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21794,may,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21795,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21796,associated,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21797,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21798,significant,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21799,adverse,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21800,effects,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21801,in,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21802,medicinal,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21803,uses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21804,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21805,larger,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21806,doses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21807,or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21808,longer,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21809,duration,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21810,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21811,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21812,and,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21813,should,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21814,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21815,clinically,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21816,monitored,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21817,.,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21981,Therefore,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21982,",",O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21983,secondary,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21984,control,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21985,measures,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21986,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21987,prevent,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21988,biogenic,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21989,amine,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21990,formation,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21991,in,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21992,foods,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21993,or,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21994,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21995,reduce,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21996,their,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21997,levels,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21998,once,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21999,formed,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22000,need,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22001,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22002,be,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22003,considered,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22004,as,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22005,alternatives,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22006,.,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22199,This,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22200,study,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22201,also,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22202,suggests,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22203,that,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22204,combinations,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22205,of,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22206,diverse,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22207,molecular,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22208,components,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22209,may,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22210,be,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22211,responsible,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22212,for,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22213,cell,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22214,-,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22215,level,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22216,bioactivities,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22217,from,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22218,mango,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22219,fractions,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22220,",",O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22221,and,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22222,that,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22223,purification,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22224,and,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22225,activity,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22226,profiling,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22227,of,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22228,individual,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22229,components,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22230,may,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22231,be,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22232,difficult,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22233,to,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22234,relate,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22235,to,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22236,whole,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22237,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22238,effects,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22239,.,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22489,However,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22490,",",O,752.0,"However , it only slightly affected human PPARgamma activity ."
22491,it,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22492,only,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22493,slightly,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22494,affected,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22495,human,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22496,PPARgamma,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22497,activity,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22498,.,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22968,To,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22969,test,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22970,this,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22971,hypothesis,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22972,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22973,rabbits,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22974,were,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22975,fed,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22976,for,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22977,30,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22978,days,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22979,diets,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22980,containing,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22981,2,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22982,g,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22983,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22984,oil/100,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22985,g,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22986,diet,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22987,(,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22988,low,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22989,fat,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22990,diet,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22991,),O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22992,or,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22993,low,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22994,fat,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22995,supplemented,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22996,with,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22997,16,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22998,g/100,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
22999,g,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23000,diet,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23001,of,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23002,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23003,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23004,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23005,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23006,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23007,with,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23008,added,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23009,cholesterol,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23010,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23011,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23012,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23013,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23014,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23015,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23016,",",O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23017,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23018,tallow,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23019,or,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23020,lard,B-http://purl.bioontology.org/ontology/SNOMEDCT/226899009,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23021,.,O,769.0,"To test this hypothesis , rabbits were fed for 30 days diets containing 2 g corn oil/100 g diet ( low fat diet ) or low fat supplemented with 16 g/100 g diet of corn oil , corn oil with added cholesterol , milk fat , chicken fat , beef tallow or lard ."
23520,We,O,788.0,We also discuss the possible mechanisms involved in these associations .
23521,also,O,788.0,We also discuss the possible mechanisms involved in these associations .
23522,discuss,O,788.0,We also discuss the possible mechanisms involved in these associations .
23523,the,O,788.0,We also discuss the possible mechanisms involved in these associations .
23524,possible,O,788.0,We also discuss the possible mechanisms involved in these associations .
23525,mechanisms,O,788.0,We also discuss the possible mechanisms involved in these associations .
23526,involved,O,788.0,We also discuss the possible mechanisms involved in these associations .
23527,in,O,788.0,We also discuss the possible mechanisms involved in these associations .
23528,these,O,788.0,We also discuss the possible mechanisms involved in these associations .
23529,associations,O,788.0,We also discuss the possible mechanisms involved in these associations .
23530,.,O,788.0,We also discuss the possible mechanisms involved in these associations .
23690,Large,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23691,-,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23692,scale,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23693,intervention,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23694,studies,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23695,and,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23696,randomized,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23697,clinical,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23698,trials,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23699,are,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23700,warranted,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23701,to,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23702,determine,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23703,if,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23704,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23705,consumption,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23706,has,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23707,beneficial,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23708,effects,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23709,on,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23710,insulin,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23711,sensitivity,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23712,and,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23713,reduces,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23714,the,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23715,risk,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23716,of,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23717,type,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23718,2,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23719,diabetes,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23720,.,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
24312,Osteoporosis,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24313,affects,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24314,a,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24315,large,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24316,proportion,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24317,of,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24318,the,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24319,elderly,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24320,population,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24321,worldwide,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24322,and,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24323,the,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24324,incidence,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24325,is,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24326,increasing,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24327,.,O,819.0,Osteoporosis affects a large proportion of the elderly population worldwide and the incidence is increasing .
24884,Cereal,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24885,grains,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24886,and,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24887,their,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24888,products,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24889,provide,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24890,around,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24891,30,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24892,%,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24893,of,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24894,total,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24895,energy,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24896,intake,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24897,in,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24898,British,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24899,adults,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24900,",",O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24901,(,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24902,much,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24903,more,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24904,than,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24905,any,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24906,of,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24907,the,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24908,other,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24909,major,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24910,food,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24911,groups,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24912,),O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24913,.,O,838.0,"Cereal grains and their products provide around 30 % of total energy intake in British adults , ( much more than any of the other major food groups ) ."
24951,Several,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24952,of,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24953,the,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24954,nutrients,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24955,in,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24956,cereals,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24957,have,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24958,known,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24959,potential,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24960,for,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24961,reducing,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24962,risk,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24963,factors,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24964,for,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24965,CHD,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24966,:,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24967,the,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24968,linoleic,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24969,acid,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24970,",",O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24971,fibre,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24972,",",O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24973,vitamin,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24974,E,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24975,",",O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24976,selenium,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24977,and,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24978,folate,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
24979,.,O,841.0,"Several of the nutrients in cereals have known potential for reducing risk factors for CHD : the linoleic acid , fibre , vitamin E , selenium and folate ."
25088,Cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25089,foods,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25090,with,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25091,low,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25092,glycaemic,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25093,index,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25094,such,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25095,as,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25096,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25097,and,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25098,oats,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25099,are,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25100,beneficial,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25101,for,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25102,people,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25103,with,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25104,diabetes,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25105,and,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25106,might,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25107,lower,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25108,plasma,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25109,lipids,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25110,.,O,847.0,Cereal foods with low glycaemic index such as pasta and oats are beneficial for people with diabetes and might lower plasma lipids .
25150,This,O,849.0,This confirms an earlier report from a small British cohort .
25151,confirms,O,849.0,This confirms an earlier report from a small British cohort .
25152,an,O,849.0,This confirms an earlier report from a small British cohort .
25153,earlier,O,849.0,This confirms an earlier report from a small British cohort .
25154,report,O,849.0,This confirms an earlier report from a small British cohort .
25155,from,O,849.0,This confirms an earlier report from a small British cohort .
25156,a,O,849.0,This confirms an earlier report from a small British cohort .
25157,small,O,849.0,This confirms an earlier report from a small British cohort .
25158,British,O,849.0,This confirms an earlier report from a small British cohort .
25159,cohort,O,849.0,This confirms an earlier report from a small British cohort .
25160,.,O,849.0,This confirms an earlier report from a small British cohort .
25757,Dry,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25758,matter,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25759,was,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25760,recovered,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25761,at,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25762,a,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25763,rate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25764,averaging,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25765,100,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25766,%,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25767,suggesting,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25768,that,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25769,the,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25770,method,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25771,used,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25772,to,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25773,measure,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25774,the,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25775,flow,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25776,rate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25777,and,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25778,sample,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25779,duodenal,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25780,digesta,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25781,was,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25782,adequate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25783,.,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25856,Olive,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25857,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25858,is,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25859,a,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25860,significant,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25861,and,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25862,promising,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25863,source,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25864,of,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25865,potential,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25866,bioactive,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25867,compounds,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25868,such,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25869,as,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25870,oleuropein,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25871,and,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25872,hydroxytyrosol,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25873,.,O,874.0,Olive fruit is a significant and promising source of potential bioactive compounds such as oleuropein and hydroxytyrosol .
25890,It,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25891,is,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25892,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25893,main,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25894,glycoside,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25895,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25896,olives,B-http://purl.bioontology.org/ontology/SNOMEDCT/227436000,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25897,",",O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25898,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25899,degradation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25900,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25901,which,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25902,results,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25903,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25904,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25905,formation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25906,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25907,hydroxytyrosol,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25908,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25909,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25910,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25911,.,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
26324,Dairy,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26325,production,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26326,plays,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26327,an,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26328,important,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26329,role,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26330,in,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26331,the,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26332,lives,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26333,of,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26334,many,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26335,people,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26336,in,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26337,Rwanda,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26338,and,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26339,Nepal,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26340,.,O,891.0,Dairy production plays an important role in the lives of many people in Rwanda and Nepal .
26455,We,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26456,conducted,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26457,literature,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26458,reviews,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26459,and,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26460,did,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26461,rapid,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26462,needs,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26463,assessments,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26464,in,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26465,both,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26466,countries,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
26467,.,O,895.0,We conducted literature reviews and did rapid needs assessments in both countries .
27148,Fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27149,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27150,intensified,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27151,oxidation,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27152,associated,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27153,with,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27154,age,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27155,",",O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27156,lowered,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27157,electron,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27158,transport,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27159,chain,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27160,activity,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27161,and,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27162,enhanced,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27163,the,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27164,relative,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27165,telomere,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27166,length,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27167,.,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27642,Next,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27643,",",O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27644,the,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27645,committee,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27646,selected,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27647,only,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27648,findings,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27649,with,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27650,a,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27651,strong,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27652,level,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27653,of,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27654,evidence,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27655,for,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27656,deriving,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27657,the,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27658,guidelines,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27659,.,O,937.0,"Next , the committee selected only findings with a strong level of evidence for deriving the guidelines ."
27697,A,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27698,general,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27699,guideline,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27700,to,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27701,eat,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27702,a,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27703,more,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27704,plant,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27705,food,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27706,-,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27707,based,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27708,dietary,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27709,pattern,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27710,and,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27711,limit,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27712,consumption,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27713,of,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27714,animal,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27715,-,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27716,based,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27717,food,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27718,and,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27719,15,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27720,specific,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27721,guidelines,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27722,have,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27723,been,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27724,formulated,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27725,.,O,940.0,A general guideline to eat a more plant food - based dietary pattern and limit consumption of animal - based food and 15 specific guidelines have been formulated .
27933,The,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27934,leaves,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27935,of,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27936,pakchoi,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27937,",",O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27938,peppermint,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27939,",",O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27940,and,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27941,coriander,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27942,had,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27943,a,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27944,strong,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27945,metal,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27946,-,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27947,accumulative,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27948,ability,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27949,and,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27950,they,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27951,were,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27952,not,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27953,suitable,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27954,for,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27955,planting,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
27956,.,O,949.0,"The leaves of pakchoi , peppermint , and coriander had a strong metal - accumulative ability and they were not suitable for planting ."
28200,The,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28201,magnitude,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28202,and,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28203,strength,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28204,of,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28205,the,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28206,association,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28207,for,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28208,mate,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28209,amount,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28210,and,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28211,",",O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28212,to,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28213,a,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28214,lesser,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28215,extent,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28216,",",O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28217,mate,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28218,temperature,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28219,were,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28220,higher,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28221,for,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28222,women,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28223,than,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28224,men,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28225,.,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28303,Consumption,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28304,of,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28305,other,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28306,very,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28307,hot,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28308,beverages,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28309,",",O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28310,such,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28311,as,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28312,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28313,and,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28314,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226470006;http://purl.bioontology.org/ontology/SNOMEDCT/29263009;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28315,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226470006;http://purl.bioontology.org/ontology/SNOMEDCT/29263009;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28316,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226470006;http://purl.bioontology.org/ontology/SNOMEDCT/29263009;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28317,but,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28318,not,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28319,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28320,alone,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28321,",",O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28322,was,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28323,also,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28324,significantly,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28325,associated,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28326,with,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28327,an,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28328,increased,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28329,risk,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28330,",",O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28331,in,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28332,the,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28333,2-,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28334,to,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28335,4,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28336,-,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28337,fold,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28338,range,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28339,.,O,958.0,"Consumption of other very hot beverages , such as tea and coffee with milk but not coffee alone , was also significantly associated with an increased risk , in the 2- to 4 - fold range ."
28406,Our,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28407,study,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28408,further,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28409,confirms,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28410,the,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28411,protective,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28412,effect,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28413,of,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28414,a,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28415,dietary,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28416,pattern,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28417,characterized,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28418,by,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28419,daily,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28420,consumption,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28421,of,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28422,fruits,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28423,and,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28424,vegetables,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28425,and,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28426,low,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28427,consumption,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28428,of,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28429,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28430,and,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28431,animal,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28432,fats,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28433,.,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28776,School,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28777,meal,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28778,programs,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28779,make,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28780,fluid,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28781,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28782,accessible,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28783,to,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28784,millions,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28785,of,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28786,children,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28787,each,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28788,day,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28789,;,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28790,however,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28791,",",O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28792,regulations,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28793,and,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28794,school,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28795,lunch,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28796,procurement,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28797,systems,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28798,in,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28799,the,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28800,United,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28801,States,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28802,sometimes,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28803,make,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28804,it,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28805,difficult,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28806,to,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28807,provide,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28808,novel,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28809,or,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28810,value,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28811,-,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28812,added,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28813,milk,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28814,products,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28815,in,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28816,these,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28817,programs,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
28818,.,O,976.0,"School meal programs make fluid milk accessible to millions of children each day ; however , regulations and school lunch procurement systems in the United States sometimes make it difficult to provide novel or value - added milk products in these programs ."
29114,No,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29115,studies,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29116,reported,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29117,adverse,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29118,effects,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29119,from,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29120,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29121,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29122,related,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29123,to,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29124,cancer,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29125,although,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29126,consuming,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29127,hot,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29128,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29129,has,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29130,been,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29131,found,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29132,to,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29133,possibly,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29134,increase,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29135,the,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29136,risk,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29137,of,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29138,esophageal,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29139,cancer,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29140,and,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29141,concerns,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29142,of,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29143,hepatotoxity,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29144,were,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29145,raised,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29146,as,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29147,a,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29148,result,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29149,of,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29150,high,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29151,doses,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29152,of,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29153,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29154,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29155,.,O,986.0,No studies reported adverse effects from green tea related to cancer although consuming hot tea has been found to possibly increase the risk of esophageal cancer and concerns of hepatotoxity were raised as a result of high doses of green tea .
29156,The,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29157,literature,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29158,overall,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29159,supports,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29160,an,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29161,inverse,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29162,association,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29163,between,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29164,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29165,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29166,and,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29167,cardiovascular,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29168,disease,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29169,-,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29170,related,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29171,health,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29172,outcomes,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29173,.,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29603,FF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29604,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29605,RFS,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29606,conditions,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29607,were,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29608,liked,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29609,more,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29610,than,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29611,RF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29612,for,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29613,the,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29614,breakfast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29615,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29616,lunch,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29617,meals,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29618,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29619,French,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29620,toast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29621,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29622,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29623,entrée,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29624,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29625,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29626,vegetables,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29627,.,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29637,FF,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29638,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29639,was,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29640,liked,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29641,more,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29642,than,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29643,RFS,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29644,and,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29645,RF,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29646,(,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29647,7.47,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29648,FF,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29649,compared,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29650,with,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29651,6.42,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29652,RFS,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29653,",",O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29654,P,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29655,<,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29656,0.0001,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29657,;,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29658,7.47,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29659,FF,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29660,compared,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29661,with,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29662,6.47,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29663,RF,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29664,",",O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29665,P,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29666,<,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29667,0.0001,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29668,),O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29669,.,O,1005.0,"FF pasta was liked more than RFS and RF ( 7.47 FF compared with 6.42 RFS , P < 0.0001 ; 7.47 FF compared with 6.47 RF , P < 0.0001 ) ."
29732,The,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29733,objective,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29734,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29735,this,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29736,work,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29737,was,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29738,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29739,identify,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29740,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29741,effect,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29742,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29743,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29744,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29745,on,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29746,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29747,expression,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29748,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29749,genes,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29750,and,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29751,levels,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29752,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29753,metabolites,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29754,related,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29755,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29756,steatosis,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29757,in,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29758,rats,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29759,.,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
30357,Multivariable,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30358,mixed,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30359,model,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30360,analyses,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30361,evaluated,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30362,associations,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30363,between,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30364,demographic,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30365,",",O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30366,socioeconomic,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30367,and,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30368,livestock,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30369,-,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30370,associated,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30371,variables,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30372,and,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30373,(,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30374,a,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30375,),O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30376,maternal,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30377,and,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30378,child,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30379,diets,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30380,",",O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30381,(,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30382,b,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30383,),O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30384,children,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30385,'s,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30386,height,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30387,-,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30388,for,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30389,-,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30390,age,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30391,and,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30392,(,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30393,c,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30394,),O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30395,children,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30396,'s,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30397,diarrhea,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30398,frequency,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30399,.,O,1028.0,"Multivariable mixed model analyses evaluated associations between demographic , socioeconomic and livestock - associated variables and ( a ) maternal and child diets , ( b ) children 's height - for - age and ( c ) children 's diarrhea frequency ."
30580,In,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30581,particular,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30582,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30583,we,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30584,recorded,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30585,modified,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30586,consumption,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30587,of,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30588,fried,B-http://purl.bioontology.org/ontology/SNOMEDCT/228002003;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30589,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/228002003;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30590,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30591,sweet,B-http://purl.bioontology.org/ontology/SNOMEDCT/228072002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30592,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/228072002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30593,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30594,legumes,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30595,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30596,vegetables,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30597,",",O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30598,and,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30599,fruits,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30600,.,O,1035.0,"In particular , we recorded modified consumption of fried food , sweet food , legumes , vegetables , and fruits ."
30660,There,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30661,is,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30662,abundant,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30663,epidemiological,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30664,evidence,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30665,that,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30666,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30667,consumption,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30668,decreases,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30669,colorectal,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30670,cancer,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30671,(,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30672,CRC,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30673,),O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30674,risk,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30675,.,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30713,Mice,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30714,were,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30715,fed,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30716,one,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30717,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30718,8,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30719,diets,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30720,:,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30721,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30722,control,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30723,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30724,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30725,no,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30726,vegetables,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30727,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30728,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30729,1,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30730,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30731,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30732,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30733,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30734,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30735,100,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30736,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30737,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30738,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30739,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30740,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30741,2,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30742,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30743,10,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30744,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30745,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30746,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30747,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30748,200,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30749,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30750,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30751,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30752,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30753,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30754,3,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30755,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30756,20,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30757,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30758,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30759,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30760,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30761,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30762,400,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30763,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30764,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30765,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30766,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30767,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30768,4,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30769,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30770,40,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30771,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30772,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30773,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30774,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30775,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30776,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30777,mixture,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30778,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30779,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30780,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30781,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30782,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30783,70,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30784,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30785,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30786,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30787,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30788,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30789,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30790,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30791,5,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30792,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30793,7,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30794,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30795,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30796,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30797,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30798,73,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30799,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30800,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30801,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30802,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30803,carrots,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30804,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30805,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30806,6,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30807,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30808,7.3,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30809,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30810,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30811,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30812,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30813,226,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30814,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30815,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30816,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30817,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30818,peas,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30819,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30820,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30821,7,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30822,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30823,22.6,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30824,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30825,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30826,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30827,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30828,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30829,31,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30830,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30831,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30832,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30833,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30834,onions,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30835,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30836,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30837,8,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30838,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30839,3.1,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30840,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30841,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30842,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30843,.,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30916,Total,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30917,RNA,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30918,was,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30919,isolated,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30920,and,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30921,microarray,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30922,technology,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30923,was,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30924,used,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30925,to,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30926,measure,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30927,the,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30928,expression,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30929,levels,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30930,of,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30931,602,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30932,genes,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30933,simultaneously,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30934,.,O,1044.0,Total RNA was isolated and microarray technology was used to measure the expression levels of 602 genes simultaneously .
30976,Eleven,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30977,genes,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30978,were,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30979,modulated,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30980,by,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30981,the,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30982,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30983,mixture,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30984,as,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30985,well,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30986,as,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30987,by,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30988,one,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30989,or,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30990,more,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30991,of,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30992,the,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30993,individual,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30994,vegetables,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
30995,.,O,1047.0,Eleven genes were modulated by the vegetable mixture as well as by one or more of the individual vegetables .
31558,A,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31559,protective,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31560,effect,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31561,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31562,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31563,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31564,on,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31565,the,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31566,development,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31567,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31568,colon,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31569,cancer,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31570,is,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31571,suggested,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31572,.,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31573,The,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31574,evidence,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31575,regarding,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31576,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31577,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31578,is,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31579,less,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31580,clear,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31581,",",O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31582,with,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31583,some,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31584,indication,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31585,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31586,a,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31587,risk,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31588,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31589,colon,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31590,or,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31591,rectal,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31592,cancer,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31593,associated,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31594,with,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31595,regular,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31596,use,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31597,of,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31598,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31599,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31600,.,O,1070.0,"The evidence regarding black tea is less clear , with some indication of a risk of colon or rectal cancer associated with regular use of black tea ."
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
32064,In,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32065,this,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32066,regard,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32067,",",O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32068,there,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32069,is,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32070,increasing,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32071,evidence,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32072,for,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32073,a,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32074,protective,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32075,effect,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32076,of,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32077,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32078,",",O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32079,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32080,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32081,and,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32082,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32083,consumption,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32084,against,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32085,this,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32086,disorder,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32087,.,O,1087.0,"In this regard , there is increasing evidence for a protective effect of tea , red wine and cocoa consumption against this disorder ."
32213,It,O,1093.0,It has been grown since at least 1000 BC in China .
32214,has,O,1093.0,It has been grown since at least 1000 BC in China .
32215,been,O,1093.0,It has been grown since at least 1000 BC in China .
32216,grown,O,1093.0,It has been grown since at least 1000 BC in China .
32217,since,O,1093.0,It has been grown since at least 1000 BC in China .
32218,at,O,1093.0,It has been grown since at least 1000 BC in China .
32219,least,O,1093.0,It has been grown since at least 1000 BC in China .
32220,1000,O,1093.0,It has been grown since at least 1000 BC in China .
32221,BC,O,1093.0,It has been grown since at least 1000 BC in China .
32222,in,O,1093.0,It has been grown since at least 1000 BC in China .
32223,China,O,1093.0,It has been grown since at least 1000 BC in China .
32224,.,O,1093.0,It has been grown since at least 1000 BC in China .
32371,Buckwheat,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32372,proteins,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32373,have,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32374,unique,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32375,amino,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32376,acid,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32377,composition,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32378,with,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32379,special,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32380,biological,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32381,activities,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32382,of,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32383,cholesterol,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32384,-,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32385,lowering,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32386,effects,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32387,",",O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32388,antihypertensition,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32389,effects,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32390,",",O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32391,and,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32392,improving,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32393,the,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32394,constipation,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32395,and,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32396,obisity,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32397,conditions,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32398,by,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32399,acting,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32400,similar,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32401,as,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32402,to,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32403,dietary,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32404,fiber,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32405,and,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32406,interrupting,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32407,the,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32408,in,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32409,vivo,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32410,metabolisms,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32411,.,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32479,Experiments,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32480,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32481,both,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32482,with,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32483,animal,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32484,models,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32485,and,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32486,with,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32487,human,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32488,beings,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32489,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32490,revealed,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32491,that,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32492,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32493,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32494,can,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32495,improve,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32496,diabetes,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32497,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32498,obesity,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32499,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32500,hypertension,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32501,",",O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32502,hypercholesterolemia,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32503,and,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32504,constipation,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32505,.,O,1105.0,"Experiments , both with animal models and with human beings , revealed that buckwheat flour can improve diabetes , obesity , hypertension , hypercholesterolemia and constipation ."
32506,Methods,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32507,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32508,exploit,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32509,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32510,seeds,I-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32511,and,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32512,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32513,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32514,produce,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32515,highly,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32516,effective,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32517,nutraceuticals,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32518,are,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32519,also,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32520,reviewed,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32521,.,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32743,These,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32744,results,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32745,suggest,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32746,that,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32747,intake,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32748,of,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32749,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32750,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32751,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32752,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32753,",",O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32754,calcium,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32755,",",O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32756,or,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32757,lactose,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32758,may,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32759,reduce,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32760,the,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32761,risk,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32762,of,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32763,ovarian,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32764,cancer,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
32765,.,O,1114.0,"These results suggest that intake of low - fat milk , calcium , or lactose may reduce the risk of ovarian cancer ."
33233,For,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33234,each,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33235,of,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33236,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33237,seven,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33238,food,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33239,groups,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33240,in,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33241,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33242,',O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33243,healthy,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33244,',O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33245,diet,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33246,",",O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33247,we,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33248,calculated,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33249,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33250,difference,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33251,between,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33252,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33253,estimated,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33254,national,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33255,supply,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33256,(,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33257,in,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33258,kcal,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33259,",",O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33260,edible,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33261,portion,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33262,only,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33263,),O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33264,and,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33265,the,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33266,target,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33267,amounts,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33268,.,O,1128.0,"For each of the seven food groups in the ' healthy ' diet , we calculated the difference between the estimated national supply ( in kcal , edible portion only ) and the target amounts ."
33399,They,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33400,are,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33401,also,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33402,endowed,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33403,for,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33404,having,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33405,essential,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33406,amino,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33407,acids,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33408,",",O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33409,selenium,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33410,",",O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33411,a,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33412,potent,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33413,antioxidant,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33414,",",O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33415,and,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33416,potassium,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33417,",",O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33418,a,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33419,healthy,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33420,heart,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33421,mineral,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33422,.,O,1137.0,"They are also endowed for having essential amino acids , selenium , a potent antioxidant , and potassium , a healthy heart mineral ."
33423,Occurrence,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33424,of,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33425,taxiphyllin,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33426,",",O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33427,a,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33428,cyanogenic,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33429,glycoside,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33430,in,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33431,raw,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33432,shoots,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33433,",",O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33434,and,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33435,its,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33436,side,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33437,effect,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33438,on,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33439,human,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33440,health,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33441,calls,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33442,for,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33443,the,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33444,demand,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33445,to,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33446,innovate,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33447,processing,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33448,ways,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33449,using,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33450,scientific,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33451,input,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33452,to,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33453,eliminate,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33454,the,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33455,toxic,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33456,compound,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33457,without,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33458,disturbing,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33459,the,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33460,nutrient,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33461,reserve,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33462,.,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33463,Lastly,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33464,",",O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33465,the,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33466,paper,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33467,also,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33468,reviews,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33469,the,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33470,utilization,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33471,of,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33472,medicinal,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33473,properties,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33474,acquired,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33475,by,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33476,bamboo,B-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33477,shoot,I-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33478,.,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33723,Evidence,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33724,of,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33725,uncoupling,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33726,of,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33727,pyruvate,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33728,-,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33729,supported,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33730,respiration,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33731,from,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33732,ATP,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33733,synthesis,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33734,was,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33735,observed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33736,in,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33737,mitochondria,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33738,from,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33739,rats,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33740,fed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33741,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33742,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33743,but,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33744,not,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33745,in,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33746,rats,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33747,fed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33748,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33749,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33750,.,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
34599,Moreover,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34600,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34601,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34602,considered,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34603,as,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34604,a,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34605,good,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34606,source,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34607,of,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34608,starch,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34609,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34610,minerals,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34611,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34612,vitamins,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34613,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34614,and,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34615,protein,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34616,pose,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34617,it,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34618,as,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34619,an,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34620,ideal,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34621,food,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34622,supplement,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34623,.,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34844,Predictive,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34845,regression,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34846,models,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34847,were,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34848,used,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34849,to,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34850,plot,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34851,mixture,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34852,response,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34853,surfaces,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34854,of,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34855,the,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34856,critical,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34857,sensory,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34858,attributes,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34859,(,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34860,taste,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34861,",",O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34862,mouthfeel,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34863,",",O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34864,and,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34865,overall,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34866,liking,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34867,),O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34868,that,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34869,influenced,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34870,purchase,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34871,intent,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34872,.,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
35006,Purchase,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35007,intent,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35008,of,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35009,all,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35010,flavored,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35011,products,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35012,also,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35013,significantly,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35014,increased,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35015,once,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35016,consumers,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35017,had,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35018,been,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35019,given,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35020,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35021,information,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35022,about,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35023,potential,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35024,health,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35025,benefits,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35026,associated,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35027,with,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35028,RBO,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35029,and,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35030,SPC,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35031,in,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35032,the,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35033,spreads,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35034,.,O,1193.0,Purchase intent of all flavored products also significantly increased once consumers had been given the information about potential health benefits associated with RBO and SPC in the spreads .
35707,The,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35708,ingestion,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35709,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35710,perchlorate,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35711,is,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35712,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35713,concern,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35714,because,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35715,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35716,its,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35717,ability,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35718,to,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35719,competitively,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35720,inhibit,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35721,iodide,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35722,uptake,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35723,by,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35724,the,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35725,thyroid,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35726,and,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35727,to,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35728,impair,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35729,synthesis,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35730,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35731,thyroid,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35732,hormones,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35733,.,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35734,A,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35735,recent,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35736,study,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35737,established,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35738,that,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35739,milk,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35740,perchlorate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35741,concentrations,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35742,in,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35743,cattle,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35744,highly,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35745,correlate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35746,with,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35747,perchlorate,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35748,intake,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35749,.,O,1223.0,A recent study established that milk perchlorate concentrations in cattle highly correlate with perchlorate intake .
35960,These,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35961,findings,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35962,",",O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35963,in,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35964,the,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35965,context,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35966,of,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35967,a,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35968,recently,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35969,published,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35970,study,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35971,",",O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35972,suggest,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35973,that,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35974,an,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35975,active,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35976,transport,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35977,process,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35978,is,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35979,operative,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35980,in,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35981,the,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35982,establishment,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35983,of,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35984,a,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35985,perchlorate,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35986,concentration,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35987,gradient,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35988,across,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35989,the,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35990,blood,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35991,-,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35992,mammary,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35993,gland,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35994,interface,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35995,",",O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35996,and,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35997,that,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35998,increases,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
35999,in,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36000,mammary,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36001,epithelial,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36002,and,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36003,vascular,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36004,endothelial,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36005,permeability,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36006,lead,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36007,to,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36008,a,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36009,net,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36010,outflow,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36011,of,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36012,milk,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36013,perchlorate,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36014,.,O,1233.0,"These findings , in the context of a recently published study , suggest that an active transport process is operative in the establishment of a perchlorate concentration gradient across the blood - mammary gland interface , and that increases in mammary epithelial and vascular endothelial permeability lead to a net outflow of milk perchlorate ."
36305,The,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36306,intervention,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36307,group,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36308,(,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36309,n,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36310,=,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36311,121,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36312,),O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36313,received,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36314,individual,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36315,dietary,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36316,counselling,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36317,aimed,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36318,at,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36319,reducing,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36320,dietary,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36321,fat,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36322,intake,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36323,to,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36324,20,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36325,-,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36326,25,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36327,%,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36328,energy,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36329,(,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36330,E%,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36331,),O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36332,",",O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36333,whereas,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36334,no,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36335,dietary,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36336,advice,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36337,was,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36338,given,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36339,to,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36340,women,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36341,in,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36342,the,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36343,control,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36344,group,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36345,(,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36346,n,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36347,=,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36348,119,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36349,),O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36350,.,O,1243.0,"The intervention group ( n = 121 ) received individual dietary counselling aimed at reducing dietary fat intake to 20 - 25 % energy ( E% ) , whereas no dietary advice was given to women in the control group ( n = 119 ) ."
36574,This,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36575,study,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36576,showed,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36577,that,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36578,dietary,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36579,counselling,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36580,can,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36581,bring,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36582,about,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36583,significant,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36584,changes,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36585,in,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36586,consumption,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36587,of,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36588,high,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36589,-,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36590,fat,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36591,foods,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36592,for,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36593,at,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36594,least,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36595,a,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36596,2,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36597,-,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36598,year,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36599,period,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36600,for,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36601,women,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36602,operated,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36603,for,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36604,breast,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36605,cancer,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36606,.,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36612,Patterns,O,1252.0,Patterns of cancer are also changing .
36613,of,O,1252.0,Patterns of cancer are also changing .
36614,cancer,O,1252.0,Patterns of cancer are also changing .
36615,are,O,1252.0,Patterns of cancer are also changing .
36616,also,O,1252.0,Patterns of cancer are also changing .
36617,changing,O,1252.0,Patterns of cancer are also changing .
36618,.,O,1252.0,Patterns of cancer are also changing .
36902,Liver,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36903,diseases,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36904,caused,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36905,by,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36906,viral,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36907,hepatitis,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36908,infections,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36909,have,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36910,a,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36911,negative,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36912,impact,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36913,on,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36914,global,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36915,health,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
36916,.,O,1262.0,Liver diseases caused by viral hepatitis infections have a negative impact on global health .
37014,Extensive,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37015,evidences,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37016,report,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37017,that,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37018,quercetin,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37019,(,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37020,QE,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37021,),O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37022,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37023,a,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37024,major,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37025,flavonol,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37026,commonly,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37027,found,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37028,in,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37029,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37030,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37031,berries,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37032,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37033,onion,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37034,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37035,citrus,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37036,fruits,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37037,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37038,cruciferous,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37039,vegetables,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37040,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37041,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37042,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37043,pepper,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37044,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37045,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37046,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37047,whole,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37048,gain,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37049,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37050,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37051,and,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37052,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37053,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37054,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37055,displays,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37056,a,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37057,wide,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37058,range,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37059,of,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37060,healthy,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37061,properties,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37062,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37063,including,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37064,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37065,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37066,oxidative,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37067,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37068,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37069,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37070,inflammatory,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37071,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37072,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37073,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37074,apoptotic,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37075,and,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37076,hepatoprotective,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37077,activities,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37078,against,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37079,various,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37080,hepatic,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37081,ailments,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37082,.,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37319,Reference,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37320,Doses,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37321,were,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37322,established,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37323,for,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37324,11,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37325,allergenic,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37326,foods,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37327,ranging,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37328,from,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37329,0.03,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37330,mg,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37331,for,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37332,egg,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37333,protein,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37334,to,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37335,10,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37336,mg,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37337,for,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37338,shrimp,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37339,protein,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37340,.,O,1276.0,Reference Doses were established for 11 allergenic foods ranging from 0.03 mg for egg protein to 10 mg for shrimp protein .
37691,The,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37692,hypothesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37693,that,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37694,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37695,intake,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37696,can,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37697,increase,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37698,fecal,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37699,NOC,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37700,levels,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37701,and,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37702,colon,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37703,carcinogenesis,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37704,was,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37705,tested,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37706,in,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37707,175,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37708,Fischer,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37709,344,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37710,rats,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
37711,.,O,1292.0,The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats .
38107,Recent,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38108,studies,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38109,have,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38110,identified,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38111,a,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38112,health,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38113,promoting,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38114,mechanism,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38115,common,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38116,to,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38117,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38118,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38119,vegetables,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38120,and,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38121,fruits,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38122,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38123,i.e.,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38124,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38125,the,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38126,activation,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38127,of,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38128,an,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38129,adaptive,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38130,cellular,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38131,response,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38132,characterized,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38133,by,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38134,the,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38135,upregulation,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38136,of,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38137,proteins,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38138,involved,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38139,in,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38140,cell,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38141,protection,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38142,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38143,notably,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38144,antioxidant,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38145,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38146,detoxifying,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38147,and,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38148,repair,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38149,enzymes,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38150,.,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38184,Coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38185,plays,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38186,a,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38187,dominant,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38188,role,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38189,in,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38190,that,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38191,regard,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38192,because,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38193,it,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38194,is,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38195,the,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38196,major,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38197,dietary,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38198,source,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38199,of,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38200,phenolic,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38201,acids,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38202,and,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38203,polyphenols,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38204,in,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38205,the,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38206,developed,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38207,world,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38208,.,O,1311.0,Coffee plays a dominant role in that regard because it is the major dietary source of phenolic acids and polyphenols in the developed world .
38274,The,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38275,relationship,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38276,between,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38277,ethanol,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38278,consumption,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38279,and,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38280,coronary,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38281,heart,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38282,disease,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38283,was,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38284,examined,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38285,in,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38286,the,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38287,original,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38288,Framingham,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38289,Heart,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38290,Study,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38291,cohort,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38292,(,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38293,1948,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38294,),O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38295,with,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38296,a,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38297,24,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38298,-,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38299,year,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38300,follow,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38301,-,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38302,up,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38303,from,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38304,exam,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38305,2,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38306,(,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38307,"2,106",O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38308,males,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38309,and,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38310,"2,639",O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38311,females,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38312,),O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38313,.,O,1315.0,"The relationship between ethanol consumption and coronary heart disease was examined in the original Framingham Heart Study cohort ( 1948 ) with a 24 - year follow - up from exam 2 ( 2,106 males and 2,639 females ) ."
38415,For,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38416,male,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38417,coronary,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38418,heart,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38419,disease,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38420,mortality,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38421,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38422,ethanol,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38423,consumption,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38424,was,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38425,subdivided,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38426,into,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38427,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38428,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38429,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38430,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38431,and,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38432,spirits,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38433,consumption,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38434,.,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
39264,Following,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39265,introduction,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39266,of,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39267,minimum,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39268,unit,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39269,pricing,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39270,in,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39271,Scotland,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39272,",",O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39273,alcohol,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39274,sales,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39275,fell,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39276,by,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39277,3,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39278,%,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39279,",",O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39280,with,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39281,the,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39282,greatest,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39283,effect,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39284,on,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39285,heavy,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39286,drinkers,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39287,of,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39288,low,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39289,-,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39290,cost,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39291,alcohol,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39292,products,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39293,.,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39472,New,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39473,funding,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39474,arrangements,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39475,for,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39476,general,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39477,practitioners,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39478,will,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39479,be,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39480,required,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39481,if,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39482,these,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39483,proposals,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39484,are,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39485,to,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39486,be,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39487,taken,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39488,up,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39489,more,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39490,widely,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39491,around,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39492,the,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39493,country,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39494,.,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39660,In,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39661,the,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39662,present,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39663,study,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39664,",",O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39665,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39666,",",O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39667,at,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39668,levels,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39669,ranging,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39670,from,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39671,0.25,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39672,to,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39673,10,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39674,%,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39675,",",O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39676,was,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39677,included,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39678,in,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39679,a,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39680,nutritionally,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39681,balanced,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39682,AIN-76,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39683,diet,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39684,fed,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39685,to,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39686,Wistar,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39687,rats,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39688,for,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39689,a,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39690,period,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39691,of,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39692,8,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39693,weeks,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39694,.,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39695,The,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39696,serum,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39697,lipid,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39698,profiles,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39699,of,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39700,these,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39701,animals,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39702,showed,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39703,a,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39704,dose,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39705,dependent,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39706,decrease,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39707,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39708,total,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39709,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39710,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39711,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39712,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39713,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39714,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39715,very,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39716,low,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39717,density,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39718,lipoproteins,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39719,cholesterol,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39720,",",O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39721,and,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39722,triglyceride,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39723,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39724,when,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39725,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39726,was,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39727,present,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39728,at,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39729,levels,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39730,greater,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39731,than,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39732,2.5,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39733,%,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39734,in,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39735,the,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39736,diet,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39737,.,O,1365.0,"The serum lipid profiles of these animals showed a dose dependent decrease in total cholesterol , low density lipoproteins and very low density lipoproteins cholesterol , and triglyceride levels when ghee was present at levels greater than 2.5 % in the diet ."
39839,This,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39840,study,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39841,revealed,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39842,that,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39843,the,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39844,consumption,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39845,of,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39846,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39847,up,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39848,to,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39849,a,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39850,10,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39851,%,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39852,level,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39853,in,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39854,the,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39855,diet,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39856,altered,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39857,blood,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39858,lipid,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39859,profiles,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39860,in,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39861,such,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39862,a,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39863,manner,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39864,as,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39865,not,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39866,to,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39867,elevate,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39868,the,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39869,risk,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39870,factors,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39871,for,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39872,cardiovascular,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39873,diseases,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
39874,.,O,1370.0,This study revealed that the consumption of ghee up to a 10 % level in the diet altered blood lipid profiles in such a manner as not to elevate the risk factors for cardiovascular diseases .
40279,The,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40280,National,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40281,Institutes,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40282,of,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40283,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40284,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40285,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40286,(,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40287,NIH,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40288,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40289,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40290,),O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40291,Diet,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40292,and,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40293,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40294,Study,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40295,recruited,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40296,"566,398",O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40297,individuals,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40298,aged,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40299,50,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40300,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40301,71,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40302,at,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40303,baseline,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40304,in,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40305,1995,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40306,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40307,1996,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40308,.,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40484,Weight,O,1388.0,Weight was closely associated with skinfold thickness .
40485,was,O,1388.0,Weight was closely associated with skinfold thickness .
40486,closely,O,1388.0,Weight was closely associated with skinfold thickness .
40487,associated,O,1388.0,Weight was closely associated with skinfold thickness .
40488,with,O,1388.0,Weight was closely associated with skinfold thickness .
40489,skinfold,O,1388.0,Weight was closely associated with skinfold thickness .
40490,thickness,O,1388.0,Weight was closely associated with skinfold thickness .
40491,.,O,1388.0,Weight was closely associated with skinfold thickness .
40658,A,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40659,higher,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40660,percentage,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40661,of,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40662,the,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40663,obese,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40664,group,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40665,reported,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40666,skipping,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40667,one,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40668,meal,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40669,and,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40670,eating,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40671,no,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40672,snack,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40673,at,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40674,school,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40675,.,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
41337,We,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41338,therefore,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41339,assessed,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41340,the,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41341,effect,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41342,of,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41343,decreasing,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41344,postprandial,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41345,glucose,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41346,excursions,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41347,on,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41348,measures,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41349,of,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41350,oxidative,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41351,damage,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41352,.,O,1417.0,We therefore assessed the effect of decreasing postprandial glucose excursions on measures of oxidative damage .
41353,Fifteen,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41354,healthy,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41355,subjects,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41356,ate,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41357,2,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41358,bread,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41359,control,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41360,meals,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41361,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41362,3,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41363,test,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41364,meals,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41365,:,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41366,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41367,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41368,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41369,;,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41370,parboiled,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41371,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41372,;,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41373,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41374,instant,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41375,mashed,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41376,potatoes,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41377,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41378,balanced,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41379,in,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41380,carbohydrate,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41381,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41382,fat,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41383,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41384,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41385,protein,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41386,",",O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41387,using,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41388,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41389,and,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41390,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41391,.,O,1418.0,"Fifteen healthy subjects ate 2 bread control meals and 3 test meals : almonds and bread ; parboiled rice ; and instant mashed potatoes , balanced in carbohydrate , fat , and protein , using butter and cheese ."
41726,Cox,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41727,proportional,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41728,hazards,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41729,regression,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41730,was,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41731,used,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41732,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41733,calculate,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41734,hazard,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41735,ratios,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41736,for,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41737,incident,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41738,diabetes,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41739,according,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41740,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41741,categories,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41742,of,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41743,total,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41744,flavonoids,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41745,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41746,anthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41747,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41748,flavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41749,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41750,flavanones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41751,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41752,flavonols,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41753,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41754,flavan-3,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41755,-,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41756,ol,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41757,monomers,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41758,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41759,isoflavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41760,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41761,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41762,proanthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41763,.,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41800,Flavonoid,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41801,consumption,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41802,was,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41803,not,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41804,associated,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41805,with,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41806,diabetes,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41807,risk,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41808,after,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41809,multivariable,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41810,adjustment,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41811,.,O,1433.0,Flavonoid consumption was not associated with diabetes risk after multivariable adjustment .
41945,Dietary,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41946,patterns,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41947,have,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41948,been,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41949,proposed,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41950,to,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41951,be,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41952,related,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41953,to,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41954,dyslipidemia,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41955,and,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41956,hyperglycemia,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
41957,.,O,1438.0,Dietary patterns have been proposed to be related to dyslipidemia and hyperglycemia .
42016,A,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42017,total,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42018,of,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42019,"13,609",O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42020,subjects,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42021,aged,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42022,between,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42023,20,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42024,and,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42025,50,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42026,years,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42027,were,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42028,selected,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42029,.,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42129,Higher,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42130,scores,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42131,of,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42132,the,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42133,vegetables,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42134,-,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42135,fruits,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42136,-,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42137,seafood,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42138,dietary,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42139,pattern,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42140,(,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42141,high,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42142,intake,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42143,of,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42144,vegetables,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42145,",",O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42146,vegetables,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42147,with,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42148,oil,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42149,or,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42150,dressing,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42151,",",O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42152,fruits,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42153,",",O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42154,seafood,B-http://purl.bioontology.org/ontology/SNOMEDCT/44027008,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42155,",",O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42156,legumes,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42157,",",O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42158,soy,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42159,products,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42160,",",O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42161,and,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42162,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42163,or,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42164,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42165,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42166,),O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42167,was,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42168,inversely,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42169,associated,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42170,with,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42171,hypercholesterolemia,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42172,and,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42173,positively,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42174,associated,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42175,with,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42176,hyperglycemia,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42177,.,O,1446.0,"Higher scores of the vegetables - fruits - seafood dietary pattern ( high intake of vegetables , vegetables with oil or dressing , fruits , seafood , legumes , soy products , and rice or flour products ) was inversely associated with hypercholesterolemia and positively associated with hyperglycemia ."
42626,A,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42627,high,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42628,intake,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42629,of,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42630,cooked,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42631,green,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42632,vegetables,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42633,",",O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42634,fresh,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42635,noncitrus,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42636,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42637,and,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42638,dried,B-http://purl.bioontology.org/ontology/SNOMEDCT/227449005;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42639,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/227449005;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42640,showed,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42641,an,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42642,inverse,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42643,association,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42644,with,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42645,the,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42646,risk,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42647,of,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42648,gastric,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42649,cancer,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42650,.,O,1461.0,"A high intake of cooked green vegetables , fresh noncitrus fruit and dried fruit showed an inverse association with the risk of gastric cancer ."
42672,The,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42673,intake,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42674,of,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42675,protective,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42676,food,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42677,items,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42678,seems,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42679,to,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42680,neutralize,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42681,the,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42682,effects,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42683,of,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42684,food,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42685,items,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42686,which,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42687,increase,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42688,risk,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42689,.,O,1463.0,The intake of protective food items seems to neutralize the effects of food items which increase risk .
42751,A,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42752,dietary,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42753,food,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42754,pattern,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42755,naturally,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42756,rich,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42757,in,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42758,polyphenols,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42759,is,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42760,the,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42761,Mediterranean,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42762,diet,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42763,and,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42764,evidence,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42765,suggests,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42766,those,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42767,of,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42768,Mediterranean,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42769,descent,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42770,have,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42771,a,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42772,lower,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42773,breast,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42774,cancer,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42775,incidence,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42776,.,O,1466.0,A dietary food pattern naturally rich in polyphenols is the Mediterranean diet and evidence suggests those of Mediterranean descent have a lower breast cancer incidence .
42777,Whilst,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42778,dietary,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42779,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42780,have,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42781,been,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42782,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42783,subject,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42784,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42785,breast,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42786,cancer,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42787,risk,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42788,-,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42789,reduction,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42790,",",O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42791,this,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42792,review,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42793,will,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42794,focus,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42795,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42796,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42797,clinical,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42798,effects,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42799,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42800,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42801,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42802,reducing,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42803,recurrence,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42804,.,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42957,In,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42958,this,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42959,study,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42960,",",O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42961,10,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42962,common,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42963,vegetables,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42964,were,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42965,selected,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42966,on,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42967,the,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42968,basis,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42969,of,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42970,consumption,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42971,per,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42972,capita,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42973,data,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42974,in,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42975,the,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42976,United,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42977,States,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
42978,.,O,1474.0,"In this study , 10 common vegetables were selected on the basis of consumption per capita data in the United States ."
43214,Polyphenol,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43215,benefits,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43216,have,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43217,been,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43218,proposed,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43219,supported,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43220,by,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43221,in,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43222,vitro,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43223,studies,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43224,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43225,animal,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43226,work,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43227,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43228,and,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43229,clinical,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43230,trials,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43231,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43232,which,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43233,have,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43234,been,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43235,conducted,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43236,mostly,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43237,in,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43238,healthy,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43239,volunteers,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43240,.,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43587,Urinary,O,1497.0,Urinary arsenic was measured in 310 participants .
43588,arsenic,O,1497.0,Urinary arsenic was measured in 310 participants .
43589,was,O,1497.0,Urinary arsenic was measured in 310 participants .
43590,measured,O,1497.0,Urinary arsenic was measured in 310 participants .
43591,in,O,1497.0,Urinary arsenic was measured in 310 participants .
43592,310,O,1497.0,Urinary arsenic was measured in 310 participants .
43593,participants,O,1497.0,Urinary arsenic was measured in 310 participants .
43594,.,O,1497.0,Urinary arsenic was measured in 310 participants .
43693,Associations,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43694,with,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43695,urinary,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43696,arsenic,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43697,were,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43698,similar,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43699,to,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43700,those,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43701,for,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43702,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43703,intake,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43704,.,O,1500.0,Associations with urinary arsenic were similar to those for rice intake .
43817,Many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43818,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43819,these,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43820,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43821,cooperate,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43822,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43823,oxidative,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43824,stress,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43825,reduction,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43826,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43827,plants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43828,",",O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43829,and,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43830,we,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43831,hypothesize,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43832,that,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43833,many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43834,different,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43835,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43836,may,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43837,also,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43838,be,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43839,needed,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43840,for,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43841,the,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43842,proper,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43843,protection,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43844,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43845,animal,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43846,cells,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43847,.,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
44230,60,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44231,migraine,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44232,patients,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44233,completed,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44234,elimination,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44235,diets,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44236,after,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44237,a,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44238,5,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44239,-,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44240,day,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44241,period,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44242,of,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44243,withdrawal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44244,from,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44245,their,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44246,normal,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44247,diet,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44248,.,O,1524.0,60 migraine patients completed elimination diets after a 5 - day period of withdrawal from their normal diet .
44475,A,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44476,positive,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44477,immediate,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44478,skin,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44479,prick,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44480,test,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44481,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44482,SPT,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44483,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44484,for,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44485,paprika,B-http://purl.bioontology.org/ontology/SNOMEDCT/227408005,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44486,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44487,dry,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44488,powder,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44489,of,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44490,Capsicum,B-http://purl.bioontology.org/ontology/SNOMEDCT/421556008,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44491,annuum,I-http://purl.bioontology.org/ontology/SNOMEDCT/421556008,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44492,[,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44493,Solanaceae,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44494,],O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44495,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44496,",",O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44497,coriander,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44498,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44499,Coriandrum,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44500,sativum,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44501,[,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44502,umbelliferous,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44503,],O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44504,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44505,",",O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44506,and,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44507,mace,B-http://purl.bioontology.org/ontology/SNOMEDCT/227404007,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44508,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44509,shell,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44510,of,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44511,nutmeg,B-http://purl.bioontology.org/ontology/SNOMEDCT/735046009,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44512,",",O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44513,Myristica,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44514,fragrans,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44515,[,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44516,Myristicaceae,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44517,],O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44518,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44519,at,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44520,a,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44521,concentration,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44522,of,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44523,10,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44524,%,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44525,(,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44526,w,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44527,/,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44528,v,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44529,),O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44530,was,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44531,obtained,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44532,.,O,1533.0,"A positive immediate skin prick test ( SPT ) for paprika ( dry powder of Capsicum annuum [ Solanaceae ] ) , coriander ( Coriandrum sativum [ umbelliferous ] ) , and mace ( shell of nutmeg , Myristica fragrans [ Myristicaceae ] ) at a concentration of 10 % ( w / v ) was obtained ."
44533,SPT,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44534,with,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44535,other,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44536,sausage,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44537,ingredients,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44538,",",O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44539,mites,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44540,",",O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44541,pollens,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44542,",",O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44543,and,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44544,molds,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44545,were,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44546,negative,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44547,.,O,1534.0,"SPT with other sausage ingredients , mites , pollens , and molds were negative ."
44781,One,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44782,hundred,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44783,female,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44784,Fischer,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44785,344,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44786,rats,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44787,were,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44788,given,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44789,a,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44790,single,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44791,injection,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44792,of,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44793,azoxymethane,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44794,(,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44795,20,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44796,mg,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44797,/,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44798,kg,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44799,i.p,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44800,.,O,1545.0,One hundred female Fischer 344 rats were given a single injection of azoxymethane ( 20 mg / kg i.p .
44886,The,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44887,diets,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44888,were,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44889,given,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44890,ad,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44891,libitum,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44892,for,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44893,100,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44894,days,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44895,",",O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44896,then,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44897,colon,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44898,tumor,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44899,promotion,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44900,was,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44901,assessed,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44902,by,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44903,the,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44904,multiplicity,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44905,of,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44906,aberrant,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44907,crypt,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44908,foci,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44909,[,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44910,number,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44911,of,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44912,crypts,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44913,per,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44914,aberrant,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44915,crypt,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44916,focus,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44917,(,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44918,ACF,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44919,),O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44920,],O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
44921,.,O,1550.0,"The diets were given ad libitum for 100 days , then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [ number of crypts per aberrant crypt focus ( ACF ) ] ."
45236,Finally,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45237,",",O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45238,human,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45239,volunteers,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45240,consumed,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45241,this,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45242,dairy,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45243,product,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45244,and,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45245,24,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45246,-,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45247,h,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45248,urine,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45249,Ca,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45250,was,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45251,measured,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
45252,.,O,1563.0,"Finally , human volunteers consumed this dairy product and 24 - h urine Ca was measured ."
46580,We,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46581,examined,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46582,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46583,Barilla,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46584,Center,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46585,for,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46586,Food,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46587,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46588,Nutrition,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46589,'s,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46590,double,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46591,pyramid,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46592,to,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46593,describe,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46594,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46595,carbon,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46596,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46597,water,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46598,",",O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46599,and,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46600,ecological,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46601,footprints,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46602,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46603,the,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46604,components,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46605,of,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46606,a,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46607,cardio,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46608,-,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46609,protective,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46610,diet,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46611,.,O,1611.0,"We examined the Barilla Center for Food and Nutrition 's double pyramid to describe the carbon , water , and ecological footprints of the components of a cardio - protective diet ."
46649,In,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46650,order,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46651,to,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46652,increase,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46653,the,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46654,sustainability,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46655,of,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46656,a,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46657,cardio,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46658,-,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46659,protective,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46660,diet,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46661,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46662,consumers,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46663,can,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46664,choose,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46665,nuts,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46666,(,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46667,e.g.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46668,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46669,walnuts,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46670,),O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46671,and,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46672,oils,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46673,(,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46674,e.g.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46675,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46676,sunflower,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46677,),O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46678,with,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46679,lower,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46680,water,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46681,footprints,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46682,and,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46683,sustainably,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46684,produced,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46685,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46686,.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
47012,Tea,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47013,flavonoids,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47014,are,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47015,known,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47016,to,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47017,be,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47018,rapidly,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47019,absorbed,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47020,into,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47021,the,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47022,circulation,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47023,following,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47024,oral,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47025,ingestion,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47026,.,O,1627.0,Tea flavonoids are known to be rapidly absorbed into the circulation following oral ingestion .
47433,In,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47434,this,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47435,narrative,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47436,review,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47437,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47438,we,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47439,present,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47440,evidence,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47441,on,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47442,traditional,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47443,endemic,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47444,Mexican,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47445,foods,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47446,such,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47447,as,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47448,cacao,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47449,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47450,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47451,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47452,common,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47453,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47454,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47455,prickle,B-http://purl.bioontology.org/ontology/SNOMEDCT/735050002,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47456,pear,I-http://purl.bioontology.org/ontology/SNOMEDCT/735050002,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47457,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47458,chili,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47459,",",O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47460,avocado,B-http://purl.bioontology.org/ontology/SNOMEDCT/735249009,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47461,and,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47462,salba,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47463,-,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47464,chia,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47465,as,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47466,functional,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47467,agents,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47468,to,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47469,improve,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47470,the,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47471,metabolic,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47472,status,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47473,in,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47474,risk,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47475,phenotypes,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47476,.,O,1641.0,"In this narrative review , we present evidence on traditional endemic Mexican foods such as cacao , corn , common bean , prickle pear , chili , avocado and salba - chia as functional agents to improve the metabolic status in risk phenotypes ."
47544,Baseline,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47545,FFQ,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47546,data,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47547,were,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47548,used,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47549,to,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47550,generate,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47551,thirty,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47552,-,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47553,four,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47554,food,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47555,groups,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47556,.,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47878,The,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47879,glucose,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47880,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47881,insulin,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47882,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47883,C,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47884,-,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47885,peptide,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47886,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47887,alpha,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47888,amino,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47889,nitrogen,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47890,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47891,AAN,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47892,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47893,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47894,glucagon,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47895,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47896,plasma,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47897,urea,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47898,nitrogen,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47899,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47900,PUN,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47901,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47902,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47903,nonesterified,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47904,fatty,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47905,acid,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47906,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47907,NEFA,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47908,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47909,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47910,and,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47911,triglyceride,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47912,area,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47913,responses,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47914,were,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47915,determined,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47916,using,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47917,the,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47918,water,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47919,meal,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47920,as,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47921,a,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47922,baseline,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47923,.,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47956,The,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47957,serum,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47958,insulin,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47959,area,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47960,response,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47961,was,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47962,3.6,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47963,-,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47964,fold,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47965,greater,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47966,following,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47967,ingestion,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47968,of,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47969,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47970,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47971,compared,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47972,with,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47973,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47974,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47975,(,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47976,309,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47977,v,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47978,86,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47979,pmol,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47980,/,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47981,L.h,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47982,),O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47983,.,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
48307,Consistently,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48308,",",O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48309,cholesterol,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48310,appeared,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48311,as,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48312,a,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48313,risk,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48314,factor,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48315,and,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48316,vitamin,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48317,E,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48318,",",O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48319,vitamin,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48320,D,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48321,and,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48322,phosphorus,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48323,as,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48324,independent,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48325,protective,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48326,factors,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48327,.,O,1670.0,"Consistently , cholesterol appeared as a risk factor and vitamin E , vitamin D and phosphorus as independent protective factors ."
48499,The,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48500,objective,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48501,of,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48502,this,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48503,study,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48504,was,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48505,to,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48506,identify,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48507,drivers,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48508,of,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48509,liking,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48510,for,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48511,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48512,chip,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48513,and,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48514,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48515,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48516,samples,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48517,seasoned,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48518,with,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48519,differing,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48520,sodium,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48521,and,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48522,flavor,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48523,enhancer,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48524,concentrations,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48525,using,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48526,sensory,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48527,descriptive,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48528,analysis,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48529,and,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48530,acceptance,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48531,data,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48532,.,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48623,For,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48624,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48625,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48626,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48627,consumers,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48628,liked,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48629,samples,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48630,with,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48631,attributes,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48632,of,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48633,crunchy,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48634,texture,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48635,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48636,garlic,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48637,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48638,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48639,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48640,savory,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48641,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48642,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48643,disliked,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48644,bitter,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48645,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48646,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48647,chili,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48648,powder,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48649,aroma,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48650,-,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48651,by,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48652,-,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48653,mouth,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48654,.,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48830,In,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48831,order,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48832,to,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48833,test,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48834,the,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48835,clinical,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48836,utility,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48837,of,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48838,these,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48839,observations,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48840,",",O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48841,we,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48842,evaluated,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48843,plasma,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48844,glucose,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48845,",",O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48846,insulin,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48847,",",O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48848,and,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48849,gastric,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48850,inhibitory,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48851,polypeptide,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48852,responses,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48853,to,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48854,four,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48855,major,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48856,sources,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48857,of,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48858,carbohydrate,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48859,(,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48860,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48861,",",O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48862,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48863,",",O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48864,spaghetti,B-http://purl.bioontology.org/ontology/SNOMEDCT/226744006,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48865,",",O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48866,lentil,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48867,),O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48868,as,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48869,part,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48870,of,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48871,a,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48872,conventional,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48873,mixed,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48874,meal,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48875,in,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48876,patients,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48877,with,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48878,noninsulin,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48879,-,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48880,dependent,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48881,diabetes,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48882,mellitus,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48883,.,O,1687.0,"In order to test the clinical utility of these observations , we evaluated plasma glucose , insulin , and gastric inhibitory polypeptide responses to four major sources of carbohydrate ( potato , rice , spaghetti , lentil ) as part of a conventional mixed meal in patients with noninsulin - dependent diabetes mellitus ."
48884,Each,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48885,test,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48886,meal,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48887,provided,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48888,40,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48889,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48890,of,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48891,the,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48892,subjects,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48893,',O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48894,calculated,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48895,caloric,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48896,requirement,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48897,and,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48898,contained,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48899,15,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48900,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48901,of,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48902,total,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48903,calories,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48904,as,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48905,protein,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48906,",",O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48907,40,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48908,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48909,as,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48910,fat,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48911,",",O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48912,and,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48913,45,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48914,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48915,as,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48916,carbohydrate,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48917,.,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
49330,In,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49331,total,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49332,",",O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49333,324,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49334,quarters,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49335,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49336,82,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49337,Holstein,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49338,Friesian,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49339,heifers,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49340,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49341,3,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49342,commercial,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49343,dairy,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49344,herds,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49345,equipped,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49346,with,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49347,an,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49348,automatic,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49349,milking,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49350,system,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49351,were,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49352,included,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49353,and,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49354,followed,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49355,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49356,calving,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49357,up,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49358,to,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49359,4,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49360,mo,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49361,in,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49362,lactation,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49363,.,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49441,Overall,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49442,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49443,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49444,IMI,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49445,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49446,early,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49447,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49448,caused,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49449,only,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49450,a,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49451,slight,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49452,but,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49453,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49454,increase,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49455,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49456,qSCC,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49457,compared,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49458,with,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49459,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49460,from,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49461,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49462,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49463,during,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49464,the,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49465,first,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49466,4,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49467,mo,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49468,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49469,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49470,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49471,whereas,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49472,no,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49473,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49474,difference,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49475,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49476,daily,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49477,qMY,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49478,was,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49479,present,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49480,between,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49481,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49482,-,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49483,infected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49484,and,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49485,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49486,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49487,.,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49507,Our,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49508,data,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49509,suggest,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49510,that,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49511,IMI,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49512,with,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49513,NAS,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49514,(,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49515,as,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49516,a,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49517,group,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49518,),O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49519,present,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49520,shortly,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49521,after,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49522,calving,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49523,do,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49524,not,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49525,have,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49526,an,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49527,adverse,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49528,effect,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49529,on,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49530,later,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49531,production,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49532,.,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49565,The,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49566,main,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49567,operators,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49568,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49569,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49570,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49571,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49572,sector,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49573,are,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49574,continuously,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49575,involved,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49576,in,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49577,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49578,development,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49579,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49580,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49581,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49582,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49583,mechanical,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49584,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49585,process,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49586,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49587,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49588,common,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49589,aim,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49590,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49591,increasing,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49592,both,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49593,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49594,quality,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49595,and,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49596,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49597,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49598,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49599,yield,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49600,coupled,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49601,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49602,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49603,potential,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49604,enhancement,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49605,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49606,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49607,working,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49608,efficiency,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49609,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49610,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49611,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49612,mill,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49613,.,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49614,The,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49615,pulsed,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49616,electric,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49617,field,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49618,(,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49619,PEF,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49620,),O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49621,is,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49622,a,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49623,recently,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49624,studied,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49625,technological,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49626,innovation,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49627,for,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49628,the,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49629,improvement,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49630,of,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49631,olive,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49632,oil,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49633,extraction,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49634,technology,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49635,.,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49670,A,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49671,PEF,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49672,can,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49673,increase,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49674,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49675,permeability,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49676,and,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49677,breaking,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49678,of,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49679,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49680,cell,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49681,membranes,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49682,with,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49683,a,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49684,consequent,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49685,positive,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49686,result,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49687,on,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49688,oil,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49689,extractability,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49690,and,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49691,quality,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49692,",",O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49693,mainly,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49694,related,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49695,to,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49696,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49697,compounds,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49698,involved,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49699,in,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49700,the,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49701,health,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49702,and,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49703,sensory,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49704,properties,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49705,of,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49706,extra,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49707,virgin,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49708,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49709,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
49710,.,O,1714.0,"A PEF can increase the permeability and breaking of the cell membranes with a consequent positive result on oil extractability and quality , mainly related to the compounds involved in the health and sensory properties of extra virgin olive oil ."
50225,In,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50226,other,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50227,word,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50228,",",O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50229,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50230,intake,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50231,of,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50232,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50233,dose,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50234,not,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50235,increase,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50236,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50237,blood,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50238,pressure,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50239,compared,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50240,to,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50241,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50242,equivalent,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50243,intake,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50244,of,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50245,salt,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50246,.,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50492,A,O,1741.0,A total of thirteen commonly consumed foods were examined .
50493,total,O,1741.0,A total of thirteen commonly consumed foods were examined .
50494,of,O,1741.0,A total of thirteen commonly consumed foods were examined .
50495,thirteen,O,1741.0,A total of thirteen commonly consumed foods were examined .
50496,commonly,O,1741.0,A total of thirteen commonly consumed foods were examined .
50497,consumed,O,1741.0,A total of thirteen commonly consumed foods were examined .
50498,foods,O,1741.0,A total of thirteen commonly consumed foods were examined .
50499,were,O,1741.0,A total of thirteen commonly consumed foods were examined .
50500,examined,O,1741.0,A total of thirteen commonly consumed foods were examined .
50501,.,O,1741.0,A total of thirteen commonly consumed foods were examined .
50627,Monofunctional,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50628,inducers,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50629,(,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50630,MIs,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50631,),O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50632,enhance,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50633,phase,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50634,2,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50635,enzymes,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50636,such,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50637,as,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50638,nicotinamide,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50639,-,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50640,adenine,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50641,-,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50642,dinucleotide,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50643,-,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50644,phosphate,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50645,[,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50646,NAD(P)H,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50647,],O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50648,quinone,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50649,oxidoreductase,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50650,(,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50651,NQO1,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50652,),O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50653,without,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50654,modifying,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50655,oxidation,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50656,enzymes,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
50657,.,O,1744.0,Monofunctional inducers ( MIs ) enhance phase 2 enzymes such as nicotinamide - adenine - dinucleotide - phosphate [ NAD(P)H ] quinone oxidoreductase ( NQO1 ) without modifying oxidation enzymes .
51348,Wheat,O,1762.0,Wheat ( Triticum spp .
51349,(,O,1762.0,Wheat ( Triticum spp .
51350,Triticum,O,1762.0,Wheat ( Triticum spp .
51351,spp,O,1762.0,Wheat ( Triticum spp .
51352,.,O,1762.0,Wheat ( Triticum spp .
51763,After,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51764,42,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51765,d,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51766,total,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51767,cholesterol,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51768,and,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51769,HDL,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51770,-,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51771,cholesterol,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51772,levels,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51773,were,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51774,raised,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51775,significantly,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51776,in,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51777,all,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51778,groups,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51779,",",O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51780,but,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51781,to,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51782,different,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51783,extents,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
51784,.,O,1775.0,"After 42 d total cholesterol and HDL - cholesterol levels were raised significantly in all groups , but to different extents ."
52319,In,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52320,general,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52321,",",O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52322,the,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52323,data,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52324,are,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52325,not,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52326,more,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52327,consistent,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52328,for,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52329,green,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52330,than,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52331,for,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52332,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1794.0,"In general , the data are not more consistent for green than for black tea ."
52333,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226476000;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1794.0,"In general , the data are not more consistent for green than for black tea ."
52334,.,O,1794.0,"In general , the data are not more consistent for green than for black tea ."
52525,Dietary,O,1802.0,Dietary intake was assessed using a FFQ .
52526,intake,O,1802.0,Dietary intake was assessed using a FFQ .
52527,was,O,1802.0,Dietary intake was assessed using a FFQ .
52528,assessed,O,1802.0,Dietary intake was assessed using a FFQ .
52529,using,O,1802.0,Dietary intake was assessed using a FFQ .
52530,a,O,1802.0,Dietary intake was assessed using a FFQ .
52531,FFQ,O,1802.0,Dietary intake was assessed using a FFQ .
52532,.,O,1802.0,Dietary intake was assessed using a FFQ .
52533,A,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52534,Mediterranean,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52535,diet,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52536,score,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52537,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52538,including,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52539,foods,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52540,considered,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52541,to,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52542,be,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52543,characteristic,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52544,components,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52545,of,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52546,the,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52547,traditional,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52548,Mediterranean,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52549,diet,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52550,(,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52551,vegetables,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52552,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52553,fruits,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52554,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52555,pulses,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52556,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52557,nuts,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52558,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52559,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52560,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52561,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52562,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52563,cereals,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52564,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52565,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52566,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52567,",",O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52568,and,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52569,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52570,),O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52571,was,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52572,created,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52573,.,O,1803.0,"A Mediterranean diet score , including foods considered to be characteristic components of the traditional Mediterranean diet ( vegetables , fruits , pulses , nuts , fish , meat , cereals , olive oil , and wine ) was created ."
52814,Effects,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52815,of,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52816,spice,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52817,extracts,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52818,on,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52819,the,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52820,viability,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52821,of,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52822,88,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52823,anaerobic,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52824,and,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52825,facultative,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52826,isolates,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52827,from,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52828,intestinal,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52829,microbiota,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52830,were,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52831,determined,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52832,by,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52833,using,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52834,Brucella,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52835,agar,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52836,plates,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52837,containing,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52838,serial,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52839,dilutions,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52840,of,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52841,extracts,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52842,.,O,1812.0,Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts .
52863,Spice,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52864,extracts,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52865,exhibited,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52866,high,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52867,antioxidant,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52868,capacity,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52869,that,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52870,correlated,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52871,with,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52872,the,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52873,total,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52874,amount,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52875,of,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52876,major,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52877,chemicals,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52878,.,O,1814.0,Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals .
52910,Cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52911,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52912,oregano,B-http://purl.bioontology.org/ontology/SNOMEDCT/227407000,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52913,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52914,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52915,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52916,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52917,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52918,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52919,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52920,Fusobacterium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52921,strains,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52922,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52923,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52924,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52925,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52926,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52927,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52928,turmeric,B-http://purl.bioontology.org/ontology/SNOMEDCT/227414003,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52929,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52930,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52931,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52932,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52933,Clostridium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52934,spp,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52935,.,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
53227,The,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53228,insulinaemic,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53229,indices,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53230,of,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53231,the,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53232,mashed,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53233,potato,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53234,-,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53235,based,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53236,meals,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53237,varied,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53238,between,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53239,94,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53240,and,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53241,148,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53242,.,O,1830.0,The insulinaemic indices of the mashed potato - based meals varied between 94 and 148 .
53324,Neuroendocrine,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53325,tumors,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53326,(,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53327,NETs,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53328,),O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53329,are,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53330,rare,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53331,neoplasms,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53332,mostly,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53333,originating,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53334,from,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53335,the,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53336,gastroenteropancreatic,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53337,tract,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53338,(,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53339,GEP,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53340,-,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53341,NETs,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53342,),O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53343,.,O,1835.0,Neuroendocrine tumors ( NETs ) are rare neoplasms mostly originating from the gastroenteropancreatic tract ( GEP - NETs ) .
53356,The,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53357,aim,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53358,of,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53359,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53360,study,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53361,was,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53362,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53363,investigate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53364,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53365,nutritional,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53366,status,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53367,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53368,adherence,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53369,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53370,the,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53371,Mediterranean,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53372,Diet,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53373,(,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53374,MD,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53375,),O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53376,in,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53377,GEP,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53378,-,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53379,NET,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53380,patients,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53381,and,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53382,to,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53383,correlate,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53384,them,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53385,with,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53386,tumor,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53387,aggressiveness,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
53388,.,O,1837.0,The aim of the study was to investigate the nutritional status and adherence to the Mediterranean Diet ( MD ) in GEP - NET patients and to correlate them with tumor aggressiveness .
54200,It,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54201,was,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54202,suggested,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54203,that,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54204,urothelial,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54205,cancer,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54206,death,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54207,could,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54208,be,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54209,potentially,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54210,preventable,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54211,by,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54212,smoking,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54213,cessation,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54214,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54215,regular,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54216,intake,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54217,of,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54218,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54219,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54220,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54221,.,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54222,It,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54223,is,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54224,known,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54225,that,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54226,patients,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54227,with,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54228,pollinosis,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54229,may,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54230,display,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54231,clinical,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54232,characteristics,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54233,caused,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54234,by,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54235,allergy,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54236,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54237,certain,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54238,fruits,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54239,and,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54240,vegetables,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54241,",",O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54242,but,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54243,subjects,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54244,allergic,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54245,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54246,Artemisia,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54247,seem,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54248,to,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54249,show,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54250,particularly,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54251,peculiar,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54252,characteristics,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54253,.,O,1872.0,"It is known that patients with pollinosis may display clinical characteristics caused by allergy to certain fruits and vegetables , but subjects allergic to Artemisia seem to show particularly peculiar characteristics ."
54487,Results,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54488,showed,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54489,the,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54490,existence,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54491,of,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54492,common,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54493,antigenic,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54494,epitopes,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54495,in,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54496,pistachio,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54497,and,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54498,Artemisia,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54499,pollen,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54500,for,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54501,this,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54502,patient,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54503,.,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54617,For,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54618,colon,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54619,cancer,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54620,",",O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54621,no,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54622,statistically,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54623,significant,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54624,associations,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54625,with,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54626,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54627,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54628,intake,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54629,or,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54630,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54631,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54632,intake,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54633,were,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54634,found,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54635,.,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54718,For,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54719,rectal,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54720,cancer,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54721,",",O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54722,no,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54723,statistically,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54724,significant,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54725,associations,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54726,were,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54727,found,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54728,for,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54729,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54730,consumption,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54731,or,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54732,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54733,consumption,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54734,or,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54735,for,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54736,specific,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54737,groups,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54738,of,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54739,vegetables,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54740,and,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54741,fruits,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54742,;,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54743,only,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54744,Brassica,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54745,vegetables,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54746,showed,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54747,a,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54748,positive,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54749,association,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54750,in,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54751,women,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54752,.,O,1890.0,"For rectal cancer , no statistically significant associations were found for vegetable consumption or fruit consumption or for specific groups of vegetables and fruits ; only Brassica vegetables showed a positive association in women ."
54972,In,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54973,the,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54974,present,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54975,study,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54976,it,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54977,is,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54978,shown,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54979,that,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54980,the,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54981,occurrence,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54982,of,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54983,myosmine,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54984,is,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54985,widespread,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54986,throughout,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54987,a,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54988,large,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54989,number,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54990,of,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54991,plant,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54992,families,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54993,.,O,1899.0,In the present study it is shown that the occurrence of myosmine is widespread throughout a large number of plant families .
54994,Using,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
54995,a,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
54996,method,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
54997,for,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
54998,extraction,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
54999,practicable,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55000,for,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55001,all,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55002,examined,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55003,foods,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55004,",",O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55005,quantitative,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55006,analysis,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55007,through,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55008,internal,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55009,standard,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55010,addition,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55011,showed,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55012,nanograms,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55013,per,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55014,gram,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55015,amounts,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55016,.,O,1900.0,"Using a method for extraction practicable for all examined foods , quantitative analysis through internal standard addition showed nanograms per gram amounts ."
55017,Positively,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55018,tested,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55019,edibles,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55020,were,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55021,staple,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55022,foods,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55023,such,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55024,as,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55025,maize,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55026,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55027,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55028,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55029,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55030,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55031,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55032,millet,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55033,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55034,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55035,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55036,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55037,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55038,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55039,also,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55040,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55041,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55042,popcorn,B-http://purl.bioontology.org/ontology/SNOMEDCT/226726003,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55043,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55044,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55045,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55046,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55047,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55048,pineapple,B-http://purl.bioontology.org/ontology/SNOMEDCT/256313003,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55049,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55050,kiwi,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55051,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55052,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55053,apples,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55054,.,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55055,No,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55056,myosmine,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55057,was,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55058,detectable,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55059,in,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55060,other,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55061,vegetables,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55062,and,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55063,fruits,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55064,such,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55065,as,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55066,lettuce,B-http://purl.bioontology.org/ontology/SNOMEDCT/735042006,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55067,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55068,spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55069,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55070,cucumber,B-http://purl.bioontology.org/ontology/SNOMEDCT/735213008,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55071,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55072,onion,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55073,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55074,banana,B-http://purl.bioontology.org/ontology/SNOMEDCT/256307007,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55075,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55076,tangerines,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55077,",",O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55078,and,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55079,grapes,B-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55080,.,O,1902.0,"No myosmine was detectable in other vegetables and fruits such as lettuce , spinach , cucumber , onion , banana , tangerines , and grapes ."
55541,These,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55542,findings,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55543,suggest,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55544,that,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55545,current,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55546,recommendations,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55547,to,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55548,reduce,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55549,total,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55550,fat,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55551,intake,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55552,and,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55553,to,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55554,reduce,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55555,the,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55556,proportion,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55557,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55558,saturated,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55559,fats,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55560,used,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55561,are,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55562,not,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55563,being,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55564,followed,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55565,",",O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55566,at,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55567,least,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55568,in,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55569,respect,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55570,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55571,spread,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55572,",",O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55573,by,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55574,those,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55575,at,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55576,greatest,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55577,risk,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55578,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55579,coronary,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55580,heart,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55581,disease,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55582,.,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
56025,Micronutrient,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56026,inadequacies,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56027,were,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56028,also,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56029,observed,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56030,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56031,particularly,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56032,for,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56033,calcium,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56034,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56035,iron,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56036,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56037,zinc,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56038,and,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56039,vitamins,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56040,A,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56041,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56042,D,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56043,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56044,C,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56045,",",O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56046,and,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56047,folate,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56048,.,O,1935.0,"Micronutrient inadequacies were also observed , particularly for calcium , iron , zinc and vitamins A , D , C , and folate ."
56101,Pomegranate,O,1937.0,Pomegranate is a rich source of polyphenols .
56102,is,O,1937.0,Pomegranate is a rich source of polyphenols .
56103,a,O,1937.0,Pomegranate is a rich source of polyphenols .
56104,rich,O,1937.0,Pomegranate is a rich source of polyphenols .
56105,source,O,1937.0,Pomegranate is a rich source of polyphenols .
56106,of,O,1937.0,Pomegranate is a rich source of polyphenols .
56107,polyphenols,O,1937.0,Pomegranate is a rich source of polyphenols .
56108,.,O,1937.0,Pomegranate is a rich source of polyphenols .
57499,As,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57500,is,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57501,known,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57502,",",O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57503,diet,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57504,plays,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57505,an,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57506,important,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57507,role,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57508,in,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57509,the,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57510,management,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57511,of,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57512,diabetes,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57513,.,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57548,We,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57549,recruited,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57550,65,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57551,Saharawi,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57552,type,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57553,II,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57554,diabetic,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57555,women,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57556,taking,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57557,orally,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57558,glucose,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57559,-,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57560,lowering,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57561,drugs,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57562,only,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
57563,.,O,1991.0,We recruited 65 Saharawi type II diabetic women taking orally glucose - lowering drugs only .
59008,The,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59009,GI,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59010,of,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59011,pilsner,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59012,beer,I-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59013,was,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59014,89,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59015,(,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59016,SD,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59017,5,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59018,),O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59019,.,O,2041.0,The GI of pilsner beer was 89 ( SD 5 ) .
59737,This,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59738,study,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59739,confirms,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59740,previously,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59741,reported,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59742,evidence,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59743,that,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59744,heme,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59745,-,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59746,Fe,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59747,is,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59748,involved,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59749,in,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59750,the,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59751,epidemiological,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59752,association,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59753,between,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59754,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59755,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59756,consumption,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59757,and,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59758,colorectal,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59759,cancer,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59760,",",O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59761,but,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59762,questions,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59763,the,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59764,role,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59765,of,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59766,nitrite,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59767,curing,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59768,in,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59769,this,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59770,association,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59771,.,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59917,Independently,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59918,",",O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59919,frequency,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59920,of,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59921,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59922,drinking,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59923,was,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59924,associated,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59925,with,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59926,lower,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59927,mortality,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59928,risk,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59929,(,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59930,p<0.001,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59931,),O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59932,largely,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59933,because,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59934,of,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59935,lower,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59936,coronary,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59937,disease,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59938,risk,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59939,.,O,2074.0,"Independently , frequency of wine drinking was associated with lower mortality risk ( p<0.001 ) largely because of lower coronary disease risk ."
59940,Similar,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59941,risk,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59942,reductions,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59943,were,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59944,associated,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59945,with,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59946,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59947,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59948,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59949,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59950,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59951,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59952,other,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59953,types,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59954,of,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59955,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59956,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59957,and,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59958,combinations,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59959,of,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59960,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59961,types,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59962,.,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
60022,The,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60023,consumption,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60024,of,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60025,animal,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60026,products,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60027,exposes,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60028,humans,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60029,to,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60030,saturated,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60031,fat,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60032,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60033,cholesterol,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60034,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60035,lactose,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60036,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60037,estrogens,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60038,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60039,and,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60040,pathogenic,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60041,microorganisms,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60042,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60043,while,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60044,displacing,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60045,fiber,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60046,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60047,complex,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60048,carbohydrates,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60049,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60050,antioxidants,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60051,",",O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60052,and,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60053,other,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60054,components,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60055,needed,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60056,for,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60057,health,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60058,.,O,2078.0,"The consumption of animal products exposes humans to saturated fat , cholesterol , lactose , estrogens , and pathogenic microorganisms , while displacing fiber , complex carbohydrates , antioxidants , and other components needed for health ."
60705,Nutritional,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60706,information,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60707,does,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60708,impact,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60709,consumers,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60710,',O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60711,perceptions,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60712,of,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60713,the,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60714,healthfulness,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60715,of,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60716,beverages,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60717,.,O,2106.0,Nutritional information does impact consumers ' perceptions of the healthfulness of beverages .
60942,After,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60943,calving,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60944,",",O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60945,body,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60946,condition,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60947,score,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60948,(,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60949,BCS,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60950,),O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60951,decrease,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60952,was,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60953,greater,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60954,for,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60955,control,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60956,compared,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60957,with,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60958,treated,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60959,cows,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
60960,.,O,2114.0,"After calving , body condition score ( BCS ) decrease was greater for control compared with treated cows ."
61045,Blood,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61046,and,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61047,milk,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61048,parameters,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61049,do,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61050,not,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61051,indicate,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61052,any,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61053,adverse,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61054,effects,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61055,of,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61056,feeding,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61057,this,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61058,natural,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61059,compound,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61060,.,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61304,Moreover,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61305,",",O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61306,cocoa,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61307,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61308,rich,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61309,diet,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61310,suppressed,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61311,c,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61312,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61313,Jun,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61314,N,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61315,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61316,terminal,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61317,kinase,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61318,and,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61319,p38,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61320,activation,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61321,caused,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61322,by,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61323,insulin,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61324,resistance,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61325,.,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61886,Substantial,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61887,experimental,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61888,studies,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61889,indicated,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61890,that,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61891,many,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61892,dietary,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61893,natural,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61894,products,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61895,could,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61896,affect,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61897,the,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61898,development,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61899,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61900,progression,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61901,of,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61902,breast,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61903,cancer,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61904,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61905,such,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61906,as,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61907,soy,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61908,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61909,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61910,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61911,mangosteen,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61912,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61913,citrus,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61914,fruits,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61915,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61916,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61917,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61918,grape,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61919,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61920,mango,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61921,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61922,cruciferous,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61923,vegetables,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61924,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61925,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61926,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61927,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61928,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61929,black,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61930,cumin,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61931,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61932,edible,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61933,macro,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61934,-,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61935,fungi,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61936,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61937,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61938,cereals,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61939,.,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
62100,Fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2153.0,Fruit and vegetable consumption was assessed at baseline .
62101,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2153.0,Fruit and vegetable consumption was assessed at baseline .
62102,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2153.0,Fruit and vegetable consumption was assessed at baseline .
62103,consumption,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62104,was,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62105,assessed,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62106,at,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62107,baseline,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62108,.,O,2153.0,Fruit and vegetable consumption was assessed at baseline .
62144,A,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62145,lower,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62146,risk,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62147,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62148,colon,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62149,cancer,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62150,was,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62151,observed,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62152,with,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62153,higher,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62154,self,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62155,-,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62156,reported,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62157,consumption,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62158,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62159,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62160,and,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62161,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62162,combined,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62163,(,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62164,HR,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62165,Q4,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62166,vs.,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62167,Q1,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62168,0.87,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62169,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62170,95,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62171,%,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62172,CI,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62173,0.75,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62174,-,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62175,1.01,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62176,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62177,p,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62178,for,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62179,trend,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62180,0.02,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62181,),O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62182,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62183,but,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62184,no,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62185,consistent,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62186,association,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62187,was,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62188,observed,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62189,for,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62190,separate,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62191,consumption,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62192,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62193,fruits,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62194,and,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62195,vegetables,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62196,.,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62692,Due,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62693,to,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62694,their,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62695,high,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62696,endogenous,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62697,enzyme,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62698,activities,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62699,",",O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62700,apples,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62701,and,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62702,other,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62703,fruits,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62704,require,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62705,special,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62706,extraction,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62707,procedures,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62708,applying,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62709,either,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62710,low,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62711,temperature,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62712,or,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62713,enzyme,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62714,inhibitors,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
62715,.,O,2176.0,"Due to their high endogenous enzyme activities , apples and other fruits require special extraction procedures applying either low temperature or enzyme inhibitors ."
63578,Response,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63579,surface,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63580,methodology,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63581,(,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63582,RSM,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63583,),O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63584,was,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63585,used,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63586,to,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63587,optimize,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63588,the,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63589,cooking,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63590,conditions,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63591,.,O,2206.0,Response surface methodology ( RSM ) was used to optimize the cooking conditions .
63891,Two,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63892,factors,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63893,were,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63894,retained,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63895,for,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63896,both,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63897,women,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63898,and,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63899,men,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63900,",",O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63901,which,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63902,accounted,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63903,for,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63904,15.1,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63905,-,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63906,17.4,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63907,%,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63908,of,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63909,the,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63910,total,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63911,variation,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
63912,.,O,2220.0,"Two factors were retained for both women and men , which accounted for 15.1 - 17.4 % of the total variation ."
64145,Current,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64146,scientific,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64147,evidence,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64148,also,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64149,suggests,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64150,a,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64151,protective,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64152,role,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64153,for,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64154,fruits,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64155,and,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64156,vegetables,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64157,in,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64158,prevention,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64159,of,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64160,coronary,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64161,heart,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64162,disease,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64163,",",O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64164,and,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64165,evidence,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64166,is,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64167,accumulating,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64168,for,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64169,a,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64170,protective,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64171,role,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64172,in,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64173,stroke,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64174,.,O,2231.0,"Current scientific evidence also suggests a protective role for fruits and vegetables in prevention of coronary heart disease , and evidence is accumulating for a protective role in stroke ."
64264,The,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64265,evidence,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64266,reviewed,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64267,provides,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64268,additional,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64269,support,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64270,for,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64271,increased,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64272,consumption,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64273,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64274,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64275,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64276,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64277,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64278,vegetables,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64279,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64280,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64281,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64282,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64283,dark,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64284,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64285,green,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64286,leafy,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64287,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64288,cruciferous,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64289,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64290,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64291,deep,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64292,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64293,yellow,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64294,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64295,orange,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64296,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64297,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64298,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64299,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64300,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64301,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64302,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64303,fruits,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64304,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64305,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64306,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64307,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64308,citrus,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64309,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64310,deep,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64311,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64312,yellow,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64313,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64314,orange,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64315,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64316,.,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64657,In,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64658,this,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64659,study,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64660,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64661,pot,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64662,experiments,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64663,were,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64664,conducted,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64665,to,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64666,determine,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64667,the,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64668,effects,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64669,of,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64670,industrial,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64671,solid,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64672,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64673,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64674,ISWs,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64675,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64676,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64677,ceramic,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64678,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64679,stone,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64680,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64681,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64682,sugar,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64683,factory,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64684,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64685,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64686,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64687,organic,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64688,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64689,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64690,rice,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64691,husk,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64692,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64693,wheat,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64694,straw,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64695,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64696,on,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64697,growth,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64698,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64699,heavy,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64700,metals,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64701,uptake,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64702,by,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64703,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64704,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64705,Lycopersicum,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64706,esculentum,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64707,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64708,plants,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64709,.,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64710,The,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64711,soil,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64712,was,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64713,treated,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64714,with,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64715,10,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64716,%,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64717,of,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64718,ISWs,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64719,and,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64720,5,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64721,%,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64722,of,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64723,organic,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64724,wastes,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64725,.,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64799,The,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64800,application,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64801,of,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64802,ISWs,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64803,caused,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64804,an,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64805,increase,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64806,in,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64807,heavy,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64808,metal,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64809,contents,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64810,of,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64811,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64812,plants,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
64813,.,O,2255.0,The application of ISWs caused an increase in heavy metal contents of tomato plants .
65661,Complete,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65662,history,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65663,of,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65664,beverage,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65665,intake,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65666,was,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65667,assessed,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65668,by,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65669,a,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65670,personal,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65671,interview,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65672,with,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65673,reference,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65674,to,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65675,a,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65676,1,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65677,-,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65678,year,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65679,period,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65680,prior,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65681,to,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65682,diagnosis,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65683,or,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65684,interview,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65685,.,O,2289.0,Complete history of beverage intake was assessed by a personal interview with reference to a 1 - year period prior to diagnosis or interview .
65813,Soybean,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65814,oil,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65815,consumption,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65816,is,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65817,increasing,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65818,worldwide,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65819,and,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65820,parallels,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65821,a,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65822,rise,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65823,in,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65824,obesity,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
65825,.,O,2296.0,Soybean oil consumption is increasing worldwide and parallels a rise in obesity .
66332,There,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66333,is,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66334,accumulating,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66335,evidence,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66336,that,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66337,much,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66338,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66339,the,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66340,health,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66341,-,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66342,promoting,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66343,potential,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66344,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66345,these,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66346,plant,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66347,foods,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66348,may,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66349,come,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66350,from,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66351,phytochemicals,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66352,",",O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66353,bioactive,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66354,compounds,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66355,not,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66356,designated,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66357,as,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66358,traditional,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66359,nutrients,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66360,.,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66943,More,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66944,detailed,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66945,assessment,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66946,of,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66947,specific,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66948,alcoholic,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66949,beverages,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66950,is,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66951,warranted,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66952,in,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66953,future,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66954,studies,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66955,.,O,2338.0,More detailed assessment of specific alcoholic beverages is warranted in future studies .
66956,Limited,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66957,research,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66958,exists,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66959,on,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66960,how,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66961,different,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66962,oil,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66963,types,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66964,and,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66965,time,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66966,of,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66967,addition,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66968,affect,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66969,starch,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66970,digestibility,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66971,of,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66972,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
66973,.,O,2339.0,Limited research exists on how different oil types and time of addition affect starch digestibility of rice .
67167,This,O,2346.0,This is the first report to show healthier ways of preparing rice .
67168,is,O,2346.0,This is the first report to show healthier ways of preparing rice .
67169,the,O,2346.0,This is the first report to show healthier ways of preparing rice .
67170,first,O,2346.0,This is the first report to show healthier ways of preparing rice .
67171,report,O,2346.0,This is the first report to show healthier ways of preparing rice .
67172,to,O,2346.0,This is the first report to show healthier ways of preparing rice .
67173,show,O,2346.0,This is the first report to show healthier ways of preparing rice .
67174,healthier,O,2346.0,This is the first report to show healthier ways of preparing rice .
67175,ways,O,2346.0,This is the first report to show healthier ways of preparing rice .
67176,of,O,2346.0,This is the first report to show healthier ways of preparing rice .
67177,preparing,O,2346.0,This is the first report to show healthier ways of preparing rice .
67178,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2346.0,This is the first report to show healthier ways of preparing rice .
67179,.,O,2346.0,This is the first report to show healthier ways of preparing rice .
67591,Tomatoes,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67592,are,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67593,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67594,fourth,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67595,most,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67596,commonly,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67597,consumed,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67598,fresh,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67599,vegetable,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67600,and,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67601,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67602,most,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67603,frequently,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67604,consumed,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67605,canned,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67606,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67607,in,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67608,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67609,American,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67610,diet,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67611,.,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67664,Recent,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67665,animal,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67666,studies,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67667,have,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67668,investigated,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67669,tomatoes,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67670,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67671,lycopene,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67672,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67673,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67674,prostate,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67675,cancer,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67676,using,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67677,the,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67678,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67679,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67680,methyl,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67681,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67682,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67683,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67684,nitrosourea,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67685,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67686,Dunning,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67687,rat,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67688,models,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67689,.,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
68808,Proportional,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68809,multi,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68810,-,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68811,state,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68812,multiple,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68813,-,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68814,cohort,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68815,Markov,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68816,modelling,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68817,estimated,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68818,likely,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68819,resultant,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68820,health,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68821,adjusted,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68822,life,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68823,years,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68824,(,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68825,HALYs,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68826,),O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68827,gained,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68828,and,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68829,healthcare,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68830,costs,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68831,saved,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68832,over,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68833,the,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68834,lifetime,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68835,of,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68836,the,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68837,2010,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68838,Australian,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68839,population,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
68840,.,O,2400.0,Proportional multi - state multiple - cohort Markov modelling estimated likely resultant health adjusted life years ( HALYs ) gained and healthcare costs saved over the lifetime of the 2010 Australian population .
69025,Ingredients,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69026,mentioned,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69027,on,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69028,the,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69029,labels,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69030,of,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69031,commercially,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69032,available,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69033,packaged,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69034,gluten,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69035,-,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69036,free,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69037,and,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69038,similar,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69039,gluten,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69040,-,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69041,containing,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69042,food,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69043,products,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69044,were,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69045,analyzed,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69046,and,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69047,compared,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69048,",",O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69049,using,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69050,the,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69051,text,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69052,mining,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69053,technique,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
69054,.,O,2405.0,"Ingredients mentioned on the labels of commercially available packaged gluten - free and similar gluten - containing food products were analyzed and compared , using the text mining technique ."
70580,Milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70581,is,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70582,also,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70583,a,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70584,source,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70585,of,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70586,animal,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70587,fats,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70588,in,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70589,the,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70590,diet,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70591,",",O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70592,and,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70593,animal,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70594,fat,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70595,intake,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70596,is,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70597,associated,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70598,with,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70599,ovarian,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70600,cancer,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70601,risk,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70602,.,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70662,Total,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70663,frequency,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70664,of,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70665,usual,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70666,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70667,intake,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70668,was,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70669,not,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70670,associated,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70671,with,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70672,increased,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70673,risk,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70674,.,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
71234,Metabolites,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71235,of,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71236,acetic,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71237,acid,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71238,and,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71239,lactic,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71240,acid,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71241,bacteria,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71242,",",O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71243,two,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71244,major,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71245,cocobiota,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71246,members,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71247,",",O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71248,are,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71249,recently,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71250,shown,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71251,to,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71252,have,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71253,considerable,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71254,antifungal,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71255,and,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71256,cholesterol,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71257,-,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71258,lowering,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71259,activities,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71260,and,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71261,promote,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71262,the,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71263,formation,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71264,of,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71265,short,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71266,chain,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71267,fatty,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71268,acids,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71269,and,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71270,mannitol,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71271,",",O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71272,an,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71273,important,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71274,prebiotic,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71275,capable,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71276,of,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71277,modifying,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71278,gut,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71279,microbiota,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71280,.,O,2479.0,"Metabolites of acetic acid and lactic acid bacteria , two major cocobiota members , are recently shown to have considerable antifungal and cholesterol - lowering activities and promote the formation of short chain fatty acids and mannitol , an important prebiotic capable of modifying gut microbiota ."
71319,Moreover,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71320,",",O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71321,recent,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71322,results,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71323,suggest,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71324,that,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71325,bacterial,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71326,and,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71327,fungal,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71328,metabolites,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71329,produced,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71330,by,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71331,cocobiota,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71332,have,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71333,a,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71334,significant,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71335,anti,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71336,-,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71337,infective,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71338,potential,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71339,.,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
72299,Multivariate,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72300,regression,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72301,models,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72302,assessed,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72303,associations,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72304,between,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72305,dietary,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72306,patterns,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72307,and,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72308,QoL,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72309,changes,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72310,over,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72311,time,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72312,.,O,2515.0,Multivariate regression models assessed associations between dietary patterns and QoL changes over time .
72470,A,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72471,"""",O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72472,Western,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72473,"""",O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72474,dietary,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72475,pattern,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72476,after,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72477,surgery,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72478,is,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72479,inversely,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72480,associated,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72481,with,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72482,QoL,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72483,in,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72484,CRC,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72485,patients,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72486,",",O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72487,whereas,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72488,a,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72489,diet,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72490,rich,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72491,in,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72492,fruits,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72493,and,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72494,vegetables,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72495,may,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72496,be,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72497,beneficial,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72498,for,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72499,patients,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72500,',O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72501,QoL,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72502,over,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72503,time,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72504,.,O,2519.0,"A "" Western "" dietary pattern after surgery is inversely associated with QoL in CRC patients , whereas a diet rich in fruits and vegetables may be beneficial for patients ' QoL over time ."
72876,Reduced,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72877,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72878,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72879,was,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72880,the,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72881,most,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72882,commonly,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72883,consumed,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72884,dairy,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72885,product,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72886,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72887,235,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72888,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72889,200,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72890,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72891,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72892,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72893,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72894,",",O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72895,followed,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72896,by,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72897,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72898,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72899,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72900,63,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72901,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72902,128,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72903,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72904,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72905,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72906,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72907,and,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72908,yoghurt,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72909,(,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72910,53,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72911,±,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72912,66,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72913,g,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72914,/,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72915,day,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72916,),O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
72917,.,O,2531.0,"Reduced fat milk was the most commonly consumed dairy product ( 235 ± 200 g / day ) , followed by whole milk ( 63 ± 128 g / day ) and yoghurt ( 53 ± 66 g / day ) ."
73679,Each,O,2559.0,Each subject served as his own control .
73680,subject,O,2559.0,Each subject served as his own control .
73681,served,O,2559.0,Each subject served as his own control .
73682,as,O,2559.0,Each subject served as his own control .
73683,his,O,2559.0,Each subject served as his own control .
73684,own,O,2559.0,Each subject served as his own control .
73685,control,O,2559.0,Each subject served as his own control .
73686,.,O,2559.0,Each subject served as his own control .
73833,These,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73834,results,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73835,indicate,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73836,that,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73837,the,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73838,insulin,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73839,response,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73840,can,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73841,not,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73842,be,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73843,predicted,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73844,by,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73845,the,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73846,glucose,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73847,response,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73848,.,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73881,The,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73882,objectives,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73883,of,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73884,this,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73885,study,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73886,were,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73887,to,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73888,identify,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73889,associations,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73890,between,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73891,maternal,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73892,dietary,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73893,patterns,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73894,in,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73895,the,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73896,12,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73897,mo,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73898,before,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73899,conception,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73900,on,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73901,fetal,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73902,growth,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73903,and,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73904,preterm,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73905,delivery,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
73906,.,O,2567.0,The objectives of this study were to identify associations between maternal dietary patterns in the 12 mo before conception on fetal growth and preterm delivery .
74856,In,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74857,June,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74858,/,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74859,July,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74860,2010,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74861,one,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74862,hundred,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74863,samples,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74864,from,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74865,seven,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74866,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74867,categories,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74868,were,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74869,purchased,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74870,from,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74871,around,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74872,the,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74873,country,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74874,and,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74875,individually,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74876,analysed,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74877,for,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74878,the,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74879,amount,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74880,of,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74881,folic,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74882,acid,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74883,they,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74884,contained,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
74885,.,O,2601.0,In June / July 2010 one hundred samples from seven bread categories were purchased from around the country and individually analysed for the amount of folic acid they contained .
75426,Hence,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75427,",",O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75428,the,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75429,baby,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75430,food,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75431,industry,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75432,decided,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75433,to,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75434,remove,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75435,added,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75436,salt,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75437,from,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75438,formula,B-http://purl.bioontology.org/ontology/SNOMEDCT/386127005;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75439,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/386127005;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75440,.,O,2622.0,"Hence , the baby food industry decided to remove added salt from formula milk ."
75508,In,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75509,all,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75510,cases,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75511,",",O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75512,both,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75513,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75514,clinical,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75515,and,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75516,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75517,laboratory,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75518,features,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75519,remitted,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75520,in,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75521,≤7,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75522,days,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75523,when,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75524,the,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75525,infants,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75526,were,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75527,fed,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75528,on,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75529,formula,B-http://purl.bioontology.org/ontology/SNOMEDCT/386127005;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75530,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/386127005;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75531,with,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75532,a,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75533,normal,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75534,chloride,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75535,content,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75536,.,O,2625.0,"In all cases , both the clinical and the laboratory features remitted in ≤7 days when the infants were fed on formula milk with a normal chloride content ."
75652,Trends,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75653,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75654,food,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75655,consumption,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75656,show,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75657,increases,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75658,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75659,intakes,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75660,of,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75661,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75662,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75663,dairy,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75664,products,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75665,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75666,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75667,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75668,and,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75669,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75670,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75671,but,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75672,decreases,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75673,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75674,consumption,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75675,of,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75676,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75677,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75678,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75679,sugar,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75680,",",O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75681,and,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75682,all,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75683,foods,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75684,rich,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75685,in,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75686,carbohydrates,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
75687,.,O,2631.0,"Trends in food consumption show increases in intakes of meat , dairy products , fish , and fruit , but decreases in consumption of olive oil , sugar , and all foods rich in carbohydrates ."
76386,Mastitis,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76387,was,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76388,characterized,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76389,by,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76390,increased,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76391,variance,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76392,in,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76393,milk,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76394,production,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76395,volume,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76396,.,O,2653.0,Mastitis was characterized by increased variance in milk production volume .
76433,With,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76434,the,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76435,exclusion,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76436,of,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76437,the,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76438,low,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76439,-,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76440,production,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76441,cows,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76442,",",O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76443,the,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76444,model,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76445,predicted,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76446,that,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76447,healthy,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76448,cows,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76449,required,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76450,a,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76451,milk,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76452,discard,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76453,time,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76454,12,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76455,h,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76456,longer,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76457,than,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76458,that,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76459,indicated,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76460,by,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76461,the,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76462,label,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76463,",",O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76464,and,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76465,the,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76466,diseased,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76467,cows,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76468,36,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76469,h,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76470,longer,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76471,than,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76472,indicated,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76473,by,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76474,the,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76475,label,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76476,.,O,2656.0,"With the exclusion of the low - production cows , the model predicted that healthy cows required a milk discard time 12 h longer than that indicated by the label , and the diseased cows 36 h longer than indicated by the label ."
76477,More,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76478,pirlimycin,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76479,was,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76480,systemically,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76481,absorbed,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76482,in,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76483,the,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76484,gram,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76485,-,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76486,positive,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76487,infected,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76488,compared,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76489,with,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76490,the,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76491,gram,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76492,-,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76493,negative,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76494,infected,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76495,or,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76496,healthy,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76497,cows,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76498,",",O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76499,suggesting,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76500,a,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76501,greater,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76502,risk,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76503,of,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76504,violative,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76505,meat,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76506,residues,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76507,in,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76508,gram,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76509,-,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76510,positive,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76511,infected,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76512,cows,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76513,.,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
77653,This,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77654,decrease,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77655,in,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77656,salt,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77657,and,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77658,highly,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77659,salted,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77660,foods,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77661,also,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77662,seems,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77663,to,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77664,account,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77665,for,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77666,the,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77667,decrease,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77668,in,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77669,stomach,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77670,cancer,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77671,.,O,2694.0,This decrease in salt and highly salted foods also seems to account for the decrease in stomach cancer .
77772,Cox,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77773,regression,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77774,models,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77775,were,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77776,used,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77777,to,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77778,analyze,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77779,the,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77780,relationships,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77781,between,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77782,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77783,and,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77784,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77785,intake,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77786,and,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77787,EC,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77788,risk,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77789,.,O,2699.0,Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk .
77894,In,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77895,current,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77896,smokers,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77897,",",O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77898,a,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77899,significant,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77900,and,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77901,inverse,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77902,association,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77903,was,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77904,observed,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77905,between,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77906,ESCC,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77907,risk,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77908,and,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77909,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77910,(,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77911,HR,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77912,0.46,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77913,",",O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77914,95,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77915,%,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77916,CI,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77917,0.23,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77918,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77919,0.93,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77920,;,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77921,p,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77922,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77923,trend=0.053,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77924,),O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77925,and,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77926,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77927,consumption,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77928,(,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77929,HR,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77930,0.37,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77931,",",O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77932,95,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77933,%,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77934,CI,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77935,0.19,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77936,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77937,0.73,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77938,;,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77939,p,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77940,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77941,trend=0.011,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77942,),O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77943,.,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
78280,Triple,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78281,-,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78282,negative,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78283,breast,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78284,cancer,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78285,(,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78286,TNBC,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78287,),O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78288,is,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78289,a,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78290,common,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78291,subtype,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78292,of,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78293,breast,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78294,cancer,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78295,among,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78296,women,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78297,with,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78298,dense,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78299,breasts,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78300,and,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78301,is,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78302,associated,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78303,with,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78304,a,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78305,poor,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78306,prognosis,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78307,.,O,2715.0,Triple - negative breast cancer ( TNBC ) is a common subtype of breast cancer among women with dense breasts and is associated with a poor prognosis .
78364,After,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78365,total,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78366,mastectomy,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78367,or,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78368,breast,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78369,conserving,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78370,surgery,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78371,",",O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78372,patients,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78373,with,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78374,TNBC,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78375,(,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78376,n,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78377,=,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78378,38,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78379,),O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78380,and,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78381,non,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78382,-,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78383,TNBC,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78384,(,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78385,n,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78386,=,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78387,178,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78388,),O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78389,were,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78390,recruited,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78391,.,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78427,Additionally,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78428,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78429,intake,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78430,of,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78431,animal,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78432,fat,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78433,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78434,eggs,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78435,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78436,and,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78437,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78438,was,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78439,positively,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78440,associated,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78441,with,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78442,the,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78443,risk,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78444,of,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78445,TNBC,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78446,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78447,but,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78448,intake,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78449,of,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78450,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78451,fats,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78452,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78453,nuts,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78454,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78455,and,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78456,vegetables,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78457,showed,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78458,a,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78459,negative,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78460,association,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78461,.,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78546,We,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78547,evaluated,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78548,the,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78549,consumption,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78550,of,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78551,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78552,and,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78553,other,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78554,beverages,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78555,and,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78556,food,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78557,containing,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78558,caffeine,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78559,in,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78560,relation,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78561,to,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78562,the,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78563,incidence,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78564,of,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78565,diabetes,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78566,.,O,2724.0,We evaluated the consumption of coffee and other beverages and food containing caffeine in relation to the incidence of diabetes .
78799,The,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78800,results,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78801,imply,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78802,that,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78803,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78804,consumption,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78805,decreased,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78806,the,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78807,risk,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78808,of,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78809,developing,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78810,diabetes,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
78811,.,O,2732.0,The results imply that coffee consumption decreased the risk of developing diabetes .
79293,Overall,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79294,",",O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79295,incorporating,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79296,an,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79297,80,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79298,-,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79299,90,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79300,g,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79301,portion,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79302,of,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79303,raisins,B-http://purl.bioontology.org/ontology/SNOMEDCT/227463004,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79304,(,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79305,half,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79306,a,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79307,cup,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79308,),O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79309,into,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79310,the,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79311,daily,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79312,diet,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79313,may,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79314,be,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79315,favorable,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79316,for,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79317,human,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79318,health,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79319,.,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79575,Fermented,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2758.0,Fermented milk intake was not associated with increased risk of PD .
79576,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2758.0,Fermented milk intake was not associated with increased risk of PD .
79577,intake,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79578,was,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79579,not,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79580,associated,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79581,with,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79582,increased,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79583,risk,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79584,of,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79585,PD,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79586,.,O,2758.0,Fermented milk intake was not associated with increased risk of PD .
79893,These,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79894,foods,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79895,contain,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79896,phytochemicals,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79897,that,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79898,can,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79899,modulate,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79900,gene,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79901,expression,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79902,to,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79903,inhibit,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79904,carcinogenesis,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79905,via,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79906,multiple,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79907,pathways,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79908,.,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
80029,Orange,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80030,-,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80031,yellow,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80032,foods,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80033,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80034,including,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80035,oranges,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80036,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80037,tangerines,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80038,and,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80039,lemons,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80040,contain,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80041,citrus,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80042,flavonoids,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80043,.,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80044,Green,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80045,foods,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80046,",",O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80047,including,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80048,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80049,",",O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80050,Brussels,B-http://purl.bioontology.org/ontology/SNOMEDCT/735122004,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80051,sprouts,I-http://purl.bioontology.org/ontology/SNOMEDCT/735122004,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80052,and,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80053,kale,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80054,",",O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80055,contain,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80056,glucosinolates,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80057,.,O,2773.0,"Green foods , including broccoli , Brussels sprouts and kale , contain glucosinolates ."
80324,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80325,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80326,light,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80327,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80328,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80329,125,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80330, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80331,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80332,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80333,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80334,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80335,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80336,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80337,200,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80338, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80339,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80340,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80341,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80342,1,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80343,glass,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80344,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80345,125,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80346, ,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80347,ml,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80348,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80349,of,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80350,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80351,and,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80352,extra,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80353,virgin,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80354,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80355,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80356,;,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80357,weekly,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80358,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80359,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80360,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80361,3,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80362,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80363,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80364,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80365,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80366,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28230009;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80367,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80368,3,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80369,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80370,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80371,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80372,legumes,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80373,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80374,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80375,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80376,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80377,eggs,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80378,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80379,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80380,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80381,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80382,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80383,seasoned,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80384,cheeses,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80385,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80386,2,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80387,portions,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80388,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80389,",",O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80390,and,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80391,red,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80392,or,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80393,processed,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80394,meats,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80395,(,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80396,once,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80397,a,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80398,week,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80399,),O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80400,.,O,2782.0,") , light yogurt ( 125   ml ) , skim milk ( 200   ml ) , 1 glass ( 125   ml ) of wine and extra virgin olive oil ; weekly , fish ( 3 portions ) , white meat ( 3 portions ) , legumes ( 2 portions ) eggs ( 2 portions ) , seasoned cheeses ( 2 portions ) , and red or processed meats ( once a week ) ."
80570,Information,O,2789.0,Information about method of cooking was also requested .
80571,about,O,2789.0,Information about method of cooking was also requested .
80572,method,O,2789.0,Information about method of cooking was also requested .
80573,of,O,2789.0,Information about method of cooking was also requested .
80574,cooking,O,2789.0,Information about method of cooking was also requested .
80575,was,O,2789.0,Information about method of cooking was also requested .
80576,also,O,2789.0,Information about method of cooking was also requested .
80577,requested,O,2789.0,Information about method of cooking was also requested .
80578,.,O,2789.0,Information about method of cooking was also requested .
80579,Odds,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80580,ratios,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80581,(,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80582,ORs,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80583,),O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80584,and,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80585,95,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80586,%,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80587,confidence,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80588,intervals,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80589,(,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80590,CIs,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80591,),O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80592,quantifying,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80593,the,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80594,association,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80595,of,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80596,GBC,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80597,risk,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80598,consumption,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80599,of,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80600,different,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80601,types,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80602,of,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80603,oil,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80604,",",O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80605,method,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80606,of,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80607,cooking,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80608,",",O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80609,and,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80610,dietary,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80611,food,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80612,items,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80613,",",O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80614,were,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80615,estimated,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80616,using,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80617,logistic,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80618,regression,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80619,models,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80620,",",O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80621,after,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80622,adjusting,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80623,for,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80624,potential,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80625,confounders,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80626,.,O,2790.0,"Odds ratios ( ORs ) and 95 % confidence intervals ( CIs ) quantifying the association of GBC risk consumption of different types of oil , method of cooking , and dietary food items , were estimated using logistic regression models , after adjusting for potential confounders ."
80627,High,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80628,consumption,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80629,of,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80630,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80631,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80632,was,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80633,associated,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80634,with,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80635,GBC,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80636,risk,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80637,in,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80638,both,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80639,high-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80640,and,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80641,low,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80642,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80643,risk,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80644,regions,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80645,(,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80646,OR,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80647,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80648,1.33,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80649,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80650,95,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80651,%,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80652,CI,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80653,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80654,0.99,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80655,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80656,1.78,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80657,;,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80658,OR,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80659,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80660,3.01,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80661,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80662,95,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80663,%,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80664,CI,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80665,=,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80666,1.66,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80667,-,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80668,5.45,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80669,),O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80670,",",O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80671,respectively,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80672,.,O,2791.0,"High consumption of mustard oil was associated with GBC risk in both high- and low - risk regions ( OR = 1.33 , 95 % CI = 0.99 - 1.78 ; OR = 3.01 , 95 % CI = 1.66 - 5.45 ) , respectively ."
80780,The,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80781,bioaccessibility,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80782,of,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80783,fat,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80784,has,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80785,implications,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80786,for,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80787,satiety,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80788,and,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80789,postprandial,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80790,lipidaemia,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
80791,.,O,2796.0,The bioaccessibility of fat has implications for satiety and postprandial lipidaemia .
81569,Levels,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81570,of,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81571,specific,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81572,serum,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81573,IgE,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81574,to,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81575,cow,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81576,'s,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81577,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81578,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81579,whole,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81580,hen,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81581,'s,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81582,egg,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81583,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81584,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81585,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81586,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81587,and,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81588,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81589,yolk,I-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81590,were,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81591,compared,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81592,to,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81593,the,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81594,outcome,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81595,of,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81596,double,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81597,-,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81598,blind,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81599,",",O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81600,placebo,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81601,-,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81602,controlled,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81603,food,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81604,challenge,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81605,(,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81606,DBPCFC,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81607,),O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81608,with,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81609,fresh,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81610,egg,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81611,and/or,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81612,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81613,in,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81614,21,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81615,adults,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81616,with,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81617,a,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81618,case,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81619,history,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81620,of,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81621,immediate,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81622,hypersensitivity,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81623,to,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81624,egg,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81625,and/or,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81626,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81627,.,O,2827.0,"Levels of specific serum IgE to cow 's milk , whole hen 's egg , egg white , and egg yolk were compared to the outcome of double - blind , placebo - controlled food challenge ( DBPCFC ) with fresh egg and/or milk in 21 adults with a case history of immediate hypersensitivity to egg and/or milk ."
81991,This,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81992,article,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81993,reviews,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81994,the,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81995,current,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81996,data,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81997,related,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81998,to,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81999,key,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82000,nutrients,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82001,for,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82002,vegetarians,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82003,including,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82004,protein,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82005,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82006,n-3,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82007,fatty,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82008,acids,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82009,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82010,iron,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82011,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82012,zinc,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82013,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82014,iodine,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82015,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82016,calcium,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82017,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82018,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82019,vitamins,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82020,D,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82021,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82022,B-12,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82023,.,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82024,A,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82025,vegetarian,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82026,diet,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82027,can,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82028,meet,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82029,current,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82030,recommendations,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82031,for,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82032,all,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82033,of,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82034,these,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82035,nutrients,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82036,.,O,2842.0,A vegetarian diet can meet current recommendations for all of these nutrients .
82316,Between,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82317,both,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82318,beverages,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82319,",",O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82320,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82321,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82322,showed,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82323,a,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82324,clear,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82325,trend,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82326,for,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82327,being,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82328,more,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82329,active,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82330,in,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82331,stimulating,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82332,gastric,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82333,acid,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82334,secretion,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82335,than,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82336,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82337,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82338,(,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82339,p,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82340,=,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82341,0.054,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82342,),O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82343,.,O,2853.0,"Between both beverages , red wine showed a clear trend for being more active in stimulating gastric acid secretion than white wine ( p = 0.054 ) ."
82969,Nonheme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82970,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82971,was,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82972,better,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82973,absorbed,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82974,than,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82975,heme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82976,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82977,regardless,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82978,of,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82979,other,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82980,dietary,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82981,factors,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82982,.,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82983,Both,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82984,heme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82985,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82986,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82987,and,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82988,nonheme,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82989,iron,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82990,absorption,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82991,were,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82992,higher,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82993,when,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82994,high,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82995,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82996,30,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82997,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82998,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
82999,rather,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83000,than,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83001,low,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83002,(,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83003,5,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83004,%,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83005,),O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83006,dietary,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83007,fat,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83008,was,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83009,fed,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83010,.,O,2874.0,Both heme iron absorption and nonheme iron absorption were higher when high ( 30 % ) rather than low ( 5 % ) dietary fat was fed .
83011,The,O,2875.0,The type of fat had no effect .
83012,type,O,2875.0,The type of fat had no effect .
83013,of,O,2875.0,The type of fat had no effect .
83014,fat,O,2875.0,The type of fat had no effect .
83015,had,O,2875.0,The type of fat had no effect .
83016,no,O,2875.0,The type of fat had no effect .
83017,effect,O,2875.0,The type of fat had no effect .
83018,.,O,2875.0,The type of fat had no effect .
83904,We,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83905,found,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83906,that,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83907,increasing,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83908,concentrations,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83909,of,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83910,inulin,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83911,and,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83912,corn,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83913,dextrin,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83914,reduced,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83915,the,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83916,flowability,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83917,of,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83918,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83919,in,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83920,the,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83921,melting,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83922,test,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83923,and,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83924,can,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83925,thus,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83926,be,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83927,used,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83928,to,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83929,inhibit,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83930,flow,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83931,during,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83932,heating,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
83933,.,O,2909.0,We found that increasing concentrations of inulin and corn dextrin reduced the flowability of cheese in the melting test and can thus be used to inhibit flow during heating .
84426,At,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84427,the,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84428,end,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84429,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84430,each,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84431,study,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84432,period,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84433,",",O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84434,faeces,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84435,of,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84436,twelve,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84437,volunteers,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84438,were,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84439,collected,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84440,for,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84441,chemical,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84442,analyses,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84443,and,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84444,use,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84445,in,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84446,cell,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84447,-,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84448,culture,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84449,systems,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84450,.,O,2928.0,"At the end of each study period , faeces of twelve volunteers were collected for chemical analyses and use in cell - culture systems ."
84729,Two,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84730,dietary,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84731,patterns,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84732,were,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84733,identified,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84734,:,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84735,"""",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84736,alcohol,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84737,/,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84738,Western,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84739,"""",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84740,(,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84741,essentially,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84742,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/227003005;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84743,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/227003005;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84744,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84745,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84746,fries,I-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84747,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84748,appetizers,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84749,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84750,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/226740002,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84751,/,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/226740002,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84752,pasta,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/226740002,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84753,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84754,potatoes,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84755,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84756,pulses,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84757,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84758,pizza,B-http://purl.bioontology.org/ontology/SNOMEDCT/227757007,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84759,/,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84760,pies,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84761,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84762,canned,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84763,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84764,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84765,eggs,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84766,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84767,alcoholic,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84768,beverages,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84769,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84770,cakes,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84771,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84772,mayonnaise,B-http://purl.bioontology.org/ontology/SNOMEDCT/227549007,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84773,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84774,and,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84775,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84776,/,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84777,cream,B-http://purl.bioontology.org/ontology/SNOMEDCT/255621006,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84778,),O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84779,and,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84780,"""",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84781,healthy,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84782,/,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84783,Mediterranean,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84784,"""",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84785,(,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84786,essentially,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84787,vegetables,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84788,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84789,fruits,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84790,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84791,seafood,B-http://purl.bioontology.org/ontology/SNOMEDCT/44027008,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84792,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84793,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84794,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84795,",",O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84796,and,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84797,sunflower,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84798,oil,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84799,),O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84800,.,O,2940.0,"Two dietary patterns were identified : "" alcohol / Western "" ( essentially meat products , French fries , appetizers , rice / pasta , potatoes , pulses , pizza / pies , canned fish , eggs , alcoholic beverages , cakes , mayonnaise , and butter / cream ) and "" healthy / Mediterranean "" ( essentially vegetables , fruits , seafood , olive oil , and sunflower oil ) ."
84900,Adherence,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84901,to,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84902,a,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84903,diet,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84904,comprising,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84905,mostly,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84906,fruits,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84907,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84908,vegetables,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84909,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84910,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84911,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84912,and,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84913,olive,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84914,/,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84915,sunflower,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84916,oil,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84917,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84918,along,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84919,with,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84920,avoidance,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84921,of,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84922,Western,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84923,-,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84924,type,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84925,foods,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84926,",",O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84927,may,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84928,contribute,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84929,to,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84930,a,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84931,substantial,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84932,reduction,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84933,in,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84934,postmenopausal,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84935,breast,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84936,cancer,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84937,risk,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
84938,.,O,2943.0,"Adherence to a diet comprising mostly fruits , vegetables , fish , and olive / sunflower oil , along with avoidance of Western - type foods , may contribute to a substantial reduction in postmenopausal breast cancer risk ."
85716,Three,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85717,consistent,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85718,roles,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85719,can,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85720,be,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85721,identified,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85722,:,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85723,1,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85724,),O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85725,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85726,treat,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85727,emaciated,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85728,patients,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85729,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85730,gain,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85731,weight,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85732,;,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85733,2,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85734,),O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85735,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85736,stimulate,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85737,nervous,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85738,systems,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85739,of,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85740,apathetic,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85741,",",O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85742,exhausted,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85743,or,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85744,feeble,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85745,patients,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85746,;,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85747,and,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85748,3,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85749,),O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85750,to,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85751,improve,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85752,digestion,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85753,and,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85754,elimination,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85755,where,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85756,cacao,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85757,/,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85758,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85759,countered,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85760,the,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85761,effects,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85762,of,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85763,stagnant,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85764,or,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85765,weak,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85766,stomachs,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85767,",",O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85768,stimulated,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85769,kidneys,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85770,and,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85771,improved,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85772,bowel,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85773,function,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85774,.,O,2970.0,"Three consistent roles can be identified : 1 ) to treat emaciated patients to gain weight ; 2 ) to stimulate nervous systems of apathetic , exhausted or feeble patients ; and 3 ) to improve digestion and elimination where cacao / chocolate countered the effects of stagnant or weak stomachs , stimulated kidneys and improved bowel function ."
85838,In,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85839,addition,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85840,to,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85841,cacao,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85842,beans,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85843,",",O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85844,preparations,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85845,of,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85846,cacao,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85847,bark,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85848,",",O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85849,oil,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85850,(,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85851,cacao,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85852,butter,I-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85853,),O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85854,",",O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85855,leaves,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85856,and,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85857,flowers,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85858,have,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85859,been,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85860,used,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85861,to,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85862,treat,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85863,burns,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85864,",",O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85865,bowel,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85866,dysfunction,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85867,",",O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85868,cuts,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85869,and,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85870,skin,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85871,irritations,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
85872,.,O,2973.0,"In addition to cacao beans , preparations of cacao bark , oil ( cacao butter ) , leaves and flowers have been used to treat burns , bowel dysfunction , cuts and skin irritations ."
86010,Mushrooms,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86011,are,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86012,a,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86013,rare,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86014,source,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86015,of,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86016,ergothioneine,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86017,as,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86018,well,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86019,as,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86020,selenium,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86021,",",O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86022,fiber,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86023,",",O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86024,and,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86025,several,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86026,other,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86027,vitamins,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86028,and,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86029,minerals,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86030,.,O,2979.0,"Mushrooms are a rare source of ergothioneine as well as selenium , fiber , and several other vitamins and minerals ."
86053,Preliminary,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86054,evidence,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86055,suggests,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86056,that,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86057,mushrooms,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86058,may,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86059,support,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86060,healthy,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86061,immune,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86062,and,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86063,inflammatory,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86064,responses,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86065,through,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86066,interaction,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86067,with,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86068,the,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86069,gut,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86070,microbiota,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86071,",",O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86072,enhancing,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86073,development,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86074,of,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86075,adaptive,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86076,immunity,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86077,",",O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86078,and,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86079,improved,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86080,immune,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86081,cell,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86082,functionality,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86083,.,O,2981.0,"Preliminary evidence suggests that mushrooms may support healthy immune and inflammatory responses through interaction with the gut microbiota , enhancing development of adaptive immunity , and improved immune cell functionality ."
86786,Our,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86787,findings,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86788,indicate,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86789,that,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86790,dietary,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86791,factors,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86792,contribute,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86793,to,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86794,the,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86795,regional,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86796,variation,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86797,of,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86798,stomach,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86799,cancer,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86800,occurrence,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86801,in,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86802,Italy,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86803,",",O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86804,and,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86805,offer,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86806,clues,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86807,for,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86808,further,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86809,etiologic,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86810,and,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86811,prevention,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86812,research,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
86813,.,O,3007.0,"Our findings indicate that dietary factors contribute to the regional variation of stomach cancer occurrence in Italy , and offer clues for further etiologic and prevention research ."
87108,These,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87109,findings,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87110,should,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87111,encourage,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87112,further,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87113,clinical,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87114,trials,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87115,to,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87116,assess,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87117,the,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87118,efficiency,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87119,of,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87120,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87121,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87122,and,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87123,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87124,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87125,or,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87126,their,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87127,derived,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87128,peptides,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87129,as,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87130,food,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87131,supplements,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87132,or,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87133,potential,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87134,nonpharmacological,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87135,therapies,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87136,for,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87137,dysglycemia,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87138,and,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87139,the,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87140,vascular,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87141,complications,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87142,of,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87143,diabetes,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87144,mellitus,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87145,.,O,3018.0,These findings should encourage further clinical trials to assess the efficiency of camel milk and bovine milk or their derived peptides as food supplements or potential nonpharmacological therapies for dysglycemia and the vascular complications of diabetes mellitus .
87464,HNC,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87465,patients,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87466,(,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87467,n,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87468,=,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87469,114,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87470,),O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87471,completed,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87472,a,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87473,three,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87474,-,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87475,day,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87476,dietary,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87477,record,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87478,and,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87479,a,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87480,tool,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87481,to,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87482,assess,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87483,Nutrition,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87484,Impact,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87485,Scores,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87486,(,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87487,NIS,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87488,),O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87489,at,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87490,baseline,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87491,",",O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87492,post,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87493,-,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87494,treatment,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87495,",",O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87496,and,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87497,follow,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87498,-,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87499,up,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87500,.,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87691,Insulin,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87692,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87693,like,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87694,growth,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87695,factor,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87696,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87697,I,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87698,(,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87699,IGF,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87700,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87701,I,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87702,),O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87703,has,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87704,been,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87705,proposed,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87706,as,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87707,the,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87708,link,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87709,between,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87710,diet,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87711,and,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87712,breast,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87713,cancer,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87714,risk,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87715,.,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87716,Due,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87717,to,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87718,their,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87719,estrogen,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87720,-,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87721,like,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87722,structure,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87723,",",O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87724,soy,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87725,isoflavones,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87726,may,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87727,affect,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87728,IGF,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87729,-,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87730,I,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87731,levels,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87732,in,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87733,a,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87734,similar,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87735,way,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87736,as,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87737,exogenous,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87738,estrogens,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87739,.,O,3036.0,"Due to their estrogen - like structure , soy isoflavones may affect IGF - I levels in a similar way as exogenous estrogens ."
87740,In,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87741,a,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87742,cross,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87743,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87744,sectional,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87745,design,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87746,",",O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87747,we,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87748,compared,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87749,IGF,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87750,-,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87751,I,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87752,levels,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87753,between,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87754,women,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87755,with,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87756,high,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87757,and,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87758,low,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87759,soy,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87760,intake,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
87761,.,O,3037.0,"In a cross - sectional design , we compared IGF - I levels between women with high and low soy intake ."
88812,Acetate,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88813,infused,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88814,alone,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88815,had,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88816,no,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88817,effect,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88818,on,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88819,milk,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88820,protein,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88821,yield,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88822,but,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88823,increased,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88824,milk,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88825,fat,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88826,yield,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88827,numerically,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88828,",",O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88829,suggesting,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88830,that,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88831,the,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88832,greater,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88833,amount,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88834,of,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88835,acetate,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88836,taken,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88837,up,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88838,by,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88839,the,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88840,mammary,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88841,gland,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88842,was,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88843,used,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88844,for,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88845,milk,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88846,fat,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88847,synthesis,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
88848,.,O,3077.0,"Acetate infused alone had no effect on milk protein yield but increased milk fat yield numerically , suggesting that the greater amount of acetate taken up by the mammary gland was used for milk fat synthesis ."
89711,The,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89712,consumption,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89713,of,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89714,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89715,correlated,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89716,to,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89717,several,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89718,health,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89719,benefits,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89720,such,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89721,as,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89722,reducing,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89723,the,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89724,risk,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89725,of,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89726,human,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89727,chronic,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89728,diseases,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89729,such,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89730,as,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89731,inflammation,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89732,",",O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89733,diabetes,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89734,",",O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89735,and,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89736,cardiovascular,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89737,disease,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89738,owing,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89739,to,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89740,its,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89741,antioxidant,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89742,potential,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89743,.,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89921,Gluten,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89922,-,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89923,free,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89924,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89925,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89926,is,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89927,dependent,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89928,on,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89929,ingredients,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89930,and,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89931,additives,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89932,combination,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89933,",",O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89934,but,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89935,also,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89936,processing,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89937,can,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89938,provide,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89939,a,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89940,way,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89941,to,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89942,improve,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89943,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89944,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89945,.,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89974,Chocolate,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89975,ice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89976,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89977,is,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89978,commonly,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89979,formulated,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89980,with,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89981,higher,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89982,sugar,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89983,levels,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89984,than,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89985,nonchocolate,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89986,flavors,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89987,to,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89988,compensate,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89989,for,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89990,the,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89991,inherent,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89992,bitterness,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89993,of,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89994,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89995,.,O,3118.0,Chocolate ice cream is commonly formulated with higher sugar levels than nonchocolate flavors to compensate for the inherent bitterness of cocoa .
89996,Bitterness,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89997,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89998,however,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
89999,",",O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90000,is,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90001,an,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90002,integral,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90003,part,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90004,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90005,the,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90006,complex,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90007,flavor,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90008,of,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90009,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90010,.,O,3119.0,"Bitterness , however , is an integral part of the complex flavor of chocolate ."
90035,Once,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90036,a,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90037,strategy,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90038,for,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90039,balancing,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90040,undesirable,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90041,bitterness,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90042,and,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90043,health,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90044,concerns,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90045,regarding,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90046,added,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90047,sugars,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90048,has,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90049,been,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90050,developed,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90051,",",O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90052,the,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90053,task,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90054,becomes,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90055,determining,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90056,whether,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90057,that,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90058,product,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90059,will,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90060,be,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90061,acceptable,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90062,to,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90063,the,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90064,consumer,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90065,.,O,3121.0,"Once a strategy for balancing undesirable bitterness and health concerns regarding added sugars has been developed , the task becomes determining whether that product will be acceptable to the consumer ."
90090,The,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90091,main,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90092,goal,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90093,of,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90094,this,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90095,study,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90096,was,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90097,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90098,estimate,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90099,group,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90100,rejection,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90101,thresholds,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90102,for,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90103,bitterness,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90104,in,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90105,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90106,ice,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90107,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90108,",",O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90109,and,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90110,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90111,see,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90112,if,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90113,solid,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90114,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90115,preferences,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90116,(,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90117,dark,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90118,vs.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90119,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90120,),O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90121,generalized,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90122,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90123,ice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90124,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90125,.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90366,Eighteen,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90367,observational,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90368,studies,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90369,were,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90370,reviewed,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90371,",",O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90372,the,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90373,results,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90374,of,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90375,which,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90376,indicate,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90377,that,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90378,total,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90379,dairy,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90380,intake,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90381,does,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90382,not,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90383,contribute,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90384,to,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90385,cardiovascular,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90386,disease,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90387,incidence,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90388,or,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90389,death,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90390,.,O,3131.0,"Eighteen observational studies were reviewed , the results of which indicate that total dairy intake does not contribute to cardiovascular disease incidence or death ."
90511,The,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90512,concentrations,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90513,effects,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90514,of,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90515,sugars,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90516,(,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90517,trehalose,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90518,and,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90519,allose,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90520,),O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90521,and,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90522,oils,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90523,(,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90524,canola,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90525,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90526,coconut,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90527,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90528,),O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90529,on,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90530,the,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90531,characteristics,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90532,of,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90533,rice,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90534,starch,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90535,suspension,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90536,and,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90537,mechanical,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90538,properties,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90539,of,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90540,rice,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90541,starch,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90542,film,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90543,were,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90544,studied,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90545,.,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
91175,Of,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91176,the,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91177,eleven,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91178,free,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91179,-,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91180,living,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91181,subjects,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91182,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91183,were,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91184,normocholesteremic,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91185,",",O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91186,three,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91187,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91188,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91189,IIa,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91190,hyperlipidemia,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91191,and,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91192,five,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91193,had,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91194,type,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91195,VI,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91196,(,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91197,IIb,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91198,),O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91199,.,O,3161.0,"Of the eleven free - living subjects three were normocholesteremic , three had type IIa hyperlipidemia and five had type VI ( IIb ) ."
91849,Numerous,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91850,sensors,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91851,that,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91852,gather,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91853,this,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91854,information,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91855,are,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91856,either,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91857,currently,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91858,available,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91859,or,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91860,in,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91861,development,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91862,.,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
92376,Apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92377,and,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92378,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92379,as,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92380,well,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92381,as,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92382,apple,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92383,seeds,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92384,and,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92385,carrot,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92386,seeds,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92387,were,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92388,fractionated,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92389,using,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92390,column,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92391,chromatography,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92392,.,O,3202.0,Apple and carrot as well as apple seeds and carrot seeds were fractionated using column chromatography .
92566,Intestinal,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92567,barrier,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92568,function,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92569,can,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92570,be,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92571,compromised,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92572,by,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92573,pathogens,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92574,",",O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92575,inflammatory,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92576,cytokines,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92577,",",O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92578,endocannabinoids,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92579,",",O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92580,diet,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92581,",",O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92582,exercise,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92583,",",O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92584,and,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92585,gastrointestinal,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92586,peptides,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92587,.,O,3211.0,"Intestinal barrier function can be compromised by pathogens , inflammatory cytokines , endocannabinoids , diet , exercise , and gastrointestinal peptides ."
92618,While,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92619,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92620,evidence,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92621,suggests,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92622,that,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92623,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92624,consumption,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92625,is,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92626,beneficial,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92627,for,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92628,obese,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92629,individuals,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92630,",",O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92631,randomized,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92632,-,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92633,controlled,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92634,trials,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92635,are,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92636,needed,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92637,to,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92638,further,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92639,support,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92640,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92641,hypothesis,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92642,.,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92874,The,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92875,outcomes,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92876,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92877,such,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92878,interventions,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92879,led,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92880,to,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92881,widespread,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92882,acceptance,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92883,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92884,functional,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92885,and,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92886,nutraceutical,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92887,foods,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92888,;,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92889,however,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92890,",",O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92891,augmenting,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92892,immunity,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92893,is,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92894,a,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92895,major,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92896,concern,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92897,of,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92898,dietary,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92899,regimens,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
92900,.,O,3222.0,"The outcomes of such interventions led to widespread acceptance of functional and nutraceutical foods ; however , augmenting immunity is a major concern of dietary regimens ."
93038,Modes,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93039,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93040,their,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93041,actions,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93042,include,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93043,boosting,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93044,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93045,functioning,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93046,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93047,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93048,system,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93049,",",O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93050,activation,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93051,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93052,suppression,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93053,of,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93054,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93055,specialized,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93056,cells,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93057,",",O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93058,interfering,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93059,in,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93060,several,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93061,pathways,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93062,that,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93063,eventually,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93064,led,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93065,to,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93066,improvement,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93067,in,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93068,immune,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93069,responses,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93070,and,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93071,defense,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93072,system,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93073,.,O,3229.0,"Modes of their actions include boosting and functioning of immune system , activation and suppression of immune specialized cells , interfering in several pathways that eventually led to improvement in immune responses and defense system ."
93536,Urine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93537,volume,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93538,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93539,pH,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93540,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93541,oxalate,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93542,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93543,creatinine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93544,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93545,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93546,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93547,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93548,theobromine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93549,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93550,and,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93551,a,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93552,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93553,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93554,crystallization,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93555,test,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93556,were,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93557,determined,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93558,for,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93559,each,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93560,sample,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93561,.,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/227610000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/227610000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93833,Botanical,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93834,products,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93835,are,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93836,widely,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93837,used,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93838,in,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93839,nutritional,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93840,supplementation,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93841,for,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93842,promotion,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93843,of,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93844,health,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93845,or,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93846,prevention,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93847,of,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93848,diseases,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93849,.,O,3258.0,Botanical products are widely used in nutritional supplementation for promotion of health or prevention of diseases .
93850,With,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93851,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93852,high,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93853,prevalence,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93854,of,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93855,obesity,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93856,and,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93857,type,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93858,2,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93859,diabetes,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93860,",",O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93861,abnormalities,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93862,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93863,carbohydrate,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93864,metabolism,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93865,are,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93866,common,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93867,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93868,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93869,general,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93870,population,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93871,and,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93872,obtaining,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93873,glycemic,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93874,control,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93875,is,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93876,important,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93877,in,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93878,reducing,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93879,the,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93880,complications,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93881,of,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93882,diabetes,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
93883,.,O,3259.0,"With the high prevalence of obesity and type 2 diabetes , abnormalities in carbohydrate metabolism are common in the general population and obtaining glycemic control is important in reducing the complications of diabetes ."
94314,In,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94315,a,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94316,second,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94317,study,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94318,",",O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94319,animals,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94320,were,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94321,fed,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94322,on,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94323,the,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94324,atherogenic,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94325,diet,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94326,for,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94327,10,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94328,weeks,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94329,",",O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94330,transferred,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94331,to,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94332,diets,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94333,containing,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94334,either,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94335,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94336,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94337,(,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94338,150,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94339,g,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94340,/,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94341,kg,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94342,diet,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94343,),O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94344,or,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94345,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94346,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94347,(,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94348,150,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94349,g,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94350,/,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94351,kg,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94352,diet,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94353,),O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94354,without,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94355,added,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94356,cholesterol,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94357,and,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94358,monitored,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94359,for,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94360,up,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94361,to,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94362,16,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94363,weeks,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94364,.,O,3273.0,"In a second study , animals were fed on the atherogenic diet for 10 weeks , transferred to diets containing either coconut oil ( 150 g / kg diet ) or olive oil ( 150 g / kg diet ) without added cholesterol and monitored for up to 16 weeks ."
94481,Self,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94482,-,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94483,monitoring,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94484,of,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94485,plasma,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94486,triglycerides,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94487,(,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94488,TG,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94489,),O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94490,may,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94491,be,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94492,a,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94493,very,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94494,useful,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94495,tool,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94496,to,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94497,monitor,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94498,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94499,on,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94500,a,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94501,daily,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94502,basis,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94503,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94504,the,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94505,TG,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94506,responses,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94507,to,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94508,different,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94509,nutrients,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94510,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94511,particularly,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94512,carbohydrates,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94513,(,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94514,CHO,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94515,),O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94516,and,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94517,fat,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94518,",",O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94519,whose,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94520,influence,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94521,on,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94522,postprandial,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94523,TG,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94524,levels,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94525,is,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94526,not,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94527,very,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94528,well,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94529,known,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94530,.,O,3278.0,"Self - monitoring of plasma triglycerides ( TG ) may be a very useful tool to monitor , on a daily basis , the TG responses to different nutrients , particularly carbohydrates ( CHO ) and fat , whose influence on postprandial TG levels is not very well known ."
94531,Therefore,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94532,",",O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94533,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94534,aim,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94535,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94536,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94537,present,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94538,study,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94539,was,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94540,to,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94541,evaluate,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94542,the,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94543,TG,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94544,response,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94545,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94546,hypertriglyceridemic,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94547,patients,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94548,to,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94549,a,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94550,similar,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94551,amount,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94552,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94553,calories,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94554,deriving,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94555,from,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94556,different,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94557,sources,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94558,of,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94559,CHO,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94560,and,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94561,fat,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
94562,.,O,3279.0,"Therefore , the aim of the present study was to evaluate the TG response of hypertriglyceridemic patients to a similar amount of calories deriving from different sources of CHO and fat ."
95117,Consequently,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95118,",",O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95119,lactose,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95120,-,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95121,containing,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95122,foods,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95123,such,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95124,as,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95125,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95126,and,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95127,other,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95128,dairy,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95129,foods,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95130,may,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95131,be,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95132,eliminated,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95133,unnecessarily,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95134,from,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95135,the,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95136,diet,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95137,.,O,3297.0,"Consequently , lactose - containing foods such as milk and other dairy foods may be eliminated unnecessarily from the diet ."
95180,This,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95181,review,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95182,is,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95183,intended,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95184,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95185,help,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95186,dietetics,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95187,professionals,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95188,alleviate,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95189,clients,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95190,',O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95191,fears,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95192,about,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95193,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95194,intolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95195,and,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95196,recommend,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95197,dietary,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95198,strategies,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95199,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95200,improve,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95201,tolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95202,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95203,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95204,.,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95860,Gluten,O,3322.0,Gluten is comprised of prolamin and glutelin .
95861,is,O,3322.0,Gluten is comprised of prolamin and glutelin .
95862,comprised,O,3322.0,Gluten is comprised of prolamin and glutelin .
95863,of,O,3322.0,Gluten is comprised of prolamin and glutelin .
95864,prolamin,O,3322.0,Gluten is comprised of prolamin and glutelin .
95865,and,O,3322.0,Gluten is comprised of prolamin and glutelin .
95866,glutelin,O,3322.0,Gluten is comprised of prolamin and glutelin .
95867,.,O,3322.0,Gluten is comprised of prolamin and glutelin .
96274,Although,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96275,uranium,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96276,in,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96277,soil,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96278,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96279,irrigation,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96280,water,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96281,and,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96282,vegetables,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96283,was,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96284,high,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96285,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96286,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96287,assessment,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96288,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96289,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96290,health,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96291,risk,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96292,based,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96293,on,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96294,hazard,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96295,quotient,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96296,indicates,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96297,that,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96298,consumption,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96299,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96300,these,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96301,vegetables,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96302,does,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96303,not,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96304,represent,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96305,potential,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96306,adverse,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96307,(,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96308,no,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96309,carcinogenic,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96310,),O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96311,effects,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96312,for,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96313,a,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96314,local,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96315,inhabitant,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96316,during,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96317,lifetime,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96318,.,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96939,Additionally,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96940,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96941,the,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96942,effects,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96943,identified,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96944,by,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96945,randomized,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96946,controlled,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96947,trials,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96948,of,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96949,less,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96950,-,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96951,studied,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96952,FD,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96953,products,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96954,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96955,such,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96956,as,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96957,kefir,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96958,and,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96959,kimchi,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96960,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96961,on,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96962,cardiometabolic,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96963,risk,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96964,factors,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96965,are,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96966,provided,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96967,.,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96996,PCSs,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96997,have,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96998,revealed,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96999,that,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97000,the,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97001,total,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97002,consumption,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97003,of,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97004,FD,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97005,appears,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97006,to,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97007,be,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97008,associated,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97009,with,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97010,a,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97011,lower,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97012,risk,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97013,of,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97014,developing,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97015,stroke,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97016,and,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97017,cardiovascular,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97018,disease,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97019,.,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97038,There,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97039,is,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97040,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97041,lack,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97042,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97043,sufficient,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97044,evidence,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97045,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97046,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97047,protective,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97048,relationship,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97049,between,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97050,FD,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97051,or,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97052,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97053,consumption,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97054,and,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97055,metabolic,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97056,syndrome,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97057,.,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97163,Many,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97164,lectins,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97165,resist,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97166,digestion,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97167,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97168,survive,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97169,gut,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97170,passage,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97171,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97172,and,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97173,bind,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97174,to,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97175,gastrointestinal,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97176,cells,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97177,and/or,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97178,enter,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97179,the,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97180,circulation,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97181,intact,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97182,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97183,maintaining,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97184,full,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97185,biological,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97186,activity,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97187,.,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97675,A,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97676,relationship,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97677,has,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97678,also,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97679,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97680,observed,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97681,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97682,certain,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97683,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97684,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97685,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97686,such,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97687,as,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97688,constituents,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97689,of,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97690,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97691,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97692,Mediterranean,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97693,diet,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97694,',O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97695,",",O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97696,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97697,the,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97698,metabolic,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97699,syndrome,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97700,;,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97701,similar,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97702,associations,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97703,have,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97704,been,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97705,noted,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97706,between,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97707,these,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97708,dietary,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97709,factors,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97710,and,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97711,dementia,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
97712,.,O,3385.0,"A relationship has also been observed between certain dietary factors , such as constituents of the ' Mediterranean diet ' , and the metabolic syndrome ; similar associations have been noted between these dietary factors and dementia ."
98005,A,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98006,correlation,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98007,was,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98008,found,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98009,too,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98010,between,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98011,acetylsalicylic,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98012,acid,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98013,intolerance,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98014,and,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98015,FS,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98016,with,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98017,some,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98018,foods,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98019,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98020,e.g.,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98021,nuts,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98022,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98023,strawberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98024,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98025,almond,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98026,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98027,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98028,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98029,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98030,hip,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98031,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98032,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98033,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98034,egg,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98035,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98036,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98037,",",O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98038,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98039,and,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98040,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98041,.,O,3397.0,"A correlation was found too between acetylsalicylic acid intolerance and FS with some foods , e.g. nuts , strawberry , almond , green pepper , hip , chocolate , egg , cabbage , milk and wine ."
98099,Avoidance,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98100,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98101,saturated,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98102,fat,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98103,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98104,cholesterol,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98105,by,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98106,"1,210",O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98107,Mexican,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98108,Americans,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98109,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98110,866,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98111,non,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98112,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98113,Hispanic,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98114,whites,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98115,was,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98116,assessed,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98117,as,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98118,part,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98119,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98120,a,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98121,population,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98122,-,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98123,based,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98124,survey,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98125,of,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98126,diabetes,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98127,and,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98128,cardiovascular,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98129,risk,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98130,factors,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98131,.,O,3399.0,"Avoidance of saturated fat and cholesterol by 1,210 Mexican Americans and 866 non - Hispanic whites was assessed as part of a population - based survey of diabetes and cardiovascular risk factors ."
98217,Saturated,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98218,fat,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98219,/,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98220,cholesterol,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98221,avoidance,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98222,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98223,significantly,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98224,with,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98225,increased,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98226,socioeconomic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98227,status,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98228,in,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98229,both,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98230,ethnic,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98231,groups,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98232,.,O,3403.0,Saturated fat / cholesterol avoidance increased significantly with increased socioeconomic status in both ethnic groups .
98305,Because,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98306,of,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98307,its,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98308,simplicity,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98309,and,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98310,ease,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98311,of,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98312,administration,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98313,",",O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98314,the,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98315,scale,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98316,may,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98317,be,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98318,a,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98319,useful,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98320,tool,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98321,in,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98322,epidemiological,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98323,research,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98324,.,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98779,Milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98780,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98781,soups,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98782,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98783,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98784,stews,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98785,were,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98786,the,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98787,top,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98788,contributors,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98789,for,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98790,all,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98791,nutrients,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98792,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98793,tortillas,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98794,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98795,eggs,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98796,",",O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98797,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98798,egg,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98799,dishes,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98800,were,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98801,among,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98802,the,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98803,top,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98804,contributors,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98805,for,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98806,iron,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98807,and,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98808,zinc,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
98809,.,O,3426.0,"Milk , soups , and stews were the top contributors for all nutrients and tortillas , eggs , and egg dishes were among the top contributors for iron and zinc ."
99268,However,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99269,",",O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99270,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99271,cows,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99272,fed,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99273,the,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99274,diet,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99275,supplemented,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99276,with,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99277,GSGME,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99278,had,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99279,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99280,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99281,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99282,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99283,and,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99284,an,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99285,increased,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99286,daily,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99287,milk,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99288,protein,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99289,yield,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99290,.,O,3441.0,"However , the cows fed the diet supplemented with GSGME had an increased milk yield and an increased daily milk protein yield ."
99957,However,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99958,",",O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99959,only,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99960,over,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99961,the,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99962,last,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99963,decade,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99964,has,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99965,epidemiological,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99966,research,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99967,confirmed,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99968,its,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99969,protective,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99970,role,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99971,against,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99972,developing,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99973,several,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99974,chronic,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99975,diseases,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
99976,.,O,3462.0,"However , only over the last decade has epidemiological research confirmed its protective role against developing several chronic diseases ."
100976,Excessive,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100977,energy,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100978,intake,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100979,and,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100980,obesity,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100981,are,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100982,major,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100983,causes,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100984,of,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100985,hypertension,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100986,.,O,3503.0,Excessive energy intake and obesity are major causes of hypertension .
100987,Obesity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100988,is,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100989,associated,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100990,with,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100991,increased,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100992,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100993,of,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100994,the,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100995,renin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100996,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100997,angiotensin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100998,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100999,aldosterone,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101000,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101001,sympathetic,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101002,nervous,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101003,systems,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101004,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101005,possibly,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101006,other,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101007,mineralcorticoid,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101008,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101009,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101010,insulin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101011,resistance,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101012,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101013,salt,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101014,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101015,sensitive,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101016,hypertension,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101017,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101018,excess,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101019,salt,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101020,intake,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101021,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101022,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101023,reduced,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101024,kidney,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101025,function,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101026,.,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101362,In,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101363,the,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101364,time,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101365,period,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101366,1996,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101367,-,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101368,2004,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101369,",",O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101370,697,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101371,cases,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101372,with,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101373,lymphoid,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101374,neoplasms,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101375,and,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101376,3606,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101377,controls,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101378,with,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101379,nonneoplastic,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101380,conditions,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101381,were,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101382,included,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101383,in,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101384,a,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101385,case,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101386,-,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101387,control,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101388,study,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101389,conducted,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101390,in,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101391,the,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101392,Cancer,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101393,Institute,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101394,of,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101395,Uruguay,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
101396,.,O,3516.0,"In the time period 1996 - 2004 , 697 cases with lymphoid neoplasms and 3606 controls with nonneoplastic conditions were included in a case - control study conducted in the Cancer Institute of Uruguay ."
102515,Furthermore,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102516,",",O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102517,a,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102518,balanced,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102519,vegetarian,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102520,diet,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102521,with,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102522,dairy,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102523,products,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102524,seems,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102525,to,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102526,be,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102527,the,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102528,most,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102529,protective,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102530,diet,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102531,for,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102532,kidney,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102533,stone,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102534,patients,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102535,.,O,3557.0,"Furthermore , a balanced vegetarian diet with dairy products seems to be the most protective diet for kidney stone patients ."
102568,High,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102569,salt,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102570,intake,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102571,is,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102572,a,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102573,major,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102574,risk,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102575,factor,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102576,of,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102577,hypertension,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102578,and,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102579,cardiovascular,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102580,disease,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102581,.,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
103678,Fermented,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103679,foods,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103680,have,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103681,long,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103682,been,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103683,produced,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103684,according,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103685,to,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103686,knowledge,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103687,passed,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103688,down,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103689,from,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103690,generation,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103691,to,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103692,generation,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103693,and,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103694,with,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103695,no,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103696,understanding,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103697,of,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103698,the,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103699,potential,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103700,role,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103701,of,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103702,the,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103703,microorganism(s,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103704,),O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103705,involved,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103706,in,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103707,the,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103708,process,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
103709,.,O,3600.0,Fermented foods have long been produced according to knowledge passed down from generation to generation and with no understanding of the potential role of the microorganism(s ) involved in the process .
104626,Clinical,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104627,manifestations,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104628,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104629,relation,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104630,to,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104631,avocado,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104632,ingestion,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104633,were,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104634,as,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104635,follows,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104636,:,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104637,systemic,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104638,anaphylaxis,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104639,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104640,seven,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104641,patients,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104642,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104643,angioedema,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104644,/,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104645,urticaria,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104646,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104647,six,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104648,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104649,vomiting,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104650,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104651,two,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104652,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104653,bronchial,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104654,asthma,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104655,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104656,one,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104657,",",O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104658,and,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104659,rhinoconjunctivitis,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104660,in,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104661,one,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104662,.,O,3640.0,"Clinical manifestations in relation to avocado ingestion were as follows : systemic anaphylaxis in seven patients , angioedema / urticaria in six , vomiting in two , bronchial asthma in one , and rhinoconjunctivitis in one ."
104875,Nevertheless,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104876,there,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104877,is,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104878,little,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104879,information,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104880,on,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104881,the,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104882,metabolic,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104883,effects,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104884,of,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104885,conventional,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104886,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104887,or,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104888,specialized,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104889,formulations,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104890,with,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104891,reduced,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104892,sucrose,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104893,content,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104894,.,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104975,The,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104976,latter,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104977,is,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104978,a,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104979,sweet,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104980,disaccharide,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104981,alcohol,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104982,which,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104983,has,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104984,no,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104985,glycaemic,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104986,effect,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104987,when,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104988,consumed,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104989,as,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104990,a,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104991,pure,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104992,compound,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104993,.,O,3652.0,The latter is a sweet disaccharide alcohol which has no glycaemic effect when consumed as a pure compound .
104994,Venous,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104995,blood,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104996,samples,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104997,were,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104998,obtained,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
104999,at,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105000,30,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105001,min,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105002,intervals,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105003,for,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105004,5,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105005,h,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105006,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105007,and,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105008,analysed,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105009,for,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105010,glucose,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105011,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105012,insulin,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105013,",",O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105014,lactate,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105015,and,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105016,triglycerides,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105017,.,O,3653.0,"Venous blood samples were obtained at 30 min intervals for 5 h , and analysed for glucose , insulin , lactate and triglycerides ."
105139,All,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105140,three,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105141,chocolates,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105142,led,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105143,to,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105144,a,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105145,similar,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105146,sustained,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105147,rise,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105148,in,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105149,serum,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105150,triglyceride,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105151,levels,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105152,.,O,3657.0,All three chocolates led to a similar sustained rise in serum triglyceride levels .
105316,The,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105317,average,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105318,potassium,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105319,intake,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105320,was,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105321,2791,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105322,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105323,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105324,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105325,per,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105326,participant,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105327,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105328,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105329,the,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105330,major,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105331,sources,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105332,were,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105333,vegetables,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105334,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105335,fruits,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105336,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105337,1262,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105338,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105339,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105340,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105341,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105342,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105343,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105344,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105345,333,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105346,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105347,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105348,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105349,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105350,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105351,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105352,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105353,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105354,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105355,206,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105356,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105357,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105358,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105359,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105360,",",O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105361,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105362,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105363,and,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105364,dairy,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105365,products,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105366,(,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105367,200,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105368,mg,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105369,/,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105370,day,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105371,),O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105372,.,O,3663.0,"The average potassium intake was 2791 mg / day per participant , and the major sources were vegetables and fruits ( 1262 mg / day ) , fish ( 333 mg / day ) , coffee and tea ( 206 mg / day ) , and milk and dairy products ( 200 mg / day ) ."
105373,Participants,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105374,in,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105375,the,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105376,higher,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105377,UK,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105378,/,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105379,BW,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105380,quartile,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105381,consumed,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105382,significantly,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105383,more,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105384,vegetables,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105385,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105386,fruits,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105387,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105388,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105389,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105390,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105391,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105392,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105393,dairy,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105394,products,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105395,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105396,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105397,ate,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105398,less,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105399,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105400,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105401,noodles,B-http://purl.bioontology.org/ontology/SNOMEDCT/226735005,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105402,.,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105809,The,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105810,pseudo,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105811,cereals,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105812,amaranth,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105813,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105814,quinoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/227515004,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105815,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105816,and,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105817,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105818,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105819,are,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105820,promising,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105821,in,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105822,gluten,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105823,-,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105824,free,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105825,diet,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105826,formulation,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105827,.,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
106443,The,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106444,Urban,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106445,pattern,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106446,was,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106447,positively,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106448,associated,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106449,with,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106450,BMI,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106451,in,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106452,multivariate,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106453,analysis,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106454,.,O,3703.0,The Urban pattern was positively associated with BMI in multivariate analysis .
106475,Prior,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106476,studies,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106477,by,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106478,our,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106479,group,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106480,have,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106481,suggested,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106482,that,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106483,expanded,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106484,supplementation,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106485,and,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106486,food,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106487,fortification,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106488,would,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106489,be,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106490,effective,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106491,in,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106492,addressing,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106493,micronutrient,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106494,inadequacies,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106495,;,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106496,these,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106497,strategies,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106498,should,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106499,be,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106500,coupled,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106501,with,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106502,measures,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106503,to,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106504,mitigate,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106505,the,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106506,growing,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106507,burden,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106508,of,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106509,chronic,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106510,disease,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106511,.,O,3705.0,Prior studies by our group have suggested that expanded supplementation and food fortification would be effective in addressing micronutrient inadequacies ; these strategies should be coupled with measures to mitigate the growing burden of chronic disease .
106887,Consumption,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106888,of,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106889,a,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106890,diet,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106891,rich,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106892,in,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106893,fruits,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106894,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106895,vegetables,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106896,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106897,folate,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106898,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106899,K,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106900,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106901,Ca,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106902,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106903,Mg,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106904,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106905,dietary,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106906,fibre,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106907,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106908,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106909,and,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106910,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106911,may,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106912,protect,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106913,against,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106914,stroke,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106915,.,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106975,There,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106976,is,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106977,also,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106978,evidence,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106979,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106980,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106981,low,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106982,serum,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106983,albumin,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106984,may,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106985,be,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106986,causally,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106987,linked,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106988,to,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106989,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106990,risk,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106991,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106992,outcome,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106993,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106994,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106995,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106996,significant,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106997,number,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106998,of,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106999,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107000,patients,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107001,are,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107002,undernourished,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107003,on,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107004,admission,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107005,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107006,their,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107007,nutritional,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107008,status,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107009,deteriorates,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107010,further,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107011,whilst,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107012,in,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107013,hospital,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107014,.,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107109,A,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107110,Cretan,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107111,Mediterranean,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107112,diet,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107113,",",O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107114,high,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107115,in,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107116,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107117,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107118,",",O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107119,whole,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107120,grains,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107121,",",O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107122,fruits,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107123,",",O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107124,vegetables,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107125,and,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107126,legumes,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107127,",",O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107128,and,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107129,low,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107130,in,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107131,cholesterol,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107132,and,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107133,saturated,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107134,fat,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107135,",",O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107136,can,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107137,reduce,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107138,stroke,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107139,by,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107140,40,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107141,%,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107142,or,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107143,more,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107144,in,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107145,high,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107146,-,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107147,risk,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107148,patients,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107149,.,O,3724.0,"A Cretan Mediterranean diet , high in olive oil , whole grains , fruits , vegetables and legumes , and low in cholesterol and saturated fat , can reduce stroke by 40 % or more in high - risk patients ."
107233,It,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107234,has,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107235,serious,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107236,neurological,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107237,consequences,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107238,",",O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107239,including,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107240,an,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107241,increase,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107242,in,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107243,the,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107244,risk,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107245,of,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107246,stroke,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107247,.,O,3729.0,"It has serious neurological consequences , including an increase in the risk of stroke ."
107274,Recently,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107275,",",O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107276,we,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107277,demonstrated,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107278,that,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107279,spaghetti,B-http://purl.bioontology.org/ontology/SNOMEDCT/226744006,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107280,caused,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107281,a,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107282,significantly,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107283,lower,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107284,glycemic,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107285,response,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107286,in,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107287,isoinsulinemic,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107288,insulin,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107289,-,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107290,dependent,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107291,diabetic,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107292,(,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107293,IDDM,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107294,),O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107295,subjects,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107296,than,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107297,an,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107298,exchangeable,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107299,amount,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107300,of,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107301,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
107302,.,O,3731.0,"Recently , we demonstrated that spaghetti caused a significantly lower glycemic response in isoinsulinemic insulin - dependent diabetic ( IDDM ) subjects than an exchangeable amount of potato ."
108258,These,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108259,results,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108260,demonstrate,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108261,the,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108262,high,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108263,frequency,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108264,(,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108265,32,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108266,%,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108267,),O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108268,of,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108269,the,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108270,association,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108271,of,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108272,sensitization,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108273,to,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108274,egg,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108275,proteins,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108276,",",O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108277,particularly,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108278,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108279,yolk,I-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108280,",",O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108281,in,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108282,a,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108283,selected,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108284,population,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108285,of,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108286,patients,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108287,with,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108288,known,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108289,allergy,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108290,to,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108291,bird,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108292,feathers,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108293,",",O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108294,thus,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108295,suggesting,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108296,that,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108297,in,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108298,some,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108299,patients,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108300,feather,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108301,sensitization,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108302,could,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108303,trigger,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108304,or,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108305,somehow,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108306,facilitate,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108307,the,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108308,later,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108309,sensitization,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108310,to,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108311,egg,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108312,yolk,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108313,proteins,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108314,.,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108345,The,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108346,increase,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108347,in,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108348,plasma,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108349,low,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108350,-,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108351,density,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108352,-,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108353,lipoprotein,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108354,-,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108355,cholesterol,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108356,(,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108357,LDL,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108358,-,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108359,C,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108360,),O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108361,concentrations,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108362,associated,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108363,with,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108364,consumption,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108365,of,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108366,saturated,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108367,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108368,oils,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108369,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108370,fats,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108371,is,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108372,largely,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108373,explained,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108374,by,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108375,a,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108376,decrease,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108377,in,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108378,hepatic,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108379,LDL,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108380,receptor,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108381,activity,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108382,and,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108383,an,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108384,increase,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108385,in,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108386,the,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108387,LDL,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108388,-,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108389,C,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108390,production,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108391,rate,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108392,.,O,3766.0,The increase in plasma low - density - lipoprotein - cholesterol ( LDL - C ) concentrations associated with consumption of saturated vegetable oils and fats is largely explained by a decrease in hepatic LDL receptor activity and an increase in the LDL - C production rate .
108566,Lauric,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108567,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108568,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108569,12:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108570,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108571,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108572,myristic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108573,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108574,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108575,14:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108576,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108577,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108578,and,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108579,palmitic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108580,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108581,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108582,16:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108583,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108584,are,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108585,approximately,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108586,equivalent,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108587,in,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108588,their,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108589,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108590,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108591,C,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108592,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108593,raising,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108594,potential,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108595,by,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108596,reducing,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108597,hepatic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108598,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108599,receptor,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108600,activity,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108601,and,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108602,increasing,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108603,the,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108604,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108605,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108606,C,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108607,production,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108608,rate,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108609,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108610,apparently,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108611,via,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108612,modulation,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108613,of,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108614,sterol,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108615,O,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108616,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108617,acyltransferase,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108618,activity,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108619,.,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108620,Stearic,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108621,acid,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108622,(,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108623,18:0,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108624,),O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108625,appears,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108626,to,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108627,be,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108628,neutral,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108629,in,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108630,its,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108631,LDL,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108632,-,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108633,C,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108634,-,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108635,raising,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108636,potential,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108637,and,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108638,how,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108639,it,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108640,affects,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108641,LDL,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108642,metabolism,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108643,.,O,3774.0,Stearic acid ( 18:0 ) appears to be neutral in its LDL - C - raising potential and how it affects LDL metabolism .
108718,We,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108719,followed,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108720,"29,142",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108721,women,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108722,and,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108723,"26,029",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108724,men,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108725,aged,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108726,50,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108727,-,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108728,64,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108729,years,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108730,in,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108731,the,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108732,Danish,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108733,Diet,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108734,",",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108735,Cancer,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108736,and,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108737,Health,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108738,cohort,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108739,.,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108740,Diet,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108741,was,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108742,assessed,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108743,at,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108744,baseline,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108745,by,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108746,using,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108747,a,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108748,detailed,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108749,validated,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108750,FFQ,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
108751,.,O,3780.0,Diet was assessed at baseline by using a detailed validated FFQ .
109154,It,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109155,is,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109156,well,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109157,known,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109158,that,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109159,variations,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109160,in,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109161,MEC,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109162,number,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109163,are,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109164,due,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109165,to,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109166,cell,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109167,proliferation,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109168,and,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109169,apoptosis,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109170,.,O,3801.0,It is well known that variations in MEC number are due to cell proliferation and apoptosis .
109385,These,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109386,findings,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109387,suggest,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109388,that,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109389,prolactin,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109390,could,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109391,regulate,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109392,MEC,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109393,exfoliation,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109394,.,O,3810.0,These findings suggest that prolactin could regulate MEC exfoliation .
109556,We,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109557,computed,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109558,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109559,odds,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109560,ratios,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109561,(,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109562,ORs,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109563,),O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109564,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109565,thyroid,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109566,cancer,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109567,and,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109568,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109569,corresponding,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109570,95,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109571,%,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109572,confidence,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109573,intervals,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109574,(,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109575,CIs,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109576,),O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109577,according,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109578,to,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109579,the,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109580,median,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109581,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109582,control,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109583,group,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109584,daily,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109585,intake,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109586,of,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109587,each,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109588,food,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109589,group,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109590,",",O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109591,using,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109592,multiple,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109593,logistic,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109594,regression,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109595,models,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109596,adjusted,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109597,for,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109598,major,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109599,confounding,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109600,factors,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109601,.,O,3818.0,"We computed the odds ratios ( ORs ) of thyroid cancer and the corresponding 95 % confidence intervals ( CIs ) according to the median of control group daily intake of each food group , using multiple logistic regression models adjusted for major confounding factors ."
109991,Ligated,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109992,probes,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109993,were,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109994,amplified,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109995,by,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109996,polymerase,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109997,chain,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109998,reaction,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
109999,(,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110000,PCR,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110001,),O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110002,",",O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110003,and,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110004,amplicons,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110005,were,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110006,detected,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110007,using,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110008,capillary,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110009,electrophoresis,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110010,.,O,3829.0,"Ligated probes were amplified by polymerase chain reaction ( PCR ) , and amplicons were detected using capillary electrophoresis ."
110182,Anthocyanins,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110183,have,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110184,demonstrated,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110185,antioxidant,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110186,potential,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110187,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110188,both,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110189,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110190,vitro,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110191,and,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110192,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110193,vivo,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110194,studies,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110195,",",O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110196,and,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110197,the,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110198,consumption,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110199,of,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110200,foods,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110201,high,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110202,in,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110203,anthocyanins,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110204,has,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110205,been,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110206,linked,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110207,to,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110208,lower,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110209,risks,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110210,of,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110211,chronic,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110212,diseases,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110213,.,O,3839.0,"Anthocyanins have demonstrated antioxidant potential in both in vitro and in vivo studies , and the consumption of foods high in anthocyanins has been linked to lower risks of chronic diseases ."
110230,This,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110231,paper,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110232,will,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110233,review,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110234,the,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110235,characteristics,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110236,of,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110237,cereal,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110238,anthocyanins,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110239,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110240,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110241,assess,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110242,their,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110243,prevalence,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110244,in,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110245,various,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110246,commercially,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110247,relevant,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110248,crops,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110249,including,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110250,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110251,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110252,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110253,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110254,maize,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110255,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110256,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110257,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110258,.,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110686,In,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110687,an,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110688,effort,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110689,to,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110690,disseminate,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110691,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110692,explore,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110693,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110694,discuss,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110695,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110696,state,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110697,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110698,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110699,science,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110700,on,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110701,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110702,relationship,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110703,between,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110704,regular,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110705,fat,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110706,dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110707,products,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110708,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110709,health,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110710,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110711,symposia,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110712,were,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110713,programmed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110714,by,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110715,dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110716,industry,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110717,organizations,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110718,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110719,Europe,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110720,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110721,North,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110722,America,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110723,at,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110724,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110725,Eurofed,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110726,Lipids,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110727,Congress,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110728,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110729,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110730,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110731,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110732,France,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110733,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110734,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110735,Dairy,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110736,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110737,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110738,Symposium,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110739,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110740,2014,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110741,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110742,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110743,Canada,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110744,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110745,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110746,American,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110747,Society,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110748,for,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110749,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110750,Annual,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110751,Meeting,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110752,held,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110753,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110754,conjunction,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110755,with,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110756,Experimental,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110757,Biology,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110758,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110759,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110760,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110761,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110762,the,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110763,United,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110764,States,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110765,",",O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110766,and,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110767,The,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110768,Federation,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110769,of,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110770,European,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110771,Nutrition,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110772,Societies,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110773,(,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110774,2015,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110775,),O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110776,in,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110777,Germany,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
110778,.,O,3857.0,"In an effort to disseminate , explore and discuss the state of the science on the relationship between regular fat dairy products and health , symposia were programmed by dairy industry organizations in Europe and North America at The Eurofed Lipids Congress ( 2014 ) in France , The Dairy Nutrition Annual Symposium ( 2014 ) in Canada , The American Society for Nutrition Annual Meeting held in conjunction with Experimental Biology ( 2015 ) in the United States , and The Federation of European Nutrition Societies ( 2015 ) in Germany ."
111228,Moreover,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111229,",",O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111230,40,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111231,%,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111232,of,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111233,the,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111234,SMEs,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111235,were,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111236,micro,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111237,entities,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111238,.,O,3875.0,"Moreover , 40 % of the SMEs were micro entities ."
111248,The,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111249,arsenic,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111250,(,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111251,As,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111252,),O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111253,content,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111254,of,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111255,solid,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111256,food,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111257,stuff,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111258,was,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111259,determined,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111260,by,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111261,hydride,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111262,generation,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111263,atomic,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111264,absorption,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111265,spectrometry,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111266,after,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111267,dry,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111268,ashing,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111269,.,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111758,Control,O,3898.0,Control group received a single intraperitoneal ( i.p .
111759,group,O,3898.0,Control group received a single intraperitoneal ( i.p .
111760,received,O,3898.0,Control group received a single intraperitoneal ( i.p .
111761,a,O,3898.0,Control group received a single intraperitoneal ( i.p .
111762,single,O,3898.0,Control group received a single intraperitoneal ( i.p .
111763,intraperitoneal,O,3898.0,Control group received a single intraperitoneal ( i.p .
111764,(,O,3898.0,Control group received a single intraperitoneal ( i.p .
111765,i.p,O,3898.0,Control group received a single intraperitoneal ( i.p .
111766,.,O,3898.0,Control group received a single intraperitoneal ( i.p .
111810,injection,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111811,of,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111812,cadmium,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111813,chloride,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111814,(,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111815,1.2,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111816, ,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111817,mg,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111818,/,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111819,kg,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111820,body,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111821,),O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111822,",",O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111823,and,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111824,after,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111825,15,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111826, ,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111827,days,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111828,",",O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111829,the,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111830,rats,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111831,were,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111832,treated,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111833,with,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111834,grape,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111835,or,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111836,apple,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111837,juices,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111838,for,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111839,15,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111840, ,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111841,days,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111842,",",O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111843,by,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111844,gavage,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
111845,.,O,3903.0,"injection of cadmium chloride ( 1.2   mg / kg body ) , and after 15   days , the rats were treated with grape or apple juices for 15   days , by gavage ."
112010,Tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112011,and,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112012,soy,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112013,protein,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112014,significantly,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112015,lowered,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112016,serum,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112017,triacylglycerol,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112018,and,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112019,cholesterol,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112020,levels,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112021,compared,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112022,to,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112023,casein,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112024,and,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112025,",",O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112026,through,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112027,microarray,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112028,analyses,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112029,",",O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112030,were,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112031,found,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112032,to,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112033,exclusively,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112034,alter,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112035,transcriptomes,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112036,involved,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112037,in,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112038,fatty,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112039,acid,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112040,and/or,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112041,steroid,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112042,synthesis,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112043,in,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112044,the,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112045,liver,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112046,",",O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112047,where,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112048,most,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112049,of,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112050,the,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112051,serum,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112052,lipids,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112053,are,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112054,synthesized,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112055,.,O,3912.0,"Tofu and soy protein significantly lowered serum triacylglycerol and cholesterol levels compared to casein and , through microarray analyses , were found to exclusively alter transcriptomes involved in fatty acid and/or steroid synthesis in the liver , where most of the serum lipids are synthesized ."
112135,Groups,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112136,of,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112137,18,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112138,-,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112139,21,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112140,male,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112141,weanling,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112142,C3H,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112143,mice,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112144,were,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112145,given,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112146,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112147,as,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112148,drinking,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112149,fluid,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112150,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112151,tap,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112152,-,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112153,water,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112154,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112155,12,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112156,%,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112157,ethanol,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112158,solution,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112159,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112160,one,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112161,of,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112162,two,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112163,commercial,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112164,white,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112165,wines,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112166,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112167,or,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112168,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112169,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112170,",",O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112171,ad,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112172,lib,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112173,.,O,3916.0,"Groups of 18 - 21 male weanling C3H mice were given , as drinking fluid , tap - water , 12 % ethanol solution , one of two commercial white wines , or red wine , ad lib ."
112930,When,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112931,compared,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112932,with,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112933,data,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112934,from,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112935,non,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112936,-,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112937,drinkers,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112938,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112939,our,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112940,findings,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112941,suggest,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112942,an,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112943,inverse,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112944,dose,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112945,-,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112946,response,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112947,relationship,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112948,for,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112949,the,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112950,lifetime,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112951,consumption,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112952,of,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112953,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112954,(,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112955,ORs,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112956,1.00,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112957,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112958,0.72,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112959,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112960,0.37,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112961,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112962,0.58,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112963,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112964,p,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112965,trend,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112966,0.06,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112967,),O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112968,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112969,whereas,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112970,lifetime,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112971,consumption,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112972,of,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112973,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112974,and,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112975,of,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112976,ground,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112977,",",O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112978,instant,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112979,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112980,decaffeinated,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112981,coffee,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112982,was,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112983,not,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112984,associated,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112985,with,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112986,risk,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
112987,.,O,3939.0,"When compared with data from non - drinkers , our findings suggest an inverse dose - response relationship for the lifetime consumption of coffee ( ORs 1.00 , 0.72 , 0.37 , 0.58 , p trend 0.06 ) , whereas lifetime consumption of tea and of ground , instant and decaffeinated coffee was not associated with risk ."
113285,There,O,3947.0,There were no associations with diet soda / orange juice .
113286,were,O,3947.0,There were no associations with diet soda / orange juice .
113287,no,O,3947.0,There were no associations with diet soda / orange juice .
113288,associations,O,3947.0,There were no associations with diet soda / orange juice .
113289,with,O,3947.0,There were no associations with diet soda / orange juice .
113290,diet,O,3947.0,There were no associations with diet soda / orange juice .
113291,soda,O,3947.0,There were no associations with diet soda / orange juice .
113292,/,O,3947.0,There were no associations with diet soda / orange juice .
113293,orange,B-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3947.0,There were no associations with diet soda / orange juice .
113294,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3947.0,There were no associations with diet soda / orange juice .
113295,.,O,3947.0,There were no associations with diet soda / orange juice .
113744,In,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113745,previous,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113746,studies,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113747,that,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113748,determined,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113749,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113750,PTHrP,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113751,concentrations,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113752,in,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113753,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113754,",",O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113755,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113756,pretreatments,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113757,and,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113758,diluent,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113759,composition,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113760,were,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113761,not,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113762,standardized,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113763,.,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
114093,The,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114094,discrepancy,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114095,in,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114096,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114097,use,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114098,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114099,foods,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114100,rendered,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114101,gluten,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114102,free,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114103,exists,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114104,because,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114105,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114106,amount,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114107,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114108,toxic,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114109,prolamins,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114110,that,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114111,individuals,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114112,with,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114113,celiac,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114114,disease,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114115,may,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114116,consume,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114117,without,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114118,damaging,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114119,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114120,mucosa,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114121,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114122,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114123,small,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114124,intestine,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114125,is,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114126,unknown,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114127,.,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114232,Until,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114233,this,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114234,research,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114235,is,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114236,conducted,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114237,",",O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114238,dietitians,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114239,in,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114240,the,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114241,United,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114242,States,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114243,should,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114244,continue,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114245,to,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114246,advise,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114247,their,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114248,patients,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114249,against,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114250,the,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114251,use,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114252,of,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114253,wheat,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114254,starch,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114255,and,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114256,other,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114257,foods,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114258,rendered,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114259,gluten,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114260,free,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114261,.,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114305,Recent,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114306,studies,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114307,have,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114308,shown,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114309,that,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114310,consumption,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114311,of,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114312,dairy,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114313,products,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114314,appears,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114315,to,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114316,be,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114317,beneficial,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114318,in,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114319,muscle,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114320,building,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114321,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114322,lowering,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114323,blood,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114324,pressure,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114325,and,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114326,low,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114327,-,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114328,density,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114329,lipoprotein,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114330,cholesterol,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114331,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114332,and,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114333,preventing,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114334,tooth,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114335,decay,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114336,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114337,diabetes,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114338,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114339,cancer,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114340,",",O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114341,and,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114342,obesity,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114343,.,O,3981.0,"Recent studies have shown that consumption of dairy products appears to be beneficial in muscle building , lowering blood pressure and low - density lipoprotein cholesterol , and preventing tooth decay , diabetes , cancer , and obesity ."
114508,We,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114509,defined,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114510,Med,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114511,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114512,style,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114513,diet,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114514,as,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114515,a,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114516,high,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114517,consumption,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114518,of,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114519,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114520,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114521,vegetables,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114522,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114523,legumes,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114524,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114525,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114526,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114527,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114528,and,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114529,low,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114530,consumption,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114531,of,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114532,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114533,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114534,dairy,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114535,products,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114536,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114537,fat,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114538,and,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114539,alcohol,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114540,categorising,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114541,participants,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114542,into,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114543,Med,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114544,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114545,style,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114546,diet,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114547,tertiles,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114548,(,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114549,low,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114550,:,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114551,0,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114552,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114553,3,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114554,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114555,moderate,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114556,:,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114557,4,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114558,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114559,5,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114560,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114561,high,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114562,:,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114563,6,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114564,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114565,9,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114566,),O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114567,.,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114797,Poor,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114798,metabolic,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114799,health,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114800,is,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114801,a,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114802,common,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114803,characteristic,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114804,of,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114805,overweight,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114806,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114807,obesity,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114808,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114809,aging,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114810,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114811,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114812,is,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114813,the,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114814,forerunner,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114815,of,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114816,T2DM,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114817,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114818,cardiovascular,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114819,disease,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114820,(,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114821,CVD,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114822,),O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114823,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114824,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114825,an,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114826,ever,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114827,increasing,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114828,global,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114829,health,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114830,issue,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114831,.,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
115121,Recently,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115122,there,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115123,has,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115124,been,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115125,a,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115126,surge,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115127,in,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115128,the,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115129,number,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115130,of,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115131,publications,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115132,that,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115133,has,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115134,investigated,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115135,their,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115136,biological,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115137,properties,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115138,.,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115260,Studies,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115261,with,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115262,tyrosol,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115263,have,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115264,shown,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115265,that,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115266,it,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115267,is,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115268,excreted,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115269,unchanged,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115270,and,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115271,as,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115272,its,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115273,conjugates,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115274,.,O,4017.0,Studies with tyrosol have shown that it is excreted unchanged and as its conjugates .
115303,Well,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115304,-,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115305,planned,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115306,vegetarian,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115307,diets,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115308,are,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115309,considered,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115310,adequate,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115311,for,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115312,all,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115313,stages,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115314,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115315,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115316,life,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115317,cycle,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115318,",",O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115319,despite,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115320,limited,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115321,data,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115322,on,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115323,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115324,zinc,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115325,status,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115326,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115327,vegetarians,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115328,during,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115329,early,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115330,childhood,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115331,.,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115577,Additional,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115578,recommended,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115579,practices,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115580,include,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115581,using,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115582,fermented,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115583,soy,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115584,foods,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115585,and,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115586,sprouting,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115587,at,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115588,least,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115589,some,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115590,of,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115591,the,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115592,legumes,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115593,consumed,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115594,.,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115728,During,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115729,8,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115730,years,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115731,of,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115732,follow,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115733,-,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115734,up,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115735,",",O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115736,there,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115737,were,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115738,431,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115739,cases,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115740,of,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115741,new,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115742,CHD,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115743,(,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115744,non,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115745,-,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115746,fatal,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115747,myocardial,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115748,infarction,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115749,or,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115750,death,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115751,from,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115752,CHD,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115753,),O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
115754,.,O,4032.0,"During 8 years of follow - up , there were 431 cases of new CHD ( non - fatal myocardial infarction or death from CHD ) ."
116109,In,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116110,virtually,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116111,every,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116112,early,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116113,civilization,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116114,known,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116115,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116116,such,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116117,as,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116118,ancient,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116119,India,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116120,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116121,Egypt,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116122,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116123,Rome,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116124,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116125,China,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116126,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116127,and,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116128,Japan,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116129,",",O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116130,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116131,was,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116132,part,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116133,of,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116134,the,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116135,therapeutic,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116136,regimen,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116137,for,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116138,a,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116139,variety,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116140,of,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116141,maladies,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116142,.,O,4047.0,"In virtually every early civilization known , such as ancient India , Egypt , Rome , China , and Japan , garlic was part of the therapeutic regimen for a variety of maladies ."
116276,The,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116277,current,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116278,state,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116279,of,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116280,knowledge,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116281,does,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116282,not,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116283,recognize,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116284,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116285,as,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116286,a,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116287,true,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116288,alternative,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116289,",",O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116290,but,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116291,it,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116292,will,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116293,likely,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116294,find,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116295,a,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116296,place,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116297,for,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116298,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116299,as,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116300,a,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116301,complement,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116302,to,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116303,established,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116304,methods,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116305,of,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116306,disease,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116307,prevention,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116308,and,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116309,treatment,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116310,.,O,4054.0,"The current state of knowledge does not recognize garlic as a true alternative , but it will likely find a place for garlic as a complement to established methods of disease prevention and treatment ."
116439,Rats,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116440,receiving,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116441,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116442,orally,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116443,and,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116444,intraperitoneally,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116445,also,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116446,showed,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116447,a,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116448,significant,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116449,reduction,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116450,in,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116451,triglyceride,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116452,levels,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116453,(,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116454,38,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116455,%,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116456,),O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116457,.,O,4060.0,Rats receiving garlic orally and intraperitoneally also showed a significant reduction in triglyceride levels ( 38 % ) .
116632,The,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116633,results,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116634,of,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116635,many,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116636,studies,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116637,have,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116638,linked,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116639,increased,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116640,consumption,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116641,of,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116642,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116643,and,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116644,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116645,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116646,with,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116647,lower,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116648,blood,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116649,pressure,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116650,and,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116651,reduced,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116652,risk,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116653,of,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116654,hypertension,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116655,.,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116830,Calcium,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116831,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116832,bioactive,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116833,peptides,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116834,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116835,as,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116836,yet,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116837,unidentified,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116838,components,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116839,in,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116840,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116841,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116842,may,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116843,protect,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116844,from,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116845,hypertension,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116846,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116847,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116848,folic,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116849,acid,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116850,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116851,vitamin,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116852,B6,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116853,(,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116854,pyridoxine,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116855,),O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116856,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116857,B12,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116858,(,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116859,cyanocobalamin,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116860,),O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116861,or,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116862,other,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116863,unidentified,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116864,components,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116865,of,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116866,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116867,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116868,may,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116869,contribute,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116870,to,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116871,low,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116872,homocysteine,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116873,levels,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116874,.,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
117408,Indices,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117409,of,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117410,beta,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117411,-,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117412,carotene,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117413,and,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117414,ascorbate,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117415,intake,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117416,were,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117417,negatively,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117418,and,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117419,strongly,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117420,related,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117421,with,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117422,gastric,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117423,cancer,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117424,risk,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117425,",",O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117426,but,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117427,the,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117428,association,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117429,with,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117430,these,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117431,micronutrients,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117432,was,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117433,no,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117434,longer,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117435,evident,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117436,after,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117437,simultaneous,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117438,allowance,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117439,for,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117440,various,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117441,food,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117442,items,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117443,.,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117444,An,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117445,approximately,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117446,7,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117447,-,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117448,fold,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117449,difference,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117450,in,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117451,risk,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117452,was,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117453,found,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117454,between,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117455,extreme,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117456,quintiles,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117457,of,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117458,a,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117459,scale,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117460,measuring,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117461,major,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117462,positive,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117463,and,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117464,negative,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117465,associations,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117466,.,O,4095.0,An approximately 7 - fold difference in risk was found between extreme quintiles of a scale measuring major positive and negative associations .
117576,Despite,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117577,their,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117578,sweet,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117579,taste,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117580,",",O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117581,dried,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117582,plums,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117583,do,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117584,not,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117585,cause,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117586,large,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117587,postprandial,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117588,rise,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117589,in,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117590,blood,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117591,glucose,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117592,and,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117593,insulin,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117594,.,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117610,The,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117611,characteristic,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117612,phenolic,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117613,compounds,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117614,and,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117615,their,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117616,metabolites,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117617,may,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117618,also,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117619,act,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117620,as,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117621,antibacterial,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117622,agents,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117623,in,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117624,both,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117625,gastrointestinal,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117626,and,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117627,urinary,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117628,tracts,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117629,.,O,4102.0,The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts .
117849,We,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117850,conclude,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117851,that,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117852,fruit,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117853,-,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117854,related,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117855,symptoms,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117856,require,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117857,not,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117858,only,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117859,high,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117860,specific,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117861,serum,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117862,IgE,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117863,",",O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117864,but,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117865,a,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117866,strong,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117867,cellular,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117868,sensitization,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117869,to,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117870,birch,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117871,pollen,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117872,allergens,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117873,together,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117874,with,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117875,an,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117876,increased,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117877,cellular,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117878,reactivity,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117879,to,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117880,fruit,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117881,allergens,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117882,.,O,4110.0,"We conclude that fruit - related symptoms require not only high specific serum IgE , but a strong cellular sensitization to birch pollen allergens together with an increased cellular reactivity to fruit allergens ."
117945,The,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117946,present,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117947,study,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117948,assesses,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117949,human,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117950,bioaccessibility,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117951,of,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117952,Cd,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117953,in,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117954,vegetables,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117955,cultivated,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117956,in,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117957,smelter,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117958,-,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117959,impacted,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117960,kitchen,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117961,garden,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117962,soils,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
117963,.,O,4114.0,The present study assesses human bioaccessibility of Cd in vegetables cultivated in smelter - impacted kitchen garden soils .
118090,Cooking,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118091,by,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118092,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118093,steaming,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118094,process,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118095,generally,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118096,increased,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118097,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118098,bioaccessibility,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118099,of,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118100,Cd,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118101,in,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118102,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118103,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118104,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118105,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118106,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118107,and,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118108,leek,B-http://purl.bioontology.org/ontology/SNOMEDCT/726755004,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118109,.,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118364,Other,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118365,structurally,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118366,homologous,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118367,nutraceuticals,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118368,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118369,derived,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118370,from,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118371,red,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118372,chili,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118373,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118374,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118375,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118376,cloves,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118377,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118378,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118379,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118380,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118381,and,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118382,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118383,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118384,also,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118385,exhibit,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118386,effects,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118387,against,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118388,obesity,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118389,and,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118390,insulin,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118391,resistance,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118392,.,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118460,Currently,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118461,",",O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118462,studies,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118463,on,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118464,the,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118465,association,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118466,between,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118467,shellfish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735029006,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118468,consumption,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118469,and,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118470,health,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118471,outcomes,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118472,have,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118473,reported,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118474,conflicting,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118475,results,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
118476,.,O,4131.0,"Currently , studies on the association between shellfish consumption and health outcomes have reported conflicting results ."
119319,Variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119320,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119321,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119322,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119323,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119324,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119325,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119326,vegetables,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119327,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119328,sugar,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119329,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119330,sweetened,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119331,beverages,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119332,(,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119333,SSB,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119334,),O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119335,across,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119336,consumer,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119337,groups,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119338,contributed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119339,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119340,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119341,largest,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119342,variance,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119343,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119344,DED,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119345,estimates,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119346,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119347,followed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119348,by,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119349,variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119350,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119351,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119352,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119353,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119354,potatoes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119355,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119356,fresh,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119357,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119358,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119359,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119360,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119361,chips,B-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119362,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119363,ready,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119364,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119365,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119366,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119367,eat,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119368,breakfast,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119369,cereals,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119370,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119371,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119372,confectionery,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119373,.,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119469,Current,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119470,DED,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119471,estimates,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119472,for,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119473,adults,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119474,were,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119475,similar,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119476,to,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119477,those,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119478,calculated,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119479,in,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119480,a,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119481,previous,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119482,survey,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119483,",",O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119484,carried,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119485,out,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119486,10,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119487,years,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119488,earlier,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119489,.,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119803,A,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119804,population,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119805,-,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119806,based,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119807,case,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119808,-,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119809,control,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119810,study,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119811,was,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119812,conducted,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119813,to,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119814,examine,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119815,the,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119816,relationship,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119817,between,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119818,certain,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119819,medical,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119820,conditions,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119821,",",O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119822,the,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119823,use,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119824,of,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119825,tobacco,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119826,",",O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119827,alcohol,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119828,and,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119829,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119830,",",O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119831,and,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119832,the,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119833,incidence,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119834,of,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119835,pancreatic,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119836,cancer,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119837,.,O,4174.0,"A population - based case - control study was conducted to examine the relationship between certain medical conditions , the use of tobacco , alcohol and coffee , and the incidence of pancreatic cancer ."
119928,Individuals,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119929,who,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119930,had,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119931,ever,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119932,smoked,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119933,cigarettes,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119934,were,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119935,at,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119936,elevated,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119937,risk,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119938,of,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119939,disease,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
119940,.,O,4179.0,Individuals who had ever smoked cigarettes were at elevated risk of disease .
121355,A,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121356,random,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121357,sample,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121358,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121359,1153,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121360,individuals,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121361,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121362,aged,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121363,18,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121364,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121365,69,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121366,years,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121367,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121368,was,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121369,recruited,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121370,to,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121371,participate,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121372,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121373,the,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121374,cross,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121375,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121376,sectional,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121377,Observation,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121378,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121379,Cardiovascular,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121380,Risk,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121381,Factors,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121382,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121383,Luxembourg,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121384,study,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121385,.,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121386,Chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121387,consumption,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121388,(,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121389,g,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121390,/,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121391,d,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121392,),O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121393,was,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121394,obtained,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121395,from,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121396,a,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121397,semi,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121398,-,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121399,quantitative,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121400,FFQ,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121401,.,O,4231.0,Chocolate consumption ( g / d ) was obtained from a semi - quantitative FFQ .
121490,After,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121491,excluding,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121492,subjects,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121493,taking,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121494,antidiabetic,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121495,medications,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121496,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121497,higher,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121498,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121499,consumption,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121500,was,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121501,associated,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121502,with,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121503,lower,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121504,HOMA,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121505,-,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121506,IR,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121507,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121508,β=-0·16,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121509,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121510,P=0·004,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121511,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121512,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121513,serum,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121514,insulin,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121515,levels,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121516,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121517,β=-0·16,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121518,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121519,P=0·003,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121520,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121521,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121522,γ,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121523,-,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121524,GT,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121525,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121526,β=-0·12,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121527,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121528,P=0·009,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121529,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121530,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121531,ALT,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121532,(,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121533,β=-0·09,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121534,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121535,P=0·004,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121536,),O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121537,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121538,after,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121539,adjustment,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121540,for,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121541,age,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121542,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121543,sex,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121544,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121545,education,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121546,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121547,lifestyle,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121548,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121549,dietary,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121550,confounding,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121551,factors,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121552,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121553,including,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121554,intakes,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121555,of,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121556,fruits,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121557,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121558,vegetables,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121559,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121560,alcohol,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121561,",",O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121562,polyphenol,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121563,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121564,rich,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121565,coffee,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121566,and,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121567,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121568,.,O,4235.0,"After excluding subjects taking antidiabetic medications , higher chocolate consumption was associated with lower HOMA - IR ( β=-0·16 , P=0·004 ) , serum insulin levels ( β=-0·16 , P=0·003 ) and γ - GT ( β=-0·12 , P=0·009 ) and ALT ( β=-0·09 , P=0·004 ) , after adjustment for age , sex , education , lifestyle and dietary confounding factors , including intakes of fruits and vegetables , alcohol , polyphenol - rich coffee and tea ."
121919,Plant,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121920,protein,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121921,sources,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121922,used,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121923,in,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121924,interventions,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121925,were,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121926,most,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121927,often,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121928,pea,B-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121929,(,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121930,The,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121931,effects,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121932,of,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121933,a,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121934,red,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121935,wine,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121936,phenolic,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121937,extract,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121938,(,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121939,PE,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121940,),O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121941,on,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121942,plasma,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121943,lipoproteins,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121944,and,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121945,early,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121946,atherosclerosis,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121947,were,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121948,studied,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121949,in,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121950,hamsters,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
121951,.,O,4247.0,Plant protein sources used in interventions were most often pea ( The effects of a red wine phenolic extract ( PE ) on plasma lipoproteins and early atherosclerosis were studied in hamsters .
122291,With,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122292,moderate,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122293,consumption,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122294,of,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122295,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122296,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122297,",",O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122298,ethanol,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122299,can,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122300,improve,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122301,the,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122302,effects,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122303,of,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122304,phenolic,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122305,compounds,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122306,.,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122350,Cancer,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122351,cases,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122352,(,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122353,n,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122354,=,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122355,419,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122356,),O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122357,were,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122358,identified,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122359,through,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122360,the,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122361,Utah,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122362,Cancer,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122363,Registry,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122364,",",O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122365,and,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122366,controls,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122367,(,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122368,n,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122369,=,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122370,889,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122371,),O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122372,were,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122373,obtained,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122374,through,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122375,random,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122376,digit,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122377,dialing,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122378,and,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122379,the,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122380,Health,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122381,Care,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122382,Financing,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122383,Administration,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122384,.,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122550,Furthermore,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122551,",",O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122552,it,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122553,is,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122554,hypothesized,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122555,that,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122556,the,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122557,dietary,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122558,components,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122559,of,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122560,these,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122561,beverages,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122562,may,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122563,be,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122564,related,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122565,to,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122566,the,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122567,development,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122568,of,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122569,bladder,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122570,cancer,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122571,.,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122572,Reduced,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122573,rank,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122574,regression,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122575,(,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122576,RRR,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122577,),O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122578,is,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122579,an,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122580,innovative,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122581,technique,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122582,to,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122583,establish,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122584,dietary,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122585,patterns,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122586,related,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122587,to,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122588,biochemical,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122589,risk,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122590,factors,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122591,for,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122592,type,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122593,2,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122594,diabetes,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122595,",",O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122596,but,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122597,has,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122598,not,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122599,been,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122600,applied,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122601,in,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122602,sub,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122603,-,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122604,Saharan,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122605,Africa,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122606,.,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
123170,From,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123171,that,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123172,study,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123173,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123174,we,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123175,now,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123176,report,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123177,measures,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123178,of,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123179,circulating,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123180,factors,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123181,that,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123182,may,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123183,influence,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123184,CRC,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123185,initiation,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123186,or,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123187,progression,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123188,including,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123189,malondialdehyde,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123190,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123191,MDA,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123192,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123193,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123194,leptin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123195,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123196,insulin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123197,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123198,like,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123199,growth,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123200,factor,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123201,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123202,I,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123203,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123204,IGF,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123205,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123206,I,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123207,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123208,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123209,insulin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123210,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123211,matrix,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123212,metalloproteinase-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123213,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123214,MMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123215,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123216,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123217,tissue,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123218,inhibitor,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123219,of,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123220,MMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123221,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123222,TIMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123223,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123224,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123225,interleukins,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123226,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123227,IL,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123228,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123229,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123230,and,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123231,short,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123232,chain,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123233,fatty,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123234,acids,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123235,.,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123292,Higher,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123293,levels,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123294,of,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123295,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123296,resulted,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123297,in,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123298,greater,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123299,insulin,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123300,concentrations,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123301,than,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123302,for,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123303,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123304,in,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123305,rats,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123306,fed,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123307,HAMS,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123308,.,O,4295.0,Higher levels of chicken resulted in greater insulin concentrations than for beef in rats fed HAMS .
123347,Colonic,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123348,DNA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123349,strand,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123350,breakage,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123351,was,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123352,positively,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123353,associated,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123354,with,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123355,circulating,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123356,leptin,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123357,and,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123358,MDA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123359,concentrations,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123360,as,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123361,well,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123362,as,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123363,tissue,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123364,MDA,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123365,concentrations,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123366,and,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123367,negatively,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123368,associated,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123369,with,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123370,plasma,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123371,TIMP-2,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123372,concentration,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123373,.,O,4299.0,Colonic DNA strand breakage was positively associated with circulating leptin and MDA concentrations as well as tissue MDA concentrations and negatively associated with plasma TIMP-2 concentration .
123500,The,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123501,mean,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123502,percent,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123503,recovery,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123504,for,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123505,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123506,from,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123507,the,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123508,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123509,dressing,I-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123510,was,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123511,only,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123512,7.7%+/-,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123513,1.6,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123514,%,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123515,.,O,4306.0,The mean percent recovery for mustard from the salad dressing was only 7.7%+/- 1.6 % .
123541,However,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123542,",",O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123543,if,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123544,the,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123545,pH,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123546,was,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123547,adjusted,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123548,to,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123549,pH,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123550,7,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123551,after,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123552,spiking,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123553,and,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123554,extraction,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123555,",",O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123556,the,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123557,recovery,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123558,was,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123559,only,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123560,11.1%+/-,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123561,1.7,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123562,%,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123563,.,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123564,When,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123565,vinegar,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123566,was,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123567,spiked,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123568,with,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123569,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123570,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/51905005;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123571,at,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123572,pH,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123573,3,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123574,",",O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123575,3.5,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123576,",",O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123577,and,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123578,4,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123579,",",O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123580,detectability,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123581,of,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123582,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123583,was,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123584,lowest,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123585,at,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123586,pH,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123587,3,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123588,.,O,4309.0,"When vinegar was spiked with mustard flour at pH 3 , 3.5 , and 4 , detectability of mustard was lowest at pH 3 ."
123589,Basic,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123590,extraction,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123591,of,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123592,mustard,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123593,proteins,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123594,from,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123595,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123596,dressing,I-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123597,did,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123598,not,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123599,improve,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123600,the,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123601,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123602,detection,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123603,.,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123632,Commercial,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123633,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123634,dressings,I-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123635,containing,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123636,100,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123637,ppm,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123638,(,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123639,mg,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123640,/,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123641,kg,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123642,),O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123643,of,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123644,egg,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123645,",",O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123646,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123647,",",O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123648,or,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123649,gluten,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123650,were,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123651,analyzed,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123652,every,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123653,2,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123654,to,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123655,4,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123656,d,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123657,for,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123658,90,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123659,d,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123660,using,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123661,3,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123662,commercially,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123663,available,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123664,ELISAs,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123665,.,O,4312.0,"Commercial salad dressings containing 100 ppm ( mg / kg ) of egg , milk , or gluten were analyzed every 2 to 4 d for 90 d using 3 commercially available ELISAs ."
123714,The,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123715,relationship,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123716,between,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123717,intake,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123718,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123719,various,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123720,indicator,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123721,foods,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123722,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123723,beverages,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123724,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123725,risk,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123726,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123727,prostatic,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123728,cancer,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123729,was,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123730,assessed,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123731,in,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123732,271,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123733,cases,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123734,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123735,prostatic,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123736,cancer,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123737,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123738,685,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123739,hospital,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123740,controls,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123741,recruited,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123742,in,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123743,two,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123744,areas,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123745,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123746,northern,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123747,Italy,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123748,",",O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123749,the,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123750,province,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123751,of,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123752,Pordenone,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123753,and,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123754,the,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123755,greater,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123756,Milan,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123757,area,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123758,.,O,4315.0,"The relationship between intake of various indicator foods and beverages and risk of prostatic cancer was assessed in 271 cases of prostatic cancer and 685 hospital controls recruited in two areas of northern Italy , the province of Pordenone and the greater Milan area ."
123870,There,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123871,was,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123872,also,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123873,a,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123874,clue,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123875,that,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123876,the,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123877,unfavorable,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123878,influence,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123879,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123880,frequent,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123881,intake,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123882,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123883,a,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123884,few,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123885,food,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123886,items,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123887,(,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123888,i.e.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123889,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123890,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123891,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123892,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123893,liver,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123894,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123895,ham,B-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123896,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123897,salami,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123898,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123899,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123900,and,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123901,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123902,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123903,and,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123904,retinol,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123905,),O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123906,may,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123907,be,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123908,greater,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123909,or,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123910,restricted,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123911,to,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123912,older,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123913,individuals,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123914,(,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123915,i.e.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123916,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123917,>,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123918,or,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123919,=,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123920,70,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123921,yrs,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123922,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123923,age,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123924,),O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123925,.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
124310,Among,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124311,the,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124312,identified,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124313,constituents,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124314,are,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124315,several,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124316,proteins,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124317,considered,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124318,to,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124319,influence,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124320,wine,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124321,stability,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124322,and,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124323,previously,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124324,described,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124325,potential,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124326,grape,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124327,allergens,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124328,.,O,4334.0,Among the identified constituents are several proteins considered to influence wine stability and previously described potential grape allergens .
124672,When,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124673,a,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124674,logistic,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124675,model,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124676,was,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124677,fitted,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124678,that,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124679,included,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124680,the,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124681,aforementioned,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124682,food,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124683,items,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124684,in,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124685,addition,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124686,to,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124687,major,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124688,nondietary,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124689,covariates,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124690,",",O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124691,all,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124692,of,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124693,the,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124694,foods,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124695,",",O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124696,except,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124697,liver,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124698,and,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124699,beverages,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124700,that,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124701,contain,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124702,methylxanthine,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124703,",",O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124704,remained,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124705,significant,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124706,.,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124736,The,O,4350.0,The liver plays an outsized role in oncology .
124737,liver,O,4350.0,The liver plays an outsized role in oncology .
124738,plays,O,4350.0,The liver plays an outsized role in oncology .
124739,an,O,4350.0,The liver plays an outsized role in oncology .
124740,outsized,O,4350.0,The liver plays an outsized role in oncology .
124741,role,O,4350.0,The liver plays an outsized role in oncology .
124742,in,O,4350.0,The liver plays an outsized role in oncology .
124743,oncology,O,4350.0,The liver plays an outsized role in oncology .
124744,.,O,4350.0,The liver plays an outsized role in oncology .
125126,Diet,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125127,was,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125128,assessed,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125129,by,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125130,a,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125131,validated,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125132,192,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125133,-,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125134,item,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125135,FFQ,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125136,at,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125137,baseline,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125138,.,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125189,Among,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125190,women,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125191,",",O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125192,the,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125193,HR,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125194,for,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125195,MI,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125196,when,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125197,replacing,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125198,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125199,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125200,with,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125201,vegetables,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125202,was,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125203,0·94,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125204,(,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125205,95,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125206,%,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125207,CI,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125208,0·90,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125209,",",O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125210,0·98,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125211,),O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125212,.,O,4368.0,"Among women , the HR for MI when replacing red meat with vegetables was 0·94 ( 95 % CI 0·90 , 0·98 ) ."
125399,There,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125400,are,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125401,several,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125402,varieties,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125403,of,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125404,sorghum,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125405,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125406,whose,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125407,coloration,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125408,varies,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125409,from,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125410,cream,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125411,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125412,lemon,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125413,-,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125414,yellow,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125415,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125416,red,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125417,",",O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125418,and,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125419,even,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125420,black,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125421,.,O,4376.0,"There are several varieties of sorghum , whose coloration varies from cream , lemon - yellow , red , and even black ."
125422,Pigmented,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125423,sorghum,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125424,grain,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125425,is,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125426,a,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125427,rich,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125428,source,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125429,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125430,antioxidants,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125431,like,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125432,polyphenols,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125433,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125434,mainly,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125435,tannins,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125436,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125437,which,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125438,have,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125439,multiple,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125440,benefits,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125441,on,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125442,human,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125443,health,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125444,such,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125445,as,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125446,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125447,antiproliferative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125448,properties,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125449,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125450,with,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125451,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125452,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125453,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125454,certain,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125455,cancers,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125456,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125457,antioxidant,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125458,activities,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125459,related,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125460,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125461,the,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125462,prevention,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125463,of,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125464,associated,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125465,diseases,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125466,to,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125467,oxidative,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125468,stress,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125469,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125470,antimicrobial,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125471,and,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125472,anti,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125473,-,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125474,inflammatory,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125475,effects,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125476,",",O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125477,it,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125478,also,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125479,improves,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125480,glucose,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125481,metabolism,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
125482,.,O,4377.0,"Pigmented sorghum grain is a rich source of antioxidants like polyphenols , mainly tannins , which have multiple benefits on human health such as , antiproliferative properties associated with the prevention of certain cancers , antioxidant activities related to the prevention of associated diseases to oxidative stress , antimicrobial and anti - inflammatory effects , it also improves glucose metabolism ."
126025,We,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126026,identified,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126027,a,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126028,modest,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126029,inverse,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126030,association,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126031,of,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126032,water,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126033,intake,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126034,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126035,odds,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126036,ratio,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126037,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126038,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126039,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126040,0.70,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126041,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126042,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126043,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126044,confidence,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126045,interval,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126046,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126047,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126048,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126049,0.48,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126050,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126051,1.02,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126052,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126053,and,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126054,total,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126055,fluid,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126056,intake,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126057,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126058,high,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126059,vs.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126060,low,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126061,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126062,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126063,0.70,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126064,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126065,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126066,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126067,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126068,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126069,0.46,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126070,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126071,1.06,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126072,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126073,with,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126074,risk,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126075,of,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126076,rectal,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126077,cancer,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126078,in,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126079,men,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126080,and,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126081,a,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126082,positive,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126083,association,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126084,with,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126085,juice,B-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126086,among,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126087,women,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126088,(,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126089,high,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126090,vs.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126091,low,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126092,OR,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126093,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126094,1.56,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126095,;,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126096,95,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126097,%,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126098,CI,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126099,=,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126100,1.00,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126101,",",O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126102,2.41,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126103,),O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126104,.,O,4395.0,"We identified a modest inverse association of water intake ( odds ratio , OR = 0.70 ; 95 % confidence interval , CI = 0.48 , 1.02 ) and total fluid intake ( high vs. low OR = 0.70 ; 95 % CI = 0.46 , 1.06 ) with risk of rectal cancer in men and a positive association with juice among women ( high vs. low OR = 1.56 ; 95 % CI = 1.00 , 2.41 ) ."
126844,Dairy,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126845,foods,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126846,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126847,ice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126848,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126849,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126850,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126851,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126852,other,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126853,meats,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126854,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126855,potatoes,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126856,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126857,pastry,B-http://purl.bioontology.org/ontology/SNOMEDCT/226749001,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126858,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126859,nuts,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126860,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126861,chips,B-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126862,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126863,snacks,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126864,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126865,condiments,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126866,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126867,alcohol,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126868,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126869,soda,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126870,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126871,significantly,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126872,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126873,with,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126874,higher,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126875,total,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126876,intake,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126877,over,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126878,the,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126879,day,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126880,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126881,while,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126882,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126883,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126884,soup,B-http://purl.bioontology.org/ontology/SNOMEDCT/227566009,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126885,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126886,breakfast,B-http://purl.bioontology.org/ontology/SNOMEDCT/226598007;http://purl.bioontology.org/ontology/SNOMEDCT/23182003,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126887,cereal,I-http://purl.bioontology.org/ontology/SNOMEDCT/226598007;http://purl.bioontology.org/ontology/SNOMEDCT/23182003,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126888,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126889,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126890,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126891,pizza,B-http://purl.bioontology.org/ontology/SNOMEDCT/227757007,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126892,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126893,water,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126894,",",O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126895,coffee,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126896,/,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126897,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126898,and,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126899,diet,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126900,soda,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126901,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126902,either,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126903,not,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126904,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126905,or,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126906,were,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126907,associated,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126908,with,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126909,lower,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126910,overall,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126911,intake,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126912,.,O,4416.0,"Dairy foods , ice cream , beef , other meats , potatoes , pastry , nuts , chips and snacks , condiments , alcohol and soda were significantly associated with higher total intake over the day , while fruit , soup , breakfast cereal , pasta , pizza , water , coffee / tea and diet soda were either not associated or were associated with lower overall intake ."
126913,Dietary,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126914,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126915,density,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126916,appeared,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126917,to,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126918,mediate,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126919,the,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126920,associations,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126921,between,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126922,particular,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126923,foods,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126924,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126925,beverages,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126926,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126927,overall,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126928,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126929,intake,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126930,.,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126968,The,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126969,increasing,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126970,prevalence,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126971,of,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126972,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126973,obesity,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126974,is,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126975,a,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126976,serious,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126977,public,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126978,health,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126979,problem,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126980,associated,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126981,with,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126982,co,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126983,-,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126984,morbidities,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126985,in,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126986,adulthood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126987,",",O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126988,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126989,well,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126990,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126991,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126992,.,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
127372,This,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127373,paper,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127374,studied,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127375,the,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127376,possible,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127377,effect,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127378,of,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127379,folic,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127380,acid,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127381,in,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127382,fortified,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127383,Baladi,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127384,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127385,on,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127386,the,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127387,prevention,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127388,of,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127389,colon,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127390,cancer,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127391,development,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127392,in,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127393,rats,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127394,.,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
128645,Chocolate,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128646,today,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128647,is,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128648,often,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128649,viewed,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128650,as,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128651,a,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128652,food,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128653,or,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128654,snack,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128655,with,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128656,little,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128657,nutritional,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128658,value,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128659,.,O,4473.0,Chocolate today is often viewed as a food or snack with little nutritional value .
128741,This,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128742,paper,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128743,demonstrates,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128744,that,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128745,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128746,makes,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128747,a,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128748,significant,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128749,contribution,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128750,to,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128751,U.S.,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128752,per,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128753,capita,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128754,dietary,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128755,antioxidants,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128756,and,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128757,by,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128758,inference,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128759,the,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128760,European,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128761,Community,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128762,'s,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128763,.,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
129298,Multivariate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129299,analyses,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129300,showed,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129301,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129302,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129303,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129304,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129305,consumption,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129306,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129307,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129308,ischemic,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129309,heart,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129310,disease,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129311,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129312,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129313,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129314,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129315,men,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129316,[,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129317,relative,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129318,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129319,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129320,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129321,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129322,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129323,2.31,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129324,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129325,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129326,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129327,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129328,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129329,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129330,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129331,=3,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129332,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129333,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129334,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129335,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129336,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129337,vegetarians,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129338,],O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129339,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129340,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129341,protective,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129342,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129343,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129344,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129345,consumption,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129346,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129347,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129348,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129349,nonfatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129350,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129351,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129352,both,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129353,sexes,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129354,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129355,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129356,approximately,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129357,0.5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129358,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129359,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129360,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129361,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129362,nuts,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129363,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129364,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129365,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129366,5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129367,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129368,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129369,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129370,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129371,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129372,those,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129373,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129374,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129375,nuts,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129376,<,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129377,1,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129378,time,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129379,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129380,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129381,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129382,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129383,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129384,reduced,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129385,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129386,of,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129387,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129388,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129389,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129390,preferring,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129391,whole,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129392,-,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129393,grain,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129394,to,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129395,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129396,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129397,.,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129649,On,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129650,2,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129651,occasions,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129652,separated,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129653,by,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129654,at,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129655,least,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129656,1,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129657,week,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129658,",",O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129659,19,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129660,adults,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129661,(,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129662,including,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129663,7,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129664,adults,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129665,with,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129666,type,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129667,2,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129668,diabetes,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129669,mellitus,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129670,),O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129671,consumed,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129672,a,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129673,standardized,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129674,evening,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129675,meal,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129676,and,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129677,fasted,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129678,overnight,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129679,before,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129680,ingesting,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129681,the,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129682,test,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129683,meal,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129684,(,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129685,bagel,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129686,",",O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129687,juice,B-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129688,",",O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129689,and,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129690,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129691,),O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129692,with,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129693,or,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129694,without,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129695,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129696,.,O,4508.0,"On 2 occasions separated by at least 1 week , 19 adults ( including 7 adults with type 2 diabetes mellitus ) consumed a standardized evening meal and fasted overnight before ingesting the test meal ( bagel , juice , and butter ) with or without almonds ."
129889,Information,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129890,was,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129891,collected,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129892,about,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129893,smoking,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129894,history,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129895,and,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129896,alcohol,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129897,and,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129898,dietary,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129899,intake,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129900,.,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129940,A,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129941,dose,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129942,-,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129943,response,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129944,relationship,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129945,was,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129946,present,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129947,with,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129948,increasing,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129949,amount,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129950,and,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129951,duration,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129952,of,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129953,cigarette,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129954,use,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
129955,.,O,4518.0,A dose - response relationship was present with increasing amount and duration of cigarette use .
130007,In,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130008,contrast,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130009,",",O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130010,the,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130011,risk,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130012,tended,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130013,to,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130014,be,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130015,positively,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130016,associated,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130017,with,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130018,consumption,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130019,of,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130020,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130021,",",O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130022,seaweed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227265009;http://purl.bioontology.org/ontology/SNOMEDCT/82114006,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130023,",",O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130024,tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130025,or,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130026,tsukudani,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130027,(,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130028,a,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130029,mixed,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130030,dish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130031,of,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130032,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130033,",",O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130034,sugar,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130035,",",O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130036,soy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227537006;http://purl.bioontology.org/ontology/SNOMEDCT/227519005,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130037,sauce,I-http://purl.bioontology.org/ontology/SNOMEDCT/227537006;http://purl.bioontology.org/ontology/SNOMEDCT/227519005,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130038,and,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130039,seaweed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227265009;http://purl.bioontology.org/ontology/SNOMEDCT/82114006,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130040,),O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130041,",",O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130042,but,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130043,the,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130044,dose,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130045,-,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130046,response,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130047,relationship,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130048,was,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130049,not,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130050,statistically,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130051,significant,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130052,.,O,4522.0,"In contrast , the risk tended to be positively associated with consumption of rice , seaweed , tofu or tsukudani ( a mixed dish of fish , sugar , soy sauce and seaweed ) , but the dose - response relationship was not statistically significant ."
130092,The,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130093,panel,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130094,of,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130095,food,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130096,products,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130097,tested,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130098,included,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130099,fruits,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130100,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130101,vegetables,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130102,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130103,grains,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130104,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130105,herbs,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130106,and,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130107,spices,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130108,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130109,most,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130110,of,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130111,which,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130112,are,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130113,common,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130114,in,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130115,a,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130116,normal,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130117,European,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130118,-,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130119,style,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130120,diet,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130121,.,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130297,Curry,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130298,and,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130299,paprika,B-http://purl.bioontology.org/ontology/SNOMEDCT/227408005,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130300,produced,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130301,reactions,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130302,most,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130303,frequently,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130304,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130305,and,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130306,when,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130307,the,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130308,components,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130309,of,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130310,curry,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130311,were,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130312,tested,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130313,separately,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130314,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130315,coriander,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130316,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130317,caraway,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130318,",",O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130319,cayenne,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130320,and,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130321,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130322,were,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130323,responsible,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130324,for,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130325,the,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130326,vast,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130327,majority,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130328,of,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130329,the,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130330,skin,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130331,reactions,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
130332,.,O,4532.0,"Curry and paprika produced reactions most frequently , and when the components of curry were tested separately , coriander , caraway , cayenne and mustard were responsible for the vast majority of the skin reactions ."
131260,Cancer,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131261,initiation,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131262,and,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131263,progression,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131264,are,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131265,the,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131266,result,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131267,of,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131268,genetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131269,and/or,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131270,epigenetic,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131271,alterations,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131272,.,O,4562.0,Cancer initiation and progression are the result of genetic and/or epigenetic alterations .
131333,Histone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131334,deacetylase,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131335,inhibitors,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131336,(,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131337,HDACi,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131338,),O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131339,regulate,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131340,the,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131341,activity,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131342,of,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131343,HDACs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131344,and,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131345,are,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131346,being,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131347,used,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131348,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131349,cancer,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131350,treatment,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131351,either,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131352,alone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131353,or,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131354,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131355,combination,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131356,with,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131357,other,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131358,chemotherapeutic,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131359,drugs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131360,/,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131361,radiotherapy,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131362,.,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131774,Bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131775,prepared,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131776,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131777,buckwheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131778,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131779,had,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131780,improved,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131781,quality,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131782,:,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131783,an,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131784,increased,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131785,specific,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131786,volume,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131787,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131788,a,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131789,softer,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131790,texture,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131791,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131792,color,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131793,characteristics,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131794,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131795,and,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131796,gas,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131797,-,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131798,cell,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131799,size,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131800,distribution,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131801,similar,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131802,to,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131803,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131804,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131805,.,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
132025,The,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132026,high,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132027,de,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132028,novo,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132029,diet,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132030,significantly,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132031,increased,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132032,milk,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132033,fat,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132034,percentage,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132035,and,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132036,milk,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132037,content,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132038,of,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132039,fatty,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132040,acids,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132041,with,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132042,chain,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132043,length,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132044,from,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132045,C6,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132046,to,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132047,C16,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132048,",",O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132049,and,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132050,decreased,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132051,content,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132052,of,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132053,C18,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132054,and,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132055,C18:1,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132056,.,O,4589.0,"The high de novo diet significantly increased milk fat percentage and milk content of fatty acids with chain length from C6 to C16 , and decreased content of C18 and C18:1 ."
132191,This,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132192,indicates,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132193,that,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132194,the,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132195,transfer,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132196,of,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132197,fat,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132198,from,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132199,diet,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132200,to,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132201,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132202,might,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132203,facilitate,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132204,transfer,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132205,of,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132206,Zn,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132207,from,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132208,diet,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132209,to,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132210,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132211,.,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132212,Colorectal,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132213,carcinoma,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132214,(,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132215,CRC,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132216,),O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132217,is,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132218,the,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132219,second,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132220,most,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132221,common,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132222,cancer,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132223,diagnosed,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132224,in,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132225,Algeria,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132226,.,O,4596.0,Colorectal carcinoma ( CRC ) is the second most common cancer diagnosed in Algeria .
132227,The,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132228,incidence,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132229,and,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132230,the,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132231,mortality,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132232,rate,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132233,of,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132234,CRC,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132235,have,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132236,increased,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132237,so,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132238,that,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132239,the,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132240,nation,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132241,now,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132242,ranks,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132243,third,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132244,in,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132245,Africa,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132246,in,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132247,both,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132248,these,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132249,variables,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
132250,.,O,4597.0,The incidence and the mortality rate of CRC have increased so that the nation now ranks third in Africa in both these variables .
